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Abstract 
The endosomal system and vesicular carriers derived from it are the membranous correlates 
of intracellular transport and serve as `dynamic platforms' and `vehicles' to sort and dispatch 
cargo and membrane to a variety of sub-cellular destinations. Proper endosomal sorting can 
be accomplished through the cargo's ability to interact with, or to avoid, cargo/destination- 
specific machinery, through retention and partitioning mechanisms. To recruit the sorting 
machinery needed, endosomal-membrane compartments dispose of defined identities that 
serve as binding cues, inter alia provided by phosphoinositides, the phosphorylated 
derivatives of phosphatidylinositol. 
Here, I have investigated the role of members of the phosphoinositide-binding protein 
family of sorting nexins (SNXs) in intracellular sorting and membrane transport processes. 
The prototypical member of this family, SNX1, had originally been implicated in regulating 
receptor traffic to degradative organelles under conditions of its overexpression. Subsequent 
studies of the endogenous protein could however not confirm its pro-degradative role. 
Here, using RNAi technology to selectively suppress SNX1 expression, the role of 
endogenous SNX1 in intracellular transport was re-examined. Using a variety of techniques, 
including live and fixed cell analyses, biochemical approaches and infection assays, I show 
that SNX1 is critically involved in promoting retrograde transport from endosomes to the 
trans-Golgi network of a variety of endogenous and exogenous cargos. This includes the 
cation-independent mannose 6-phosphate receptor, Shiga toxin B subunit and furthermore 
sortilin, which had not been identified as a recycling receptor before. In addition, these 
studies show that SNX1 is involved in remodelling early stages of Salmonella-containing 
vacuoles, exemplifying its capacity as a regulator of membrane transport. 
I have furthermore examined the role of the highly related SNX2 in these processes; I come 
to the conclusion that under the experimental conditions used in this study, its role in 
retrograde transport of the examined cargo is less prominently developed. 
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LL Preface - Intracellular Logistics' 
Logistics, n, pl. 
The organisation of supplies, stores, quarters, etc., necessary for the support of troop movements, 
expeditions, etc. 
(Oxford English Dictionary, 1989,2'd Edition). 
One of the central questions in cell biology is how cells organize and orchestrate 
intracellular transport processes. At any given time, cells receive incoming material at the 
plasma membrane that is `packed' into `carriers' and transported to a given destination. On 
the other hand, intracellularly produced material needs to be delivered to the appropriate 
target organelles. Depending on the cell type, these highly complex interconnected 
processes ensure proper cell function by fulfilling a broad range of tasks, such as uptake 
and delivery of nutrients, secretion of hormones or cell-surface proteins, antimicrobial 
defence and degradation of unwanted material. 
A better understanding of `intracellular logistics' is not only essential to further our 
knowledge about normal cell function, id est `non-disease states', but may also help to 
better understand `disease states' related to defects transport or exploits by extracellular 
pathogens. Thus, this knowledge may ultimately contribute to designing intracellularly- 
targeted therapeutic agents and further our understanding of - and how to interfere with - 
the itineraries of pathogens and toxins inside cells. 
The intracellular correlate of transport is the endosomal system, which appears as sorting 
and dispatching system. It is comprised of a morphological heterogeneous and 
interconnected network of dynamic membranous compartments.. It is emerging that 
endosomal compartments are comprised of highly organised microdomains generated and 
maintained by finely tuned mechanisms to recruit small GTPases, to create lipid 
microdomains and to partition cargo into such subdomains. An immanent problem arising 
from the high turnover and dynamic properties is the accurate description of the system 
when studying it. 
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This thesis is primarily concerned with transport processes from endosomes to the tranc- 
Golgi network and a group of peripheral membrane proteins that are transiently associated 
with endosomes (sorting nexins), members of which have been implicated in regulating 
endosomal sorting. 
The following introduction is aimed at introducing some of the major concepts in 
intracellular sorting; further introduction to the specific subjects can be found at the 
beginning of the individual chapters, or will be introduced where appropriate. 
Main concepts: 
1. `Mosaic-like organisation' of endomembranes, achieved by selective enrichment or 
generation of distinct molecules: high spatial and temporal control for transient, 
but precise targeting of peripheral membrane proteins ensures flexibility with high 
accuracy at the same time 
2. Improved targeting through `cascade effects' and `coincidence detection': to ensure 
transient, but precise targeting, more than one recruitment cue is employed (this 
includes additional protein-protein interactions, additional lipid-binding domains, 
binding enhancement through conformational changes upon recruitment or 
geometry-based targeting) 
3. Sorting is a process consisting of active removal and retention. 
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1.2. Endomembrane Organisation 
For efficient sorting of proteins and lipids the different compartments need to have a 
defined identity. It is now well accepted that compartmentalization already starts at the 
organelle level: proteins (like small GTPases) and lipids appear enriched within distinct 
`sub-organelle' membrane domains, thus creating a `mosaic-like' structure that organises 
endosomal membranes (Gruenberg, 2001; Zerial and McBride, 2001; Miaczynska and 
Zerial, 2002). 
1.2.1. Spatial organisation at lipid 1eve1 
Spatial organisation and compartmental identity can be achieved by selective accumulation 
of lipids in membranes, which can occur at specific sites in the bilayer, as with 
phosphoinositides, or in discrete `patches' or `rafts', as has been proposed for cholesterol 
and sphingolipids. 
1.2.1.1. Poly phosphatidylinositols and their binding modules 
Polyphosphoinositides (PPIn)' are minor constituents of cellular membranes, and while 
PPIn have been implicated in "nearly all aspects of cell physiology" (Di Paolo and De 
Camilli, 2006), in this thesis I have mostly concentrated on their role in intracellular 
trafficking. As lipids, they appear as ideal cues to organize endomembrane identity as they 
are partitioned into bilayers, and hence often restricted to the site of their generation, while 
within the bilayer they can rapidly diffuse. Furthermore, they can be rapidly generated and 
decomposed and can be interconverted [see (Di Paolo and De Camilli, 2006) for a recent 
review]. 
The `backbone' for the PPIn family of eight members is phosphatidylinositol (PtdIns), 
which consists of a myo-inositol-1-phosphate head group coupled, almost exclusively, to 1- 
stearoyl 2-arachidonoyl diacylglycerol (DAG) via a phosphodiester bond (Figure 1.1). The 
lipophilic `tail' allows PPIn to partition into the inner leaflet of cellular membranes leaving 
its charged sugar head group exposed to the cytosol. This inositol can be phosphorylated 
in 3-, 4- or 5-position through the actions of site-specific lipid kinases or phosphatases, 
giving rise to a total of seven derivates of Ptdlns (see Figure 1.1 and (De Matteis and 
Godi, 2004) for review). 
I The nomenclature for phosphoinositides in this thesis was adopted as outlined by Michell, Heath, Lemmon 
and Dove (Michel et aL, 2006); see also http: //www. chem. qmul. ac. uk/iupac/misc/phos2t8. html#t4 
and http: //www. chem. qmul. ac. uk/iupac/cyclitol/myo. html 
3 
Chapter 1- Introduction 
R R' R R' 
O 
2H 
;; ýH 9>1 
O 









. 0- Hp 
01 = off 




OH 4 OH 
" Phosphate Group 
Ptdlns5P Ptd1ns(4,5)P, 
1: P13-kinase Type II PI 3-kinase-C2 a (Golgi, endosomes; 13 (PM); y (Golgi) 
PI 3-kinase (Type III (Vps34) (Golgi, endosomes) 
2: PI3P 5-kinase PlKfyve (endosomes) 
3: P14-kinase IIa (Golgi, endosomes); II(3 (Golgi, PM); IIIa (ER, Golgi); HIP (Golgi, Nu) 
4: PI4P 3-kinase Type II PI 3-kinase-C2 a (Golgi, endosomes); 0 (PM); y (Golgi) 
5: PI4P 5-kinase PIP5Ka, (3, y (PM) 
6: P15-kinase PlKftve (endosomes) 
7: PI5P 4-kinase PIP4Ka, ß (PM); y (ER) 
8: PI 3-kinase Type 1 a, (3, y (PM, nucleus) 
9: PI4P 5-kinase PIP5Ka, (i, y (PM) 
10: PI3P 4-kinase PIP4Ka, (3 (PM), y (ER) 
A: PI3P 3-phosphatase M M1 (1v1); MTMR1-8 (PM, and not determined) 
B: PI4P 4-phosphatase Synaptojanin 1,2 (clathrin-coated vesicles, mitochondria), Sacl (Golgi, ER) 
C: PI(3,4)P2 3-phosphatase PTEN 1,2 (PM1, Golgi, nucleus) 
D: PI(3,4,5)P3 5-phosphatase SIIIP 1,2 (PM, nucleus) 
E: PI(4,5)P2 5-phosphatase 5-phosphatase II (not determined); OCRI. (Golgi, endosomes, lysosomes) 
Synaptojanin (synaptic vesicles, mitochondria) 
F: PI(3,4,5)P3 3-phosphatase PTEN I, II -(PM, Golgi, nucleus) 
G: PI(3,4)P2 4-phosphatase Type I, II 4-phosphatase (not determined) 
H: PI(3,5)P2 3-phosphatase NM fRI-8 (not determined) 
Figure 1.1 Phosphoinositide metabolism in mammalian cells. 
Reversible phosphorylation of the inositol ring of phosphatidylinositol (Ptdlns) either singly or 
multiply at the 3-, 4- or 5- positions yields the phosphoinositides above. Arrows indicate the 
possible phosphorylations (numbers) and dephosphorylations (letters). Reactions indicated with 
grey/dotted arrows are unconfirmed in vivo, or have been shown in vitro, but their importance in 
living cells remains unclear. PM: plasma membrane; ER: endoplasmic reticulum; Nu: nucleus. 
Compiled and adapted from Hughes et al., 2000; Stephens et al., 2000; Cullen et al., 2001; De 
Matteis and Godi, 2004; Di Paolo and De Camilli, 2006. 
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Given that most of these kinases and phosphatases are targeted to specific subcellular 
compartments (compare Figure 1.1), PPIn are generally found on only a restricted subset 
of organelles. Peripheral membrane proteins can be localized to these PPln by means of 
various protein modules (Table 1.1). These modules function to ligate the PPln head 
groups with varying degrees of affinity. While some modules, such as the as the pleckstrin 
homology (PH) domain of the general receptorforpho. cphoinositides-1 (Grpl), show affinities in 
the nanomolar range (Ferguson et al., 2000; Lietzke et al., 2000), other motifs ligate PPIn 
with micromolar affinities, thus ensuring rapid and reversible binding (Cullen et al., 2001). 
Often, increase in membrane binding capacity is achieved by protein oligomerization 
(Lemmon, 2003), or mediated through additional motifs within the protein sequence (see 
also below). Intriguingly, most PPln kinases and phosphatases are peripheral membrane 
proteins themselves, and as such recruited by certain cues, including PPln (like PlKfyve 
which binds PtdIns3P via its FYVE domain; see Shisheva et al., 2001). In some cases, 
localization cues may even provide activation cues, like endosomal Class III PI 3-kinase 
that is localized and activated upon binding to GTP-Rab5 (Christoforidis et al., 1999). 
PtdIns3P on endosomes and Ptdlns(4,5)P2 at the plasma membrane are probably by far 
the best characterized PPIn with regard to endomembrane organization. Ptdlns3P is 
present on the limiting membranes of early endosomes and on internal vesicles of 
multivesicular bodies (MVB) (Gillooly et al., 2000) and is recognized by a wide variety of 
peripheral membrane proteins by means of different Ptdlns3P-ligating domains. Most 
commonly, these proteins contain FYVE- or PX-domains (Xu et al., 2001c; Lemmon, 
2003; Birkeland and Stenmark, 2004). 
The FYVE domain - multiple cues 
The FYVE domain, named after proteins it was originally identified in (Fab1p, YOTB, 
Vaclp and EEA1), exclusively ligates Ptdlns3P (Gaullier et al., 1998; Patki et al., 1998). It 
is responsible for the localization of the early endosome antigen-1 (EEA1) (Stenmark et 
al., 1996), a protein involved in homo- and heterotypic fusion of early endosomal 
compartments. Additionally to the lipid cue, its ability to dimerize (Dumas et al., 2001) as 
well as binding to the small GTPase Rab5 (Lawe et al., 2000; Lawe et al., 2002) ensures 
effective recruitment to endosomal membranes. Hrs, another FYVE-domain containing 
protein, is involved in later events of endosomal processes and regulates sorting of cargo 
destined for degradation into MVBs. Importantly, it also provides an example how 
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transport and sorting can be uncoupled: while the sorting step of activated EGF receptors 
is dependent on PtdIns3P, the `core' of endosome formation appears independent of 
PtdIns3P (Petiot et al., 2003). 
The PX domain - multiple PPIns 
Another PtdIns3P-ligating motif, the phox homology (PX) domain was originally 
identified as a conserved module in the p40phox and p47phox subunits of the phagocytic 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (phox) complex 
(Ponting, 1996; Kanai et al., 2001). It is now clear that PX domains can be found in a wide 
range of proteins involved in transduction pathways and intracellular trafficking, including 
phosphatidylinositol 3-phosphate kinases (P13-kinases), phospholipases, and, of particular 
interest in this study, sorting nexins (see also Table 1.1). While a subset of PX domains 
solely binds to PtdIns3P, as do all yeast PX domain identified so far (Yu and Lemmon, 
2001), PX domains of mammalian sorting nexins bind to a variety of PPIn, but with a bias 
toward 3-phosphoinositides (Worby and Dixon, 2002; Carlton et al., 2005a). 
Interactions of PX domains with membranes are likely to be determined by a combination 
of electrostatic interactions with the bilayer, and structurally, likely to include insertions of 
hydrophobic loops into the membrane (Stahelin et al., 2003). 
Module Specificity example of proteins 
ENTH Ptdlns4P epsinR 
Ptdlns(3,5)P2 Ent3, Ent5, HIP1 
Ptdlns(4,5)P2 AP180, epsin-1 




Ptdlns(4,5)P2 class II P13 kinase 
Ptdlns(3,4,5)P3 CISK 
FYVE Ptdlns3P EEAI, Hrs, PlKfyve 
GRAM Ptdlns(3,5)P2 Myotubularins 
PH PtdIns4P FAPPl /2 
Ptdlns(3,4)P2 Akt/PKB 
Ptdlns(4,5)P2 PLC81, dynamin 
PtdIns 3,4,5 P3 Btk, Akt/PKB, ARNO, Grpl 
Shown are examples of 
phosphoinositides and 
identified -binding 
motifs. Binding is in most 
cases not restricted to one 
PPIn (see SNXI, which 
binds to Ptdlns3P and 
Ptdlns(3,5)P2), but not all 
binding partners are 
indicated in all cases. 
Adapted from Di Paolo 
and De Camilli, 2006. 
Table 1.1 Phosphoinositides and their binding modules in some example 
proteins 
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It is noteworthy that most PX domains ligate PPIns with relatively low (micromolar) 
affinities. Given that many PX domain-containing proteins also contain additional 
domains such as PH domains (PLD1 and PLD2), or SH3 domains (SNX9, SNX18, 
p40phox and p47phox), or GTPase interacting domains like SNX13, SNX14, SNX25 or 
SNX27 [reviewed (Xu et al., 2001c)], it is likely that correct membrane targeting of PX 
domain-containing proteins arises due to oligomerization, or with aid of more than one 
domain. 
Epsins and the ENTH domain - multiple destinations 
Until recently, the ENTH domain was thought to specifically interact with 4- 
phosphoinositides. It was first identified in epsin-1, and its homologues AP180 and 
CALM, and shown to specifically bind to Ptdlns(4,5)P2 (Ford et al., 2001; Itoh et al., 
2001). Ptdlns(4,5)P2 is enriched in the inner leaflet of the plasma membrane and 
concentrated into specialized domains (see McLaughlin et al., 2004; McLaughlin and 
Murray, 2005 for review). Here, at regions of endocytosis, it serves to co-ordinate the 
internalization process; consistent with the ability of AP180 and epsin-1 to bind to clathrin 
and the AP-2 complex, these PtdIns(4,5)P2-binding ENTH domain-containing proteins 
are found in the invagination regions at the plasma membrane. Further still, dependent 
upon their binding to Ptdlns(4,5)P2, AP180 and epsin-1 polymerize flat clathrin lattices, 
while epsin-1 is furthermore capable of physically deforming Ptdlns(4,5)P2-enriched 
membranes (Ford et al., 2001; Ford et al., 2002). 
The ENTH domain of epsinR, which is related to epsin-1, has been shown to bind to 
Ptdlns4P (Hirst et al., 2003), a PPIn found at the Golgi/frans-Golgi network (Wang et al., 
2003; Godi et al., 2004). In contrast, the ENTH domain of the yeast epsin orthologues, 
Ent3 and Ent5 (Friant et al., 2003; Eugster et al., 2004), which are localized to the vacuoles 
and associated membranes, have been shown to bind all PtdlnsP2 isomers with relatively 
low affinity (KD > 3µM) (Michell et al., 2006). In these cases, their function appears to be 
in regulating traffic at endosomes and the trans-Golgi network. Thus, the ENTH domain 
constitutes a further PPIn-binding module that is active at a number of subcellular 
destinations. 
Ptdlns(3,5)P2 - new kid on the block 
The exact role and sub-cellular localization of PtdIns(3,5)P2 in mammalian cells is currently 
being unraveled. So far, no mammalian protein has been identified that solely ligates this 
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PPIn making it difficult to discriminate its exact sub-cellular targeting. Based on the 
localization of PlKfyve, the kinase generating Ptdlns(3,5)P2, it has often been quoted as a 
late endosomal PPIn (Shisheva et al., 2001). It is now well accepted however that the 
FYVE-domain containing PlKfyve localizes in most cell types to an early, rather than a 
late endosomal compartment (Cooke, 2002; Rutherford et al., 2006). Lack of 
PtdIns(3,5)P2generating kinases (PlKfyve in mammals, Fabl in yeast) causes grossly 
enlarged vacuoles as common phenotypes, suggesting that Ptdlns(3,5)P2 is needed for 
membrane homeostasis (Michell et al., 2006). Likewise, lack of effector proteins can cause 
a similar phenotype: in yeast, Svp18/Atg18 is a specific and high-affinity PtdIns(3,5)P2- 
binding protein that has been localized to the limiting membranes of vacuoles and 
participates in retrograde membrane traffic (Dove et al., 2004). Evidence for a role of 
Ptdlns(3,5)P2 in mammalian retrograde pathways comes from the recent identification of 
the WD40 repeat protein interacting with phosphoinositides of 49kDa (WIPI49), renamed 
to PROPPIN-1 (Michell et al., 2006), a protein involved in endosome-to-TGN retrieval of 
the CI-MPR (Jeffries et al., 2004). PROPPINs is the proposed new name for a family of 
proteins found encoded for in almost all eukaryotic genomes, containing WD40-repeat- 
based seven bladed n-propeller(s) that bind PPIn. This includes Atg18 (see above), which 
is one of three yeast PROPPINs (Michell et al., 2006). 
PtdIns(3,4)P2 and PtdIns(3,4,5)P3 - the second messengers 
Ptdlns(3,4)P2 and Ptdlns(3,4,5)P3 are second messengers, hence generated in acute 
response to external signals. Localized production of PtdIns(3,4,5)P3 from plasma 
membrane-localized PtdIns(4,5)P2 occurs downstream of receptor activation through 
activation of class I PI 3-kinase (Stephens, 2000). Ptdlns(3,4,5)P3 is known to recruit a 
number of signalling molecules of the Akt/PKB pathways and thus to activate signalling 
cascades involved the mitogenic and cellular survival pathways (Brazil and Hemmings, 
2001). Further still, it is involved in re-localizing and activating proteins involved in 
cytoskeletal rearrangements, including a number of RacGEFs (Han et al., 1998; Nimnual 
et al., 1998). A definitive physiological role for Ptdlns(3,4)P2 is as yet to be assigned, 
although it is thought to regulate mitogenic stimuli, similar to the proposed role of 
Ptdlns(3,4,5)P3. Notably, many PH domains that bind Ptdlns(3,4,5)P3 also bind 
Ptdlns(3,4)P2, for example, DAPP1 (Dowler et al., 1999) and PKB (Frech et al., 1997), 
thus proteins that are responsive to PI 3-kinase activation at the plasma membrane may be 
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recruited and thus activated dependent upon relative levels of Ptdlns(3,4)P2 and 
Ptdlns(3,4,5)P3, and their ability to bind these lipids. 
1.2.1.2. Lipid rafts 
The finding that glycosylphosphatidylinositol (GPI)-anchored proteins, certain glycolipids, 
sphingomyelin and cholesterol persist, and are enriched in, membrane fractions after non- 
ionic detergent extraction, was a first evidence that lipids and sterols do not 
heterogeneously mix, but form distinct microdomains in the plane of the bilayer (Brown 
and Rose, 1992). The general concept of `rafts' is now well established: lateral membrane 
heterogeneity emerges as requirement of biological membranes; the exact nature remains 
notoriously debated (see Munro, 2003 for review), as it proves technically very challenging 
to study `nanoscale ordered lipids' From a biophysical view, microdomain formation is a 
function of both, the chain length and degree of saturation of the hydrocarbon tails for 
each lipid species. It appears that saturated, long-chain lipids are more tightly packed and 
thus their rotational mobility within the hydrophobic region of the bilayer is decreased 
compared to unsaturated, short-chain lipids. Phase separation can be observed at 
physiological temperatures as long-chain, saturated lipids display gel-like properties (! o 
phase) while unsaturated species are more fluid (Id phase). These membrane 1a 
microdomains, or `rafts' are primarily composed of cholesterol and highly ordered 
saturated glycosphingolipids [see (Jacobson et at., 2007) for a recent review]. 
Rafts are generally viewed as dynamic assemblies of cholesterol and sphingolipids that 
form in the exoplasmic leaflet of cellular membranes (Simons and Ikonen, 1997; Brown 
and London, 1998). These structures selectively incorporate - or exclude - proteins and 
thereby form `dynamic platforms' for selective interactions. It is emerging that rafts do not 
only play important roles in sorting and vesicle formation, but also vesicle movement and 
cytoskeletal interactions, as well as docking and fusion events (Ikonen, 2001). Of wider 
interest for this study in the finding that lipid rafts also affect trafficking between 
endosomes and the TGN, as exemplified by the endosome-to-TGN transport defects in 
cholesterol storage diseases, like Niemann-Pick disease type C (NPC) (Mukherjee and 
Maxfield, 2004). There is also strong indication that receptor-binding of toxins, such as 
cholera toxin (CTx), correlates with its transport to the ER The relationship between rafts 
and toxin traffic has been most well studied for CTx as its cellular receptor, the ganglioside 
GM1, strongly partitions into rafts and is often used as `bona fide' raft marker. Nevertheless, 
CTx endocytosis depends on both, clathrin-dependent and -independent mechanisms and 
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it appears that all forms of endocytosis identified so far may allow for CTx access to the 
Golgi/ER [(Orlandi and Fishman, 1998; Torgersen et al., 2001; Massol et al., 2004; 
Kirkham et al., 2005); see also below]. 
1.2.2. Spatial organisation at protein level - small Bab GTPases 
Members of the Ras superfamily also emerge as regulators of membrane organisation: this 
prominently includes members of the family of Rab GTPases, and the Arf and Arl family. 
GTPases act as molecular switches that alternate between an activated, GTP-bound form 
and an inactive GDP-bound form. While in its active form, the GTPase becomes 
associated with membranes, the conformational changes associated with GTP-hydrolysis 
render the protein cytosolic (Vetter and Wittinghofer, 2001). The activation and 
inactivation cycle of these GTPases is governed by a number of regulatory proteins, which: 
keep the protein in its inactive form to prevent random association with membranes 
(GDP-dissociation inhibitor, GDI); which allow association with membranes by displacing 
GDIs (GDI displacement factor, GDF); which allow activation of the GTPase by aiding 
replacement of the GDP by GTP (guanine nucleotide exchange factor, GEF); which 
enhance the intrinsically low GTPase activity of the GTPase (GTPase activating protein, 
GAP). 
Rab GTPases create unique `Rab domains' on endosomal organelles, which serve to recruit 
distinct effector proteins, including peripheral membrane proteins and motors, and hence 
can regulate sorting to distinct destinations from these organelles (Zerial and McBride, 
2001). As schematically illustrated in Figure 1.2, GTP-bound active Rab proteins each 
associate with different membranous compartments within the endosomal system. 
Different Rab proteins are also seen to segregate into different regions of the same 
endosomal compartment. While Rab4, Rab5 and Rab11 are all present on the membranes 
of early endosomes, they each occupy a separate area of membrane as revealed by 
fluorescence microscopy, (Sonnichsen et al., 2000). The partitioning into separate 
subdomains also reflects the different functional roles of these Rab proteins: while, 
simplified, RabS covers the vesicular portion and recruits effectors regulating early 
endosome fusion, Rab4 is required for transport form the sorting endosome to the plasma 
membrane (van der Sluijs et al., 1992), and Rab11 for recycling of cargo from the sorting 
endosome and via the recycling endosome (Ullrich et al., 1996; Ren et al., 1998). 
Communication between the separate Rab domains is mediated by divalent Rab effectors 
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(de Renzis et al., 2002). Localization of and via Rabs also imparts temporal control, being 
activated by GTP exchange, and there is much evidence now to suggest that exact spatio- 
temporal targeting of Rabs is governed by the proteins regulating the GTP/GDP cycle of 
these Rabs. In this light, GEFs are peripheral membrane proteins and localized only to a 
specific set of organelles, thus amplifying the specificity and targeting [see (Behnia and 
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Figure 1.2 Rab GTPases in the endosomal system 
Crosstalk 
Rabs and PPIn are cross-regulated and interconnected. For example, the presence of 
PtdIns3P is intimately linked to the presence of Rabs: On one hand, VPS34, the kinase 
that generates most PtdIns3P in the cell, is a direct Rab effector, meaning that synthesis of 
PtdIns3P is regulated by Rab5 (Shin et al., 2005). On the other hand, Rab effectors contain 
FYVE domain, which bind to PtdIns3P (see above). 
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1.2.3. Membrane tubules and their deformation by proteins 
`Membrane geometry' might be, in a wider sense, regarded as another aspect of membrane 
organization. Endocytic organelles exhibit a complex morphological organisation and are 
characterised by vacuolar and tubular elements. Geometry-based sorting through narrow- 
diameter tubules is the predominant way in the sorting endosome to remove recycled 
membrane from soluble cargo of endosomal vacuoles [(Dunn et al., 1989; Mayor et al., 
1993), reviewed in Maxfield and McGraw, 2004]: narrow diameter membrane tubules 
exhibit a high surface area-to-volume ratio and thus will more efficiently partition 
membrane bound proteins (receptors), than soluble content. Tubulation events are known 
to occur a number of times during an endosome's lifespan, improving the efficiency of 
recycling from the sorting endosome to greater than 99% (Mayor et al., 1993). Hence, 
through iterative, tubular-based, geometric sorting, membranous tubules can efficiently 
remove membrane bound content from the sorting endosomal body. 
To form endosomal tubules (but also at the plasma membrane and at the TGN) vacuolar 
membranes need to be deformed. While lipid composition will determine its fluidity or 
rigidity, proteins are critically involved in aiding the deformation processes. It now seems 
that clathrin polymerisation alone is insufficient to induce membrane deformation (Nossal, 
2001). Mechanistically, protein oligomerization and deformation according to the bilayer 
couple hypothesis have been proposed as mechanisms of inducing deformation. 
Oligomerization of certain proteins such as endophilin or amphiphysin is thought to 
physically deform the bilayer by forming a 3-dimensional structure that conveys rigidity, 
which is capable of deforming the `elastic' membrane. Membrane deformation according 
to the bilayer couple hypothesis describes the effects when inserting an amphipathic helix 
into a one leaflet of the bilayer. This has the effect of forcing the opposing leaflet to 
deform in a concave manner to maintain hydrophobic and van der Waals forces between 
the monolayers, and hence, will result in induce membrane deformation [see (Farsad and 
De Camilli, 2003) for review]. 
Again, the ENTH domain of epsin-1 may serve as an example: while given its 
Ptdlns(4,5)P2-binding capacity (Itoh et al., 2001), it serves to recruit epsin-1 to the plasma 
membrane, subsequent studies have shown that upon Ptdlns(4,5)P2 ligation, 
conformational changes result in the insertion of an amino-terminal amphipathic a-helix 
(helix-0) into the bilayer resulting in membrane bending (Ford et at, 2002). 
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BAR domain 
A recently discovered motif that, at least in some cases, mediates membrane tubulation is 
the BAR domain, named after the proteins it was first discovered in 
(Bin/amphiphysin/Rvs). The BAR domain can sense curvature, meaning that some BAR- 
containing proteins will only associate with liposomes of appropriate diameter, and in 
other cases, BAR domain-containing proteins are able to deform membranes. So far, BAR 
domains have been found in a variety of proteins including amphiphysins, centaurins, 
endophilins, nandrins, oligophrenins, and sorting nexins (Habermann, 2004; Peter et al., 
2004). The domain spans approximately 250 amino acids, with highly charged regions, 
which folds into a kinked tripartite a-helix. Upon dimerization, these coiled-coil regions 
can form crescent shaped structures. The positively charged concave surface then allows 
binding to oppositely charged curved membrane surfaces. A subset of BAR domains also 
contains an amino-terminal amphipathic a-helix (the N-BAR helix), and it appears that 
these proteins are able to directly impose curvature upon membranes (Habermann, 2004; 
Peter et al., 2004). Mechanistically, a protein will induce curvature if the energetic 
stabilization upon binding to a curved surface over a flat surface is sufficient to overcome 
the energy required to deform the membrane. Biophysical calculations have shown, that 
for amphiphysin, the rigidity of the BAR domain and its charge alone are sufficient to 
overcome the membrane elastic modulus. Hence, the membrane can be deformed by the 
electrostatics between BAR domain and membrane (Zimmerberg and McLaughlin, 2004). 
While BAR-domains are dimerization and membrane curvature sensors, most of the 
proteins with this domain also dispose other membrane-binding modules, such as PH 
domains (in oligophrenins and centaurins) or PX domains (in sorting nexins). Likewise, 
BAR-domains are often found adjacent to small GTPase-binding, or regulatory domains, 
such as RhoGAP, ArfGAP or ArfGEF domains (Habermann, 2004). Hence, a `tandem 
structure' may regulate the correct sub-localization, or even influence the activation state 
of small GTPases at specific subcellular localizations, especially as the BAR domain can 
function as a small G-protein binding module (Habermann, 2004; Peter et al., 2004). 
Interestingly, a number of Arf-GTPase regulators (Centaurinj3, arfaptin) contain BAR 
domains and may thus localise the GTPase to sites of high curvature (Lee and Schekman, 
2004; Peter et at, 2004). ArfGAP1 itself contains an ALPS (ArfGapl lipid-packing sensor) 
motif. Like Bar domains, this motif responds to lipid curvature and it is necessary for 
coupling ArfGAP1 activity with membrane curvature (Bigay et al., 2003; Bigay et al., 2005). 
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1.3. The Endosomal System 
The following paragraphs will give an overview over the endosomal system: the ways to 
enter it, the itineraries, the cargo and machinery associated with it that is most relevant to 
this thesis (for an overview, see Figure 1.3). 
While a `categorical description' of `early' and `late' endosome is often used, these refer to 
morphological most disparate characteristics of these organelles. However, within these 
categories a gradual change, or maturation is observed (see also below for discussion on 
maturation). Indeed, as proposed by Hopkins in 1990 (Hopkins et al., 1990), or more 
recently by Bonifacino and colleagues (Bonifacino and Rojas, 2006), the early endosome 
might morphologically be best described as a `continuous reticulum', or more functionally 
as `tubular sorting endosome', with various proteins associating with spatially distinct 
domains at different times to mediate differential sorting of cargo, and to allow for 
budding from these compartments and fusion events with other organelles. 
1.3.1. Endocytosis 
So how do molecules enter the sorting network? The classical concept that clathrin- 
mediated endocytosis (CME) provides the common mechanism for a variety of cargo has 
now been replaced by a picture where different molecules may utilize distinct entry 
mechanisms. Likewise, even when using the - nominally - same way of entry, 
different 
receptors may display dissimilar requirements for accessory and scaffolding proteins; for 
example, internalization of transferrin receptors (TfR) was shown to require both, clathrin 
and its adaptor AP-2, while epidermal growth factor receptors (EGFR) and low density 
lipoprotein receptors (LDLR) require clathrin but not AP-2 (Motley et al., 2003). 
Moreover, in some cases - especially for toxins - it appears that one given molecule may 
use more than one way of entering the cell, further adding on to the high complexity. 
1.3.1.1. Macropinocytosis 
Stimulation of cells with growth factors, such as EGF, induces actin-driven formation of 
plasma membrane ruffles that, upon contact with other membrane tips, will backfuse. In 
this process, extracellular liquid will become encapsulated in macropinosomes, which thus 
provides a route for non-selective endocytosis of solute macro-molecules (Swanson and 
Watts, 1995). Macropinosomes are heterogeneous in size and can be as large as 5 pm in 
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Macropino- 2. Phagocytosis 
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Figure 1.3 The Endosomal System - some biosynthetic and retrograde routes. 
Various endo- and exocytic routes and the endosomal network are depicted. For each itinerary a 
model cargo is shown. Some cargos might take more than one route. CLIC = non-clathrin, non- 
caveolae; GEEC = GPI-anchored protein-enriched earl), endosomal compartment; SE (EE) _ 
sorting endosomes, also referred to as early endosomes (dashed line indicates maturation, and 
centripetal transport); RE (EE) = recycling endosomes; SCV = Salmonella-containing vacuole 
(broadly speaking, early SCVs resemble SEs, late SCVs resemble LEs); LE = late endosome; TGIF 
= trans-Golgi network; ER = endoplasmic reticulum. CTx = cholera toxin; STx = Shiga toxin. 
Refer also to text for details. Adapted and modified from Perret et al., 2005. 
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diameter; these vesicles can recycle back to the cell surface or will shrink by loss of water, 
but will also fuse with endosomal compartments by homo- and heterotypic fusion. Like 
endosomes, they will mature and eventually, these compartments fuse with lysosomes. As 
the ruffling process is regulated, it has been exploited by some pathogenic bacteria as a 
route of entry (see also para. 1.3.2. ). Pathogens, like Salmonella Typhimurium will actively 
modulate the host cell's cytoskeleton to evoke uptake into epithelial cells and convert its 
phosphoinositide metabolism to promote intracellular progress and replication [see 
(Pizarro-Cerda and Cossart, 2004) for review; Chapter 5 will discuss these aspects in more 
detail]. 
1.3.1.2 Phagocytosis 
Professional phagocytic cells, such as macrophages but also neutrophils and monocytes 
engulf extracellular debris and pathogens by phagocytosis [see (Gruenberg and van der 
Goot, 2006) for review on pathogen entry] In brief, this process resembles 
macropinocytosis in that cytoskeletal rearrangements lead to membrane ruffling, which in 
the process leads to engulfment of the particles. After uptake, the phagosomes interact , 
inter alia with recycling endosomes (RE) and sorting endosomes (SE) (Desjardins, 2003). 
Interactions with lysosomes lead to creation of the degradative phago-lysosome in which 
pathogens are degraded (Desjardins et al., 2005). 
1.3.1.3. Clathrinmediated endocytosis 
Clathrin-mediated endocytosis is by far the most well studied entry pathway into cells. In 
their seminal paper of 1964, Roth and Porter first described "coated pits" at the plasma 
membrane of oocytes of the mosquito Aedes aeDpti (Roth and Porter, 1964). The 
observations made, visualized using thin-section electron microscopy (EM), lead them to 
propose that coated pits are membrane-invaginations that can pinch off from the plasma 
membrane to form coated vesicles, which following internalization, would uncoat to 
deliver their cargo to an intracellular target. Although 40 years ago the components of the 
coat were unknown, this study already described the crucial features of the process. For a 
more recent view on this topic see for example (Slepnev et al., 2000; Brodsky et al., 2001; 
Perrais and Merrifield, 2005). 
16 
Chapter 1- Introduction 
1.3.1.4. Non-clathrin, non-caveolae endocytosis, CI. IC 
One way to internalize proteins associated with lipid receptors, for example cholera toxin 
and its receptor GM1, or GPI-anchored proteins, is thought to occur via through raft-like, 
0 (diameter) 40 - 50 nm structures in a mechanism independent of clathrin and caveolin 
(see par 1.3.1.5), leading to what has been termed GPI-anchored protein-enriched early 
endosomal compartments (GEEC) (Sabharanjak et al., 2002; Kirkham et al., 2005; Kalia et 
al., 2006). These GEECs are initially negative for Rab5, and EEA1, but subsequently 
acquire these proteins and are thus competent to fuse with endosomes containing cargo 
from the clathrin-dependent endocytic pathway (Kalia et al., 2006). From ultrastructural 
studies using murine embryonic fibroblasts (EF) lacking caveolin, it appears that about 
50% of CTx enters the cells in this cholesterol-sensitive, non-caveolae, non-clathrin- 
dependent pathway (Kirkham et al., 2005). Besides caveolin, flotillin-1 has been implicated 
in clathrin-independent endocytosis. While flotillin-1 is expressed in cells that lack caveolae 
and caveolins, the exact relationship between caveolins and flotillins is not clear (Ia. ng et 
al., 1998; Santamaria et al., 2005). Flotillin-1 resides in specific subpopulation of endocytic 
intermediates defines a clathrin-independent endocytic pathway in mammalian cells. It has 
been shown that in cells depleted of flotillin-1 using siRNA, uptake of CTx and GPI- 
linked proteins is inhibited (Glebov et al., 2006). Intriguingly, coassembly of flotillin-1 and 
the related flotillin-2 into microdomains is sufficient to induce membrane curvature and 
formation of plasma-membrane invaginitations and the accumulation intracellular vesicles 
(Frick et al., 2007). This finding strongly suggests that flotillin proteins are defining 
structural components of the machinery that mediates a clathrin-independent endocytic 
pathway. 
1.3.1.5. Caveolaemediated endocytosis and caveosomes 
Caveolae are lipid raft-enriched, flask-shaped, caveolin-containing membrane invaginations 
that have been described for many cell types (Anderson, 1998). Caveolae serve as 
`anchored' multifunctional platforms for stimulated internalisation: caveolae are now 
thought to be relatively immobile organelles that do not partake in constitutive, endocytic 
uptake (Thomsen et al., 2002). Based on morphological studies, CTx has been proposed to 
be internalised via caveolae (Tran et al., 1987; Parton, 1994). It has however also been 
noted that the use of different cell lines and tools pose difficulties in comparing the 
relevance of the different entry mechanisms for this toxin. Exemplary for this, a recent 
study found that the mechanism of entry of a fluorescently-labelled CTxB probe was 
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directly dependent on the respective levels of cellular caveolin. While in cells displaying 
high levels of caveolin, uptake was found to be clathrin-independent, it was found to be 
dependent on clathrin in cells with low caveolin (Singh et al., 2003). And while CTx has 
been found in caveosomes, an intracellular, caveolin-1 positive membrane-bounded 
structure (Pelkmans et al., 2001), it appears possible that CTx can enter a caveolin- 
containing compartment after entry by caveolae-independent mechanisms: indeed, it 
appears that all forms of endocytosis identified so far may allow for CTx access to the 
Golgi/ER [(Orlandi and Fishman, 1998; Torgersen et al., 2001; Massol et al., 2004; 
Kirkham et al., 2005) see Kirkham et al., for a comparative study]. Interestingly, GM1- 
binding simian virus-40 (SV40) is transported differently to CTx: SV40 must reach the ER 
to infect the host cell and given the same receptor, somewhat expectedly, both are 
dependent on lipid rafts. However, there appear to be clear differences between the two. 
While CTx and SV40 can both enter cells using caveolae and move together to the 
caveosome, they subsequently partition away from each other. Whilst SV40 appears to be 
directly transported to the ER in separate vesicles, CTx reaches the Golgi (Pelkmans et al., 
2004). In any case, this pathway appears to avoid the degradative endosomal-lysomal route 
(Pelkmans et al., 2001). 
For completeness, the exotoxin of Shigella djsenteriae, STx, can also enter cells by both, 
clathrin-dependent and -independent mechanisms, and entry depends on binding to 
its 
glycolipid receptor, the globoside Gb3. Thus, like CTx, STx is sorted by lipids rather than 
proteins, and it has been proposed that the heterogeneity of the ceramide domains 
(Degroote et al., 2004) may ultimately influence their intracellular itinerary (Lencer and 
Saslowsky, 2005). Potentially, the CTx- and STx-induced clustering of their respective 
receptors might also contribute to their endocytosis and trafficking properties (see also 
Chapter 4). 
1.3.2. Endosomal Transport Routes 
After uptake from the plasma membrane, the first discernible organelles most cargo is 
delivered to, are early/sorting endosomes, which however also receive input from the 
TGN. Receptors like the transferrin receptor (TfR) and EFGR are internalized by CME 
into these highly fusogenic organelles whose ability to fuse with incident endocytic 
material and pre-existing sorting endosomes is regulated by Rab5 and EEA1 (Lawe et al., 
2000; Lawe et al., 2002). Here, the receptors will segregate from their ligands due to the 
more acidic environment created through action of the V. H+-ATPase (Yoshimori et al., 
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1991; van Weert et al., 1995). The major part of actively signalling receptors, such as the 
EGFR, are delivered to lysosomes, as they are retained in the sorting endosomes by 
ubiquitination (see below). Nutrient receptors, in their apo-form, are recycled back to the 
plasma membrane - either directly, or via recycling endosomes (RE) (Gruenberg and 
Maxfield, 1995; Maxfield and McGraw, 2004). 
1.3.2.1. Recycling pathway to the plasma membrane 
Recycling endosomes are composed of mainly tubular membranes of about 60 nm and are 
positioned juxtanculearly near the microtubule organizing centre (Hopkins et al., 1994). 
They are characterized by a more neutral pH (around pH 6.4) compared to sorting 
endosomes but considered part of the `early endosome', as opposed to late endosomes, 
which are characterized by their commitment to the degradative route [see (Maxfield and 
McGraw, 2004) for review on endocytic recycling]. Tubular exit from the recycling 
endosome is thought to return both, cargo and membrane, to the plasma membrane with a 
t112 of approximately 10-12 minutes (Mayor et al., 1993). It is to be noted that a faster 
phase of recycling is thought to occur directly from early endosomes with a t, /2 of 
approximately 2 minutes (Stoorvogel et al., 1987). Given the speed at which this phase of 
recycling occurs, it has proved hard to study and little is known of its regulation. Sorting 
through the recycling endosome is thought to by tubule-based geometric sorting (see 
para. 1.2.3), and to occur independently of recycling motifs but it has been shown to 
require the small GTPases Rab4, Rab5 and Rab11, although their exact role in these 
processes is not clear. 
1.3.2.2Anterograde transport: TGN-to-endosome transport 
The mannose 6-phosphate receptors 
Besides input from the plasma membrane, sorting endosomes also receive input from 
intracellular organelles like the TGN. This pathway provides molecules from the 
biosynthetic routes, including lysosomal hydrolases that are delivered to endosomes by 
mannose 6-phosphate receptors. The cation-dependent (CD-) and the cation-independent 
(CI-) mannose 6-phosphate receptors (MPRs) are two transmembrane receptors involved 
in transport of lysosomal hydrolases (Kornfeld, 1992; Ghosh et al., 2003). These receptors 
recognize phosphomannosyl residues on the post-translationally modified hydrolases in 
19 
Chapter 1- Introduction 
the TGN, and deliver these enzymes to prelysosomal compartments. For transport, MPR- 
hydrolase complexes are packed into clathrin-coated transport carriers, and the packing is 
thought to be mediated via AP-1, as this clathrin adaptor directly binds to a di-leucine 
motif in the cytoplasmic MPR tail (Johnson and Kornfeld, 1992). In support of this model 
is also the finding that clathrin, AP-1 and the MPRs co-localize on buds at the TGN 
(Kiumperman et al., 1998), and that interfering with this interaction causes MPR mis- 
sorting in living cells (Hille-Rehfeld, 1995). In addition to the AP-1/MPR interaction, a 
second association involving the di-leucine motif in the MPR tail has been identified. Here, 
it has been found that Golgi-localizing, gamma-adaptin ear homology domain, ARF- 
binding (GGA) proteins also bind to this motif, and participate in the incorporation of the 
MPR into clathrin coated buds at the TGN (Doray et al., 2002; Shiba et al., 2002). GGAs 
are monomeric clathrin adaptor proteins, and it has been proposed that GGAs and AP-1 
may act processively - with the GGAs retaining MPRs on non-clathrin-coated regions of 
the TGN and in a phosphorylation dependent process, and passing them on to AP-1 at 
bud sites (Doray et al 2002, Ghosh et al., 2003). 
1.3.23. Retrograde transport: endosome-to-TGNretrieval 
In addition to the anterograde transport of biosynthetic cargo from the TGN to 
endosomes, a retrograde pathway from endosomes exists to return receptors to the TGN: 
in contrast to their cargo, the MPRs do not enter the degradative pathway (Dahms et al., 
1989). Once at the endosome, the hydrolase is released from the receptor, mediated by 
the relatively lower endosomal pH, and while the soluble enzymes remain in the luminal 
body of the endosome, the receptor is efficiently retrieved to the Golgi/TGN for further 
rounds of delivery (for mechanism see below). Besides the MPRs, receptors and molecules 
on this route also includes furin, a subtilisin-like dibasic endopeptidase, and orthologue of 
S. cerevitiae Kex2p [see (Molloy et al., 1999) for review], murine TGN38 and its human 
orthologue TGN46 (proteins of unknown function; see (Stanley and Howell, 1993) for 
review], the carboxypeptidase D, a metallocarboxypeptidase [see (Varlamov and Fricker, 
1998) for review]. Furthermore, several bacterial exotoxins traffic on this retrograde route 
to eventually reach the ER [(Bonifacino and Rojas, 2006) for review; generally see Chapter 
4 for details). 
20 
Chapter 1- Introduction 
Molecular machinery involved in retrieval 
The proteins thought to be involved in the retrieval steps of the MPRs include AP-1, 
which also participates in anterograde TGN-to-endosome: due to defective endosome-to- 
TGN transport, embryonic fibroblasts from mice deficient in the µ1A subunit of AP-1 
exhibit a redistribution of MPRs to early endosomes (Meyer et al., 2000; 2001). 
Additionally, a novel adaptor protein, the phosphofurin acidic cluster sorting protein-1 
(PACS-1), has also been implicated. Originally identified through its interactions with 
furin, PACS-1 also binds to clusters of acidic amino acids in the CI-MPR tail (Wan et al., 
1998). RNAi-mediated PACS-1 depletion, caused redistribution of cellular furin and CI- 
MPR to peripheral compartments indicative of inhibited retrograde transport (Wan et al., 
1998). PACS-1, an AP-1 binding protein, can ligate the acidic cluster motif within the 
cytosolic domains of proteins retrieved from endosomes to the TGN (Wan et al., 1998). In 
this manner, PACS-1 has been proposed to co-operate with AP-1 to package proteins 
containing acidic clusters (such as the CD- and CI-MPRs and furin) into transport 
intermediates. 
A role for the dathrin adaptor epsinR has also been proposed. Overexpressed epsinR 
prevented the endosome-to-TGN retrieval of Shiga toxin, overexpressed CI-MPR, and 
TGN38/46 (Saint-Pol et al., 2004). EpsinR has recently been shown to interact with Vtilb 
(Chidambaram et al., 2004), a SNARE related to Vtila, itself implicated in transport from 
the sorting endosome-to-TGN transport (Mallard et al., 2002). 
Late endosome-retrieval 
Besides the machinery described above, retrieval machinery from late endosomes appears 
also to exist for the CI-MPR the GTPase Rab9 and its effectors tail interacting protein-47 
(TIP47) and p40 have all been implicated in traffic from the late endosome. Rab9 
associates with both late endosomes and the TGN destined vesicles that bud from them. 
Retrograde traffic is disrupted by expression of dominant negative Rab9 in vivo and 
stimulated by recombinant Rab9 in vitro (Lombardi et al., 1993) (Riederer et al., 1994). 
TIP47 is able to bind is able to bind GTP-Rab9 and CI-MPR via separate sites and it was 
proposed that Rab9 recruits TIP47 to late endosomes, where it may be involved in cargo 
recognition. Depletion of TIP47 was reported to inhibit CI-MPR transport in vivo (Diaz 
and Pfeffer, 1998). However it has recently been suggested that TIP47 plays no role in 
MPR retrieval (Medigeshi and Schu, 2003). Indeed, the finding that structurally, TIP47 is a 
member of a family of lipid droplet-binding proteins (Hickenbottom et al., 2004) is 
difficult to reconcile with a role in MPR retrieval (Bonifacino and Rojas, 2006). 
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L3.24. The degradative pathway 
Lysosomes are often referred to as the end-points of the endosomal system and are acidic, 
proteolytic compartments that receive degradative cargo and input from the biosynthetic 
route in the form of lysosomal hydrolases. Trough fusion of lysosomes with late 
endosomes, cargos retained in endosomes will become subject to degradation. Retention 
of cargo is achieved through specialised endosomal domains that are able to undergo a 
process of inward budding into the endosomal lumen, and thus cargos are incorporated 
into intraluminal vesicles. These intraluminal vesicle-containing endosomes are referred to 
as multivesicular bodies (MVBs), and are commonly thought to represent late endosomes. 
The molecular mechanism of intralumenal sorting is highly complex and only beginning to 
unravelled. Presently, the actual mechanistic basis for invagination into the endosomal 
lumen is unknown. Ubiquitin addition appears as dominant sorting signal for 
incorporation into the intraluminal vesicles of the MVB and subsequent degradation. And 
ubiquitinated cargo (Ub-cargo) is retained in a specialised PI 3-kinase sensitive, bi-layered, 
clathrin-containing coat upon sorting endosomes (Sachse et al., 2002b). This coat contains 
Hrs, a protein that is heavily phosphorylated upon activation of growth factor receptors 
and retention and concentration of Ub-cargo within the clathrin-containing bi-layered coat 
is dependent upon the interaction of the incorporated ubiquitin moiety with Hrs (Raiborg 
et al., 2002; Urbe et al., 2003). Hrs is able to interact with TSG101, which in turn acts to 
recruit the endosomal sorting complex required for transport-I (ESCRT-1), a multi-protein 
complex, to endosomal membranes. This in turn is required for correct recruitment of two 
other ESCRT complexes (ESCRT II and III), and it has been proposed that these 
complexes function in a sequential manner to coordinate the delivery of Ub-cargo to the 
intraluminal vesicles of the MVB (Katzmann et al., 2002). 
Maturation versus vesicular delivery 
Two mechanisms for progression between early and late endosomes have been proposed - 
maturation and vesicular delivery. The maturation hypothesis proposes that the endosome 
effectively matures around the cargo present within the endosome. As recycling proteins 
are removed from - and acid hydrolases are delivered to - this endosome, it matures into a 
late endosome (Murphy, 1991; Stoorvogel et al., 1991; Dunn and Maxfield, 1992; Futter et 
al., 1996; Hirst et al., 1998). The vesicular delivery hypothesis suggests that the detachment 
of membrane containing intraluminal vesicles from sorting endosomes gives rise to an 
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endosomal carrier vesicle (ECV), which subsequently fuses with a late endosome (Griffiths 
and Gruenberg, 1991; Gu and Gruenberg, 1999; Gruenberg and Stenmark, 2004). 
Recently a third model of maturation by "Rab conversion" has been proposed which 
integrates aspects of both models (Rink et al., 2005). This model, based largely on live-cell 
fluorescence microscopy, suggests that incoming vesicles from the plasma membrane 
undergo homotypic fusion to generate early endosomes. These Rab5-positive endosomes 
continue to accept incoming vesicles, while recycling cargo exits via Rab4-positive tubules. 
Continual fusion causes these Rab5 structures to increase in size and decrease in number 
as they move towards the cell centre, until a rapid mass replacement of Rab5 with the late 
endosome defining Rab7 occurs. This Rab conversion is mediated by the Rab5-dependent 
recruitment of a Rab7 nucleotide exchange factor, although the trigger for this has not 
been specified (Deretic, 2005; Rink et al., 2005). All three models incorporate the same 
mechanism of degradative sorting, and agree that once the late endosome has formed, it 
undergoes a heterotypic fusion with the lysosome (Futter et al., 1996; Mullock et al., 1998). 
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1.4. Sorting Nexins 
The family of sorting nexins comprises a diverse group of PX domain-containing proteins, 
members of which have been implicated in regulating intracellular sorting (see also 
Table 1.4). Based upon sequence homology of this SNX-specific PX domain, there are 
currently 30 mammalian proteins assigned to this family (see (Worby and Dixon, 2002; 
Carlton et al., 2005a) for review; compare Figure 1.41. Sorting nexins can be found in 
species ranging from plants Uaillais et al., 2006) to Drosophila (Worby et al., 2001), Dania 
rerio (Yoo et al., 2006) and yeast (10 members). 
Given that the PX domain has been identified as PPIn-ligating motif, it is not surprising 
that the majority of studies have localized SNXs to endomembranes; in every SNX 
examined so far, its PX domain targets its host to phosphoinositide-enriched membranes, 
mostly ligating 3-phosphoinositides (see (Teasdale et al., 2001) for review; compare 
Table 1.2). 
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Figure 1.4 Domain architecture of mammalian sorting nexins 
Sequences for the mammalian SNXs (as deposited on NCBI) were analysed using the 
SMART (http: //smart. embl-hcidclberg. de) and Pfam (http: //www. sanger. ac. uk/Software/Pfam) 
architecture research tools to generate predicted domain structures. Calculated percentage 
similarity between the SNX-PX domain and the SNX1-PX domain is given in brackets. 
BAR - Bin/Amphiphysin/Rvs, F- forkhcad, FERM = 4.1, ezrin, radixin, moesin; GAP - GTPase 
activating domain, MIT - microtubule interacting and trafficking molecule domain, PDZ - 
PSD95/Dlg/ZO1/2; PX Phox homology, PXA - PX associated, SH3 - Src homology 3, RA - 
Ras association, RGS - regulator of G-protein signalling. Asterisk (*) indicates that the 
domain is 
predicted, but is below threshold levels for identification. (Modified from a figure compiled by Jez 
Carlton) 
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Apart from their `hallmark' PX domain, the sequence homology is generally low between 
SNXs. Solely based on further domain structures and predicted motifs, the sorting nexins 
may be further subclassified: members of group A contain C-terminal coiled-coil domains, 
and these may also be referred to as SNX-BAR proteins, although strictly speaking, in 
most cases a functional classification as BAR protein' (see par. 1.2.3) is still lacking. 
Members of group B have no recognisable motifs other than the PX domain. Sorting 
nexins in group C are `multi-domain proteins' and contain a number of protein-protein 
interaction motifs, like Src homology (SH3) domains2 or PDZ (postsynaptic density-95/ 
discs large/zona occludens-1) motifs, as well as motifs involved in cell signalling, like RGS 
(regulator of G-protein signalling) domains, or the RasGTP effector domain, RA. 
Most members of this family are still poorly characterised, and it remains to be established 
whether they are all involved in sorting. 
SNX PPin-binding Specificity 
SNXI PtdIns3P, PtdIns(3,5)Pz, PtdIns(3,4,5)P2 
SNX2 PtdIns3P, Ptdlns(3,5)P2 
SNX3 PtdIns3P 
SNX4 Ptdlns3P 
SNX5 PtdIns3P, Ptdlns(3,4)P2 
Reference 
(Cozier et al., 2002; Zhong et al., 2002) 
(Carlton et al., 2005b) 
(Xuet aLa 2001b) 
AC Rutherfords unpublished) 
(Merino-Trigo et al., 2004) 
SNX7 PtdIns3P 
SNX9 Ptdlns3P, Ptdlns(3,4)P2, Ptdlns(4,5)P2, 
Ptdlns(3,4,5)P3 
SNX13 PtdIns3P, PtdIns5P, Ptdlns(3'. 5)P2 
SNX16 PtdIns3P 
(Xu et al., 2001 a) 
(Lundmark and Carlsson, 2003; Badour et 
al., 2007) 
(Zheng et al., 2001) 
(Hanson and Hong, 2003) 
SNX17 Ptdlns3P (Czubayko et aL, 2006) 
SNX23 PtdIns3P, Ptdlns(3,4)P2, Ptdlns(3,4,5)P3 (Hoepfner et al., 2005) 
F16B 
SNX27 Ptdlns3P QG Carlton - unpublished) 
Table 1.2 Phosphoinositide-binding properties on mammalian SNXs 
2 So strictly speaking, SNX9 and SNX18 could be classified into `group A' as well as `group B'. 
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1.4.1. Sorting Nexin-1 
SNX1 was originally identified in a yeast two-hybrid screen as binding partner for the 
cytoplasmic tail of the EGF receptor, and subsequently, in cells overexpressing SNX1, 
levels of EGFR were found to be markedly reduced compared to untransfected cells. 
SNX1 was thus proposed as a positive regulator of lysosomal sorting (Kurten et al., 1996). 
This proposed role was subsequently confirmed by a number of other groups (Chin et al., 
2001; Cozier et al., 2002; Zhong et al., 2002). Overexpressed SNX1 was also shown to be 
capable of homo- and hetero-oligomerisation and was found to interact with a number of 
surface receptors (Haft et al., 1998; compare Table 1.3); this included Hrs, suggesting a 
possible mechanism whereby the EGFR could be passed from SNX1 onto Hrs for correct 
ESCRT dependent degradative sorting (Chin et al., 2001). Interestingly, besides the EGFR, 
SNX1 was shown to interact with receptors for PDGF under conditions of dual 
overexpression (Haft et al., 1998); in contrast to its role in EGFR degradation however, 
overexpressed SNX1 exerted no effect upon PDGFR degradation (Kurten et al., 1996). 
Besides interaction with cargo destined for degradation, SNX1 was shown to interact with 
VPS35 (Haft et al., 2000; Gullapalli et al., 2004; Merino-Trigo et al., 2004; Rojas et al., 
2007) and thus implicated in a different itinerary of endosomal sorting. the retrograde 
endosome-to-TGN retrieval (see below, para. 1.5). 
1.4.2. Other Sorting Ne xin s 
To exemplify the diversity of this family, some members of the sorting nexin family will be 
briefly introduced (see also Tables 1.3 and 1.4). 
SN11 6 and SNX 17 - 'sorting 51%/Is' 
SNX16 possesses both, a PX domain and C-terminal regions of coiled coil structure, both 
of which are involved in localising the protein to its early and late endosomal localizations 
(Hanson and Hong, 2003). SNX16 has been implicated in the early to late endosome 
sorting step of the EGFR following EGF stimulation, SNX16 was shown to associate 
with the EGFR in COS-7 cells, and overexpression of SNX16 enhanced the rate of EGF- 
induced receptor degradation, whilst at the same time inhibiting downstream EGF 
signalling events (Choi et al., 2004). More recent studies have also implicated SNX16 in 
backfusion of intralumenal vesicles with the limiting membrane of the late endosome, and 
hence to participate in endosome-to-cytosol transport of viral nucleocapsids (Le Blanc et 
al., 2005). 
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SNX Interaction Reference 
SNX1 EGFR (Kurten et al., 1996; Haft et al, 1998) 
Enterophilin-1 (Pons et al., 2003; Pons et al., 2004) 
VPS35 (Haft et al., 2000; Gulla alli et al., 2004) 
(Merino-Triet al., 2004; Rojas et al., 2007) 
Hrs (Chin et al., 2001) 
PAR-1 receptor (Wang et al., 2002) 
PDGF receptor (Haft et al., 1998 
Transferrin receptor (Haft et al., 1998) 
Le tin receptor (Haft et al., 1998) 
D5-Do amine receptor e dorn et al., 2004) 
P-Selectin (Williams iet al., 2004) 
SNX2 EGFR, PDGFR, Le tin receptor (Haft et al., 1998 
TGF- receptor (Barr et al., 2000) 
VPS35 (Rojas et al., 2007) 
SNX4 Am hi h sing (Leprince et al., 2003) 
EGFR, PDGFR (Haft et al., 1998 
Le tin receptor (Haft et al., 1998) 
TGF- receptor (Parks et al., 2001) 
SNX6 Pim-1 shibashi et al., 2001) 
TGF-(3 receptors (Parks et al., 2001) 
SNX9 Insulin and IGF receptor (MaCaulay et al., 2003) 
AP-2 (a and 2 appendages) (Lundmark and Carlsson, 2002) 
Clathrin (Lundmark and Carlsson, 2003) 
Dynamin-2 undmark and Carlsson, 2003) 
ACK2 (Lin et al., 2002) 
MDC9, MDC15 (Howard et al., 1999 
Aldolase undmark and Carlsson, 2004) 
p85 (P13-kinase) (Badour et al., 2007) 
WASp (Badour et al., 2007) 
SNX15 VPS29*, VPS35* (Barr et al., 2000) 
PDGFR hilh s et al., 2001) 
SNX16 EGFR (Choi et al., 2004) 
SNX17 P-Selectin (Florian et al., 2000; Williams et al., 2004 
LDL receptor Stockin r et al., 2002; Burden et al., 2004 
Table 1.3 SNXs and their interaction partners 
The table illustrates the variety of proposed SNX interaction partners. Note that the list is not 
exhaustive and that several of the roles proposed from older studies, especially where based solely 
on overexpression data, may eventually be refined, or redefined (* documented but unconfirmed). 
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SNX Proposed Functions Reference 
SNX1 Endosome-to-TGN retrieval of the CI-MPR This study; Rojas et al., 
2007 
Pro-degradative sorting of the EGFR Kurten et al., 2002; 
Cozier et al., 2002 
Pro-degradative sorting of PAR-1 Gullapalli et al., 2006 
SNX2 Pro-degradative EGFR sorting Gullapalli et al., 2004 
Endosome-to-TGN transport of ricin Skanland et al. 2007 
SNX3 Recycling from the early endosome Xu et al., 2001 
(early-to-recycling endosome TfR transport) 
SNX4 Endocytosis? (amphiphysin interaction, TfR Leprince et al., 2002 
internalization inhibited) 
Rutherford/Traer, 
Endosome-to-ERC transport of Tf/TfR unpublished 
Endosome-to-TGN transport of ricin Skanland et al. 2007 
SNX5 Inhibitory regulation of EGFR degradation Liu et al., 2006 
Endosome-to-TGN transport of CI-MPR Wassmer et al., 2007 
SNX6 Nuclear traffic of Pim-1 Ishibashi et al., 2006 
Endosome-to-TGN transport of CI-MPR Wassmer et al., 2007 
SNX9 GLUT4-translocation MaCauley et al., 2003 
Co-ordination of endocytic machinery (dynamin, (undmark and 
adaptor protein recruitment) Carlsson, 2004) 
Integration of signalling; endocytosis, actin Soulet et al., 2005 
cytoskeleton Badour et al., 2007 
EGFR de adation Lin et al. 2002 
SNX13 GAP for G pro-degradative EGFR sorting Zheng et al 2001 
SNX15 Traffickin between endosomes and the TGN Barr et al. 2000 
SNX16 Early to late endosomal sorting (EGFR) Hanson and Hong, 
2003; Choi et al., 2004 
Back fusion of MVB intraluminal vesicles Le Blanc et al. 2005 
SNX17 Recycling of LRP from the early endosome 
E d l fP l i i S 
Van Kerkhof et al., 2005 
n osoma retent on o - ect n (prevents e (Knauth et al., 2005) 
entKy into MVB vesicles) 
SNX23 A kinesin that directs +end movement of earl Hoepfner et al., 2005 
endosomes (thus regulates degradative traffic 
Table 1.4 Proposed Roles of SNXs in endosomal sorting 
In some cases, very recent findings were included, and will be discussed at the appropriate 
chapters. Adapted and extended from AC Rutherford. 
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SNX17 might also be considered as a `classical SNX' as it binds to PtdIns3P, and is 
primarily localized to early endosomal membranes and involved in endosomal sorting. 
Electron microscopy revealed the presence of SNX17 on both, the limiting membrane and 
recycling tubules of the early endosome (van Kerkhof et al., 2005). SNX17 appears mainly 
involved in endosome-to-plasma membrane recycling; by virtue of its FERM domain and 
C-terminal region, SNX17 interacts with several low-density lipoprotein (LDL) receptors 
(Stockinger et al., 2002; Burden et al., 2004): SNX17 binds to and promotes the recycling 
of the LDL receptor-related protein (LRP) from the early endosome, as siRNA mediated- 
knockdown of SNX17 causes a reduction in LRP recycling, and enhances the lysosomal 
degradation of LRP (Van Kerkhof et al., 2005). Additionally, SNX17 has been implicated 
in the internalisation and recycling of the leukocyte receptor P-selectin (Florian et al., 2001; 
Williams et al., 2004). 
S1VX9 - integration ofactin cytoskeleton, endocytosis, and signalling? 
In addition to its PX domain, SNX9 possesses an N-terminal SH3 domain, which is 
followed by a region of low complexity. Through these N-terminal regions, SNX9 is 
capable of interacting with core components of the CME machinery, including dynamin-2, 
AP-2 and clathrin itself (Lundmark and Carlsson, 2003). It has been proposed that SNX9 
regulates CME by mediating dynamin recruitment to the plasma membrane (Lundmark 
and Carlsson, 2004), and knockdown of SNX9 inhibited transferrin internalisation in HeLa 
cells (Soulet et al., 2005). The substrate specificity of its PX domain remains a matter of 
debate (compare Table 1.2), and accordingly, besides a cytosolic distribution, it has been 
described to localize to plasma membrane, the TGN and endosomes. 
Additionally, SNX9 has been recently implicated in bacterial invasion processes although 
its exact role is not yet clear. Here, SNX9 was identified as interaction partner for the 
bacterially secreted protein EspF (Marches et al., 2006), an effector protein of 
enteropathogenic E. coli (EPEC). Functionally, EspF is essential for F-actin assembly 
because it promotes recruitment of the host actin-nucleating machinery to sites of bacterial 
adherence, which is thought to be important for actin pedestal formation that are crucial 
for the invasion process (Campellone et al., 2004; Garmendia et al., 2004). SNX9 has also 
been recently shown to inducibly bind to Wiskott-Aldrich syndrome protein (WASp), and 
interact with the P13-kinase regulatory subunit p85 and its product, to stimulate CD28 
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uptake in T-cells in a P13-kiase-dependent manner, thus coupling cytoskeletal 
rearrangements to endocytic events and signalling function (Badour et al., 2007). 
SNX23 - endosomal motility 
Recent work has shown that KIF16B, a kinesin-3 (also known as SNX23), drives plus-end, 
as well as minus-end directed motility of sorting endosomes in a process dependent on 
Rab5 and P13-kinase (Hoepfner et al., 2005). It appears that KIF16B directly modulates 
the steady state distribution of endosomes by regulating the `switch' between centrifugal, 
plasma membrane-bound recycling, and centripetal late endosomal/lysosomal degradative 
transport. Overexpression of SNX23 caused a redistribution of early endosomes towards 
the cell periphery whereas SNX23 depletion caused the early endosomes to cluster in the 
perinuclear region. In terms of receptor trafficking, the former scenario inhibited 
degradative delivery (EGFR), whereas in the latter receptor recycling was delayed and 
degradation accelerated (Hoepfner et al., 2005). 
SNX3 
Although multiple domains are a feature of the SNX family, `group B' SNXs are 
composed of very little sequence outside their PX domain. Of these smaller SNXs, SNX3 
which is comprised largely of its Ptdlns3P-binding PX domain, and thus does not 
oligomerize with other SNXs, is nevertheless implicated in endosomal function. SNX3 is 
localised to early and perinuclear endosomes (Xu et al., 2001b), where it is believed to 
function in the trafficking of membrane from the early endosome to the recycling 
endosome. SNX3 overexpression leads to endosomal swelling, and microinjection of anti- 
SNX3 antibodies into cells results in defective early endosome-to-recycling endosome TfR 
traffic (Xu et al., 2001b). 
SNX13 
The diversity within the SNX family is also illustrated by the domain architecture of 
SNX13. In addition to its SNX-PX domain, SNX13 possesses a RGS (regulator of G 
protein signalling) domain that can function as a GTPase activating protein. SNX13 
enhances GTP hydrolysis upon Ga,,, thus attenuating signalling via Ga and reducing 
adenylate cyclase mediated AMP production. SNX13 is targeted to endosomes and the 
presence of a Gas GAP on endosomes intriguingly suggests that it might function to 
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attenuate signalling from receptors, such as the 02-adrenergic receptor as they traffic 
through endosomes (Zheng et al., 2001). SNX13 might also provide a potential link 
between signalling and trafficking; as recently SNX13 has been shown to promote EGFR 
degradation in a Ga,, stimulated manner (Zheng et al., 2004). 
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1.5. Making the case -sorting nexins in cargo retrieval 
1.5.1. Insights from yeast sorting nexins on retrieval 
The consistent theme for all yeast sorting nexins identified so far is that they mediate 
retrieval of cargo from endosomes. The yeast retromer subunits Vps5p and Vpsl7p have 
been shown to function in the retrieval of the hydrolase receptor VpslOp [see also below; 
(Horazdovsky et al., 1997; Seaman et al., 1998; Hettema et al., 2003) and Pepl2p (Hettema 
et al., 2003) from prevacuolar endosomes (PVEs). Snx4p, Snx41p and Snx42p, the 
predicted yeast orthologues of mammalian SNX4, are thought to control retrieval of the 
late-Golgi SNARE Snclp from PGEs to the TGN. In the absence of Snx4p, Snclp mis- 
localises to the vacuole (Hettema et al., 2003). Yeast Grdl9p, the predicted orthologue of 
mammalian SNX3 is required for the retrieval of the late Golgi proteins Kex2p (the 
homolog of furin), Stel3p, Pepl2p and A-ALP. These proteins are mis-localised to the 
vacuole in grdl9d cells (Voos and Stevens, 1998; Hettema et al., 2003). Similarly, the 
predicted orthologue of mammalian SNX8, Mvp1p, is also required for the retrieval of late 
Golgi proteins from the degradative route, as it retrieves the carboxypeptidase Y (CPY) 
receptor VpslOp, and Kex2p from endosomes; mvp10 cells secrete an immature form of 
CPY, characteristic of a defect in the sorting of the CPY receptor (Ekena and Stevens, 
1995) 
1.5.2. The yeast retromer complex 
The hydrolase receptor VpslOp, a receptor with analogous function to the CI-MPR, is 
efficiently retrieved from prevacuolar endosomes (PVE) to the late-Golgi complex with 
the aid of a multimeric protein complex called retromer (Seaman et al., 1997; Seaman et al., 
1998). This pentameric coat complex consist of two sub-complexes; one half comprises 
the vacuolar protein sorting proteins Vps26p, Vps29p and Vps35p (Seaman et al., 1998), 
while the second sub-complex is formed by the sorting nexins Vps5p and Vpsl7p 
(Horazdovsky et al., 1997; Nothwehr and Hindes, 1997). These yeast sorting nexins 
associate with prevacuolar membranes by means of their phox homology (PX) domain 
being capable of ligating phosphatidylinositol 3-monophosphate, while the Vps26p- 
Vps29p-Vps35p sub-complex is cargo-selective due to the ability of Vps35p to recognize a 
(Y/F)XX(D motif within the cytoplasmic tail of Vps10p. Additionally, Vps35p has been 
shown to directly interact with Vps5p, thus connecting both complexes (Nothwehr et al., 
1999; Nothwehr et al., 2000). 
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1.5.3. The mammalian retromer complex 
With the exception of Vpsl7p, mammalian orthologues of all retromer components have 
been identified (Haft et al., 1998). Like its yeast counterpart, the mammalian retromer 
complex is thought to be pentameric, with one sub-complex consist of VPS26, VPS29 and 
VPS35. In light of the lack of a mammalian orthologue of Vpsl7p, the composition of the 
second sub-complex is less clear. The mammalian proteins sorting nexin-1 (SNX2) and 
sorting nexin-2 (SNX2) show high sequence similarities with Vps5p, and as indeed, SNX1 
binds to SNX2, as well as VPS35 (Haft et al., 1998), they have been proposed as 
orthologues of Vps5p. 
VPS35 is a hydrophilic membrane protein that shows 43% identity to Vps35p (Edgar and 
Polak, 2000). Co-immunoprecipitation and yeast two-hybrid analyses have shown that 
VPS35-VPS29-VPS26 form a stable complex, with VPS35 being the core component of 
this complex. Interestingly, in co-elution experiments, when these components are co- 
expressed with either SNX1 or SNX, the majority of the sorting nexins elute at a size 
consistent with its monomeric or dimeric form, while expressing the sorting nexins alone 
or in combination, results in large oligomers. This suggests that the other forms compete 
with the ability of SNXs to form larger complexes. (Haft et al., 2000) 
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1.6. Perspectives and aims of this thesis 
At the beginning of my PhD studies in October 2003, the literature on SNX1 was 
dominated by overexpression approaches mainly identifying its interactions with various 
receptors and other sorting nexins. Seven years after its discovery as regulator of pro- 
degradative transport, this role had been questioned, as it could not be confirmed under 
conditions of siRNA-mediated SNX1 suppression. 
Thus, my primary aim was to scrutinize the proposed role of SNX1 as component of a 
potential cargo retrieval complex in more detail, a model that had been proposed through 
the discovery of potential mammalian orthologues of the yeast retromer complex. 
Within the first six month of my PhD, through the work in the Bonifacino Labs and by 
Matt Seaman, a breakthrough in mammalian retromer biology had been made: this 
included identifying a functional mammalian retromer complex, and hence providing tools 
and models, with the aid of which this work swiftly progressed toward identifying and 
characterizing the role of SNXI in endosome-to-TGN transport processes. 
As the yeast retromer complex appeared as a `multi-cargo' sorting complex, our interest 
was sparked as to whether SNX1 had more generalised role in retrograde transport, and 
hence we expanded our studies to include a variety of cargo. 
This thesis may be further viewed under the aspect of attempting to analyse protein 
function in an integrative and synergistic approach: dissecting transport by studying 
endogenous cargo and utilizing exogenous molecules, by employing a broad range of 
techniques combining overexpression and RNA interference techniques with live and 
fixed cell approaches, and through collaborative efforts, to combine these with 
ultrastructural analysis, functional studies using biochemical assays, and infection models. 
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Chapter 2- Material and Methods 
2.1 Materials 
This chapter lists all general material and contains a list of suppliers. Experiment-specific 
materials are also listed in individual chapters. If not stated, reagents were either purchased 
from SigmaAldrich (SIGMA) or Invitrogen. 
2. L1. Bacteria! Strains 
BL21-Gold (DE3) (STRATAGENE) 
E. coli B strain, F- episome, dem+, The, ompT, hcdS(rB- MB-), 
gal d DE3), end-1, Tet` 
XL, Blue (STRATAGENE) 
recA1, endA 1, gyrA96, thi-1, hsdR17, supE44, rz1A11ac (F'praAB 
laclgZ"15 Tn10(Teit)]. 
XL10-Gold (STRATAGENE) 
Teti 0(mcrA)183 d(maCB-hsdSMR-mrr)173 endAl supE44 
thi-1 recA1 gyrA96 reL41 lac Hte [F' proAB 1acPZzM15 Tn10 
(Tet`) Amy Cam]' 
DH5a (INVITROGEN) 
F º80d/acZAM15 A(lacZYA-ar gF) U169 recAl endAl 
hsdR17(rk, mk{) phoA sMPE44 ).. thi-1 gyrA96 relAl 
Growth Media 
Bacterial growth media were either provided by the Department of Cellular and Molecular 
Medicine, University of Bristol or purchased from Invitrogen. 
Luria Bertani (LB) 10 g NaCl, 10 g tryptone (DIFCO), 5g yeast extract 
(DIFCO); in 1 litre of sH2O, pH 7.0, autoclaved 
LB agar 20 g agar (DIFCO) added per 1 litre of LB prior to 
autoclaving 
SOC Media 20 g tryptone (DIFCO), 5g yeast extract (DIFCO), 0.5 g 
NaCl; in 980 ml of sH2O pH 7.0, autoclaved, then added 
to 20 ml of a sterile 1M glucose solution 
Antibiotics 
Ampicillin (SIGMA) 
100 pg/ml stock solution in dHZO, 1: 1000, stored at -20°C 
Kanamycin (SIGMA) 
50 µg/ml stock solution dHZO, 1: 1000, stored at -20°C 
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21.2. Eukaryotic Cell Limes and Tissue Culture 
HeLa Cells (CCl-2) (ATCC) 
Epithelial, human, derived from cervical adenocarcinoma 
(Gey et al., 1952) 
HeLaM Cells A kind gift from Dr Matthew Seaman, CIMR, Cambridge, 
UK (Seaman, 2004) 
stably transfected with a CD8-CI-MPR chimera 
HepG2M Cells A kind gift from Prof Judith Klumperman, Cell Microscopy 
Center, University of Utrecht, The Netherlands 
Epithelial, human, derived from hepatocellular carcinoma 
MDCK Cells A kind gift from Dr Mark Jepson, University of Bristol, UK 
Epithelial (unpolarized), canine, derived from kidney cells 
by S. H. Madin and N. B. Darby (1958) 
Growth Media 
DMEM- full (HeLa) Dulbecco's Modified Essential Medium with 4.5g/l 
glucose, 1 mM pyruvate, supplemented with 10% fetal calf 
serum (FCS), 2 mM L-glutamine, 100 units/ml penicillin, 
100 µg/ml streptomycin (all INVITROGEN) 
DMEM (HeLaM) DMEM- full (HeLa), additionally supplemented with 
0.5mg/ml geneticin (G418) (INVITROGEN) 
MEM (HepG2) Minimum essential medium containing Hank's salts, 2 mM 
L-glutamine 0.1 mM non-essential amino acids, 1.0 mM 
Na-pyruvate, supplemented with 10% FCS, 100 units/ml 
penicillin, 100 µg/ml streptomycin (all INVITROGEN) 
EMEM (MOCK) EMEM supplemented 10% FCS, 0.1 mM MEM non- 
essential amino acids, 2 mM L-glutamine, 100 units/ml 
penicillin, 100 gg/ml streptomycin (all INVITROGEN) 
DH buffered medium (DHB) DMEM with 4.5g/l glucose, 25 mM HEPES, 1mM 
pyruvate 
OptiMEM (INVITROGEN) 
General Solutions for Tissue Culture 
1x PBS 4g NaCl, 0.2 g KCI, 0.2 g KH2CO3,0.144 g 
Na2HCO3.2H20; to 1 litre, autoclaved 
4x poly-D-lysine solution 100 mg/ml poly-D-lysine hydrobromide (SIGMA) in H2O 




10x HBS 5g HEPES, 8g NaCl, 0.37 g KCI, 0.9 g Glucose, 0.103 g 
Na2HPO4 to 100 ml, pH 7.05 - 7.12 (1N NaOH) 
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Cell lysis buffer 50 mM HEPES, 0.1 M NaCl, 1 mM EGTA pH8,10 mM 
MgC12,1% Triton X-100,0.1 mM DTT, 5 µg/ml each of 
benzamidine, trypsin inhibitor, leupeptin, aprotonin 
pepstatin A and antipain, 0.5 mM PMSF, pH 7.5 
2.1.3. Molecular Biology 
Agarose gels agarose (BIOEINE) 
x% (w/v) in 1x TEB 
0.5 µl EtBr stock per 10 ml gel 
1x TAE 0.8M Tris-acetate, 20mM EDTA, pH 7.8 
Ethidium bromide (stock) (BIORAD) 
10 mg/ml ethidium bromide solution 
DNA sample buffer (5x) 25% (w/v) Ficoll, 10 mM EDTA, 0.125% (w/v) 
bromophenol blue (MERCK), 0.125% (w/v) xylencyanole 
(MERCK) 
DNA Molecular Weight 
Marker X (0.07 - 12.2 kbp) (ROCHE) 
DNA ladders (NEW ENGLAND BIOLABS) 
1 Kb and100 bp DNA ladder 
jg Aprep Min prep KitTM (QIAGEN) 
Plasmid Maxi Kit (QIAGEN) 
QIAEXII Gel extraction Kit (QIAGEN) 
WIZARD® SVGe1 and PCR (PROMEGA) 
Clean-Up System 
Ollgonucleotide Primers (Sequences refer to Appendix I) 
All oligonucleotides were synthesized by Sigma-Genosys (0.025 µM). Stock solutions were 
made to 100 µg/ml in sHZO, prior to storage at -20 °C. 
Restriction Enzymes 
Restriction enzymes were purchased from MBI FERMENTAS, NEW ENGLAND BIOLABS, 
PROMEGA, ROCHE, and used according to manufacturer's instruction. 
Other Enzymes 
T4-DNA Ligase (ROCHE) 
dNTPs (ROCHE) 
KOD Hot Start DNA (NOVAGEN) 
polymerase 
Phosphatase, alkaline (1000U) (ROCHE) 
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PCR Master Mix (PROMEGA) 
Containing Taq polymerase 50U/ml in reaction buffer 
400 pM dNTPs, 3mM Mg2C12 
QuickStick Ligation Kit (BIOEINE) 
21.4. Commercial Plasmids 
pEGFP-C1 (CLONTECH) 








Dr Alex McGregor, former University of Bristol, Bristol, 
UK. 
Dr Anna Rutherford, University of Bristol, Bristol, UK. 
Prof George Banting, University of Bristol, Bristol, UK 
(Pattni et al., 2001) 
Dr Rohan Teasdale, University of Queensland, Brisbane, 
Australia 
pmRFPC1 Dr Jez Carlton, University of Bristol, Bristol, UK 
(developed using the pEGFP-C1 from Clontech, and 
replacing the GFP-coding sequence of with RFP from the 
pGEXmRFP vector, a kind gift of Dr Roger Tsien, UCSD, 
La Jolla, USA) 
21.6. GenBankAccession numbers (NCBI) 
SNX1 ACCESSION NUMBER B0000357 
SNX2 ACCESSION NUMBER B0003382 
Vps35 ACCESSION NUMBER B0002414 
2L Z Sequences ofsmall interfering RNAs 
siRNA duplexes (DHARMACON) 
Option C, reconstituted at 40 µM in RNase free HZO 
SNX1 TARGET: AAGAACAAGACCAAGAGCCAC 
SNX2 TARGET: AAGUCCAUCAUCUCCAGAACC 
Control TARGET: AAGACAAGAACCAGAACGCCA 
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21.8. Antibodies and Reagents 
Key: 
WB = Western blotting 
IF = immunofluorescence, UA = IF Uptake Assays (fixed or Live Cell Imaging), 
IP = immunoprecipitation experiments 
Primary Antibodies 
Species Dilution Supplier 
anti- f 3-actin Mouse 1: 5,000 WB SigmaAldrich 
anti-CD8 (UCHT4) Mouse 1: 200 IF Ancell 
anti-CD8 Rat 1: 1000 IF Serotec 
10 tg/ml UA 
anti-CD8 Mouse 50 gg/ml UA Serotec 
(RPE-coupled) 
anti-CI-MPR Rabbit 1: 200 IF Prof Paul Luzio, CIMR, 
1: 1,000 WB Cambridge, UK 
(Reaves et al., 1996) 
anti-CI-MPR Mouse 1: 500 WB Affinity BioReagents 
anti-EEA1 Mouse 1: 200 IF BD Transduction Labs 
anti-giantin Rabbit 1: 500 IF Covance 
anti-Lamp-1 Mouse 1: 500 IF Research Diagnositics 
anti-Salmonella (LPS) Rabbit 1: 200 IF Difco 
anti-SNX1 Mouse 1: 200 IF BD Transduction Labs 
1: 1,000 WB 
anti-SNX1 Rabbit 1: 200 IF Dr Matthew Seaman, 
CIMR, Cambridge, UK 
(Seaman, 2004) 
anti-SNXI Goat 1: 200 IF Santa Cruz Biotechnology 
anti-SNX2 Mouse 1: 200 IF BD Transduction Labs 
anti-sortilin (tail) Rabbit 1: 1000 IF Gifts from Dr CM Petersen, 
anti-sortilin (VpsD) mouse 1: 400 IF Aarhus University, Denmark 
anti-STxB (13C4) Mouse IP Dr Ludger Johannes, 
Institut Curie, Paris, France 
Qohannes et al., 1997) 
anti-TGN46 Sheep 1: 500 IF Serotec 
anti-tubulin Mouse 1: 15,000 WB SigmaAldrich 
anti-VPS26-1 Mouse 1: 200 IF, WB Dr Matthew Seaman, 
CIMR, Cambridge, UK 
(Seaman, 2004) 
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SecondaryAntibodles for Immunofluorescence and Western Blotting 
JACKSON IMMUNORESEARCH Laboratories 
Cy2-anti-mouse IgG Donkey 1: 500 Cy3-anti-mouse IgG Donkey 1: 500 
Cy2-anti-rabbit IgG Donkey 1: 500 Cy3-anti-rabbit IgG Donkey 1: 500 
TRITC-anti-goat Rabbit, 1: 200 
INVITROGEN 
Alexa488 anti-goat IgG Donkey 1: 200 Alexa568 anti-mouse IgG Donkey 1: 200 
Alexa488 anti-mouse IgG Donkey 1: 500 Alexa568 anti-mouse IgG Goat 1: 200 
Alexa488 anti-rabbit IgG Donkey 1: 200 Alexa568 anti-rabbit IgG Donkey 1: 200 
Alexa568 anti-sheep IgG Donkey 1: 500 Alexa647 anti-mouse IgG Donkey 1: 200 
Alexa594 anti-rabbit IgG Donkey 1: 200 Alexa680 anti-sheep IgG Donkey 1: 200 
HRP-anti-goat IgG Donkey 1: 2000 Santa Cruz Biotechnology 
HRP-anti-mouse IgG Sheep 1: 5000 (GE HEALTHCARE) 
HRP-anti-rabbit IgG Sheep 1: 5000 (GE HEALTHCARE) 
2.1.9. Solutions for Immunoiluorescence and Live Ceff Imaging 
PFA stock solution 20% paraformaldehyde (RIEDEL DE HAEN) 
in 1x PBS 
alkaline hydrolysis with 1N NaOH at 60°C 
pH 7.0, stored at -20°C 
4% PFA working solution 1: 5 diluted PFA stock in DMEM or PBS 
PBS-T 0.1% (v/v) TritonX-100 (SIGMA) 
in 1x PBS 
P-BSA-T 1% (w/v) BSA (SIGMA), 0.1% (v/v) TritonX-100 
in 1x PBS 
P-BSA 1% (w/v) BSA (SIGMA) 
in 1x PBS 
Mowiol mounting medium 6g glycerol, 2.4 g Mowiol 4-88 (CALBIOCIIEM), to 6 ml 
sH2O; 12 ml 0.2 M Tris (pH 8.5). Stored at -20°C 
DAPI (HOECHST) 
4', 6'-diamidino-2-phenylindole, 1: 5000 (in H2O) 
TRITC-phalloidin (INVITROGEN) 
1: 1000 in immunofluorescence analyses 
Imaging buffer 125 mM NaCl, 42 mM HEPES, pH 7.4,18 mM 
glucose, 5.4 mM KCI, 3 mM Na14CO3,1.6 mM 
MgC12,1.3 mM EGTA 
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2.1.10. Protein Biochemistry 
Material and Solutions for SDS-PAGE 





Lower Tris stock 
Stacking gel 
Higher Tris stock 
SDS-electrophoresis buffer 





30% acrylamide, 0.8% bis-acrylamide 
10% (w/v) ammonium persulphate 
(ACROS) 
in H2O, stored at -20°C 
N, N, N ', N '-tetramethyle thylenediamine 
(RIEDEL DE HAP-N) 
10% (w/v) SDS in H2O 
1.5 M Tris-HCI, pH 8.8 
1.0 M Tris-HCI, pH 6.8 
125 mM Tris-HC1, pH 8.6 
1M glycine 
0.5 % (w/v) SDS in H2O 
0.72 M (3-mercaptoethanol, 62.5 mM Tris- 
pH 6.8,25% (v/v) glycerol, 2% (w/v) SDS, 
0.02% (w/v) bromophenol blue 
0.2% (w/v) Coomassie Brilliant Blue R250 
12.5% (v/v) acetic acid 
20% (v/v) ethanol 
1: 1 (v/v) mix of 10% (v/v) acetic acid and 
100% (v/v) ethanol 
Precision Plus Protein Pre-stained Standards (BIORAD) 
BRADFORD reagent (BIORAD) 
NuPAGE gel system (INVITROGEN) 
Novex range of Bis-Tris polyacrylamide gels 
Material and Solutions for Western Blotting 
Blotting buffer 200 mM Tris-Base, 1.5 M glycine, 




0.2% (w/v) Ponceau S 
3% (w/v) Trichloroacetic acid 
3% (w/v) Sulfosalicylic acid 
4g NaC1,0.2 g KC1,0.2 g KHZCO3, 
0.144 g Na2HCO3.2H20,0.05% Tween-20, 
to 1 litre with sHZO 
62.5 mM Tris-HC1, pH 6.8; 2% SDS, 
100 mM ß-mercaptoethanol; heated to 56°C 
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Blot blocking solution A 10% (w/v) skimmed milk powder 
in lx PBS-Tween 
Blot blocking solution B 
ECLTM-Hyperfilm 
ECLTM Western Blotting Detection Reagent 
Whatman-Papier (G-002) 
PolyScreen PVDF Transfer Membrane 
(45µm pore) 
22 Additional Equipment 
Incubators, Laminar Flow cabinet 
Shaker 
ELISA-Eary Reader 400AT 
PTC-100 thermal cycler 
Mini-Protean-II Slab Cell Apparature 
Gel electrophoresis equipment, 
power supplies 









(NEN LIFE SCIENCE PRODUCTS) 
HERAEUS 
NEW BRUNSWICK 
SLT LAB INSTRUMENTS 







General plastic ware (various) 
GREINER, FALCON, STARLAB, Bibby-Sterilin, CORNING, Nalgene, TPP, CORNING 
Pipettors 
Chemi-Doc imaging system 
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2.3. Suppliers 
Adobe Systems PLC Uxbridge, UK LKB Wallac Turku, Finland 
AGFA Mortsel, BEL Ma ienfeld Lauda-Königshofen, GER 
Apple Cupertino, CA, USA Mattek Ashland, MA, USA 
Applied Biosystems Warrington, UK MBI Fermentas York, UK 
ATCC/GC Promochem Manassas, VA, USA Menzel Glaeser Braunschweig, GER 
BDH Chemicals Ltd Poole, UK Millipore Watford, UK 
Beckman Coulter High Wycombe, UK M) Research Reno, NV, USA 
Becton Dickinson Oxford, UK Molecular Devices Corp. Sunnyvale, CA, USA 
Bibby Sterilin Ltd. Stone, UK Molecular Probes Cambridge, UK 
Bioline London, UK New Brunswick Scientific St Albans, UK 
BioRad Ltd. Hemel-Hempstead, UK New England Biolabs Ltd Hitchin, UK 
Cell Signaling Tech. Beverley, MA, USA National Institutes of Health Bethesda, MD, USA 
Cell Signals Inc. Columbus, OH, USA Novagen Ltd. Abingdon, UK 
Clontech Inc. San Jose, CA, USA Olympus Microscopes London, UK 
Coming Inc. Corning, NY, USA Packard Biosciences Groningen, NL 
Covance Berkley, CA, USA Perkin Elmer Seer Green, UK 
DAKO Cytomation Carpenteria, CA, USA Pierce Rockford, IL, USA 
Diagnostics Scotland Edinburgh, UK Promega Ltd. Southampton, UK 
Dharmacon Lafeyette, CO, USA Qiagen Ltd. Crawley, UK 
Dow Chemical Co. Luddington, MI, USA Roche Lewes, UK 
Du Pont NEN Ltd. Stevenage, UK Santa Cruz Biotech. Santa Cruz, CA, USA 
Eppendorf Hamburg, GER Sigma-Aldrich Poole, UK 
GE Heathcare UK Ltd Little Chalfont, UK Sigma-Genosys Poole, UK 
Gilson Middleton, WI, USA Somerfield Supermarkets Bristol, UK 
Improvision Coventry, UK Stratagene Ltd. La Jolla, CA, USA 
Invitrogen Paisley, UK Till Photonics Gräfelfing, GER 
Jouan St-Herblain, France TPP Trasadingen, SUI 
JacksonlmmunoResearch 
Labs, Inc West Grove, PA, USA Upstate Maidstone, UK 
Leica Microsystems Milton Keynes, UK Vector Laboratories, Ltd Petersborough, UK 
Life Technologies Ltd. Paisley, UK Whatman International Maidstone, UK 
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24. General Methods 
The following paragraphs describe general molecular biology, protein biochemistry and tissue 
culture techniques. For more subject-specific techniques, one is referred to the individual chapters. 
Detailed information regarding buffer compositions, equipment and material can be found in the 
preceding paragraphs and was omitted for clarity. 
24.1. Amplification of DNA byPCR 
To amplify DNA, a PCR was routinely performed using KOD Hot-Start DNA polymerase 
(Novagen). Amplification was typically performed in a total volume of 50 W. Each individual 
reaction was routinely composed of 50 ng template DNA, 0.3 LIM sense and antisense 
oligonucleotide primers, and either a dNTP mix (dATP, dCTP, dGTP, dTTP; each at 0.2mM) 
1.5 mM MgSO4, and 5 µl of 10 x polymerase buffer (Novagen), or using a pre-mixed PCR Master 
Mix (Promega). Thermal cycling was performed at conditions optimized dependent on the 
sequences amplified. PCR commenced with an initial denaturing step at 94°C for 2 minutes, 
followed by 20 - 30 rounds of amplification cycles, comprising a 1-minute denaturing step at 94°C, 
followed by a 1-minute annealing step (-5 °C below the primer melting temperature), and finally a 
68°C extension step (performed for 1 min per 1000 nucleotide amplification sequence). A final 
10-minute extension step at 68°C was performed, before samples were cooled to 4°C. The 
reactions products were stored at -20°C, and an aliquot was separated by agarose gel 
electrophoresis to check successful amplification. 
2.4.2. Restriction Digests 
Vector and DNA were digested as required to generate complementary sticky ends at the 
conditions required for the respective restriction enzyme. Depending on the required scale, digests 
were either performed in 15 µl (`diagnostic digest) to 50 µl (PCR products, cloning). Restriction 
enzymes were used at a maximum of 10% of the total volume according to manufacturer's 
recommendations. After heat inactivating the enzyme, the cut vector was routinely subjected to 
gel-electrophoretic separation (para. 2.4.2) and subsequent gel purification (para. 2.4.5) to reduce 
the fraction of uncut vector, while cut PCR fragments were purified as described under 
para. 2.4.3. 
24.3. Purification ofDNA from PCR Reactions and Restriction digests 
When no immediate electrophoretic separation step was required, DNA was purified directly from 
a PCR reaction or a restriction digests using the WIZARD®SVGe1 and PCR Clean-Up System 
(Promega), following the manufacturer's protocol. The DNA was routinely eluted in 2x 15 tl 
sH2O and stored at -20°C. 
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2.4.4. Agarose Gel Electrophoresis 
For most DNA separation problems, 1% (w/v) agarose gels were sufficient. Agarose was weighed 
and added to 1x Tris-Acetate-EDTA (TAE) buffer. The mixture was heated to dissolve the 
agarose, and left to cool. Once the solution had cooled to below 50°C, ethidium bromide was 
added to a final concentration of 5µg/ml. The gel was poured into the casting block and the comb 
inserted. Once set, the gel was transferred to an electrophoresis tank and immersed in 1x TAE 
buffer. The samples were mixed with 5x sample buffer prior to loading into the wells of the gel. 
Electrophoresis was generally performed at approximately 10 V/cm for 40 minutes. The DNA was 
visualized in the gel upon the excitation of the intercalated ethidium bromide by UV trans- 
illumination. 
24.5. Purification ofDNA from Agarose Gels 
From an electrophoresis gel, the band of interest was rapidly excised under UV illumination using 
a clean razor blade. DNA was routinely extracted and purified using the QIAquick gel extraction 
kit (Qiagen), according to the manufacturer's instruction. The DNA was eluted using 2x 15 µl of 
sH2O. Alternatively, the WIZARD SVGe1 and PCR Clean-Up System (Prornega), following the 
manufacturer's protocol, was used. 
24.6. DNA Ligation 
Ligation reactions were routinely performed in 20 t1 reaction volumes, usually at a 1: 10 ration of 
vector to insert, with a minimum of 50 ng vector. As control, a reaction containing only vector, 
but no insert (`mock-ligation') was prepared. Routinely, 2 units of T4 DNA ligase were used 
(Roche) and ligations were incubated overnight at 16°C. Alternatively, a QuickStick ligation Kit 
(Bioline) according to the manufacturer's instructions was used, incubating ligation mix for 1 hour 
at room temperature. 
24. Z Transformation of Chemically Competent Bacteria 
From both, the ligation mix and `mock ligation' (control), 5 µl were used to transform chemically 
competent E. coli strains (strains as listed under para. 2.1.1). Typically, a 50 µl aliquot was 
transferred to a pre-chilled 15 ml polypropylene tube. Where appropriate 2 µl ß-mercaptoethanol 
were added (manufacturer's protocol) and the cells were left on ice for 10 minutes. To these 
bacteria, 100 ng DNA (either plasmid DNA, or a ligation mixture) was added and carefully mixed, 
before being incubated on ice for a further 30 minutes. Cells were then subjected to a heat shock 
(37°C for 30 seconds, or 42°C for 45 sec, depending on strain used, according to the 
manufacturer's manual), and quickly returned to ice for 2 minutes. Pre-warmed SOC media was 
added at a 10: 1 ratio, and the mixture was incubated at 37°C for 1 hour. The mix was briefly 
centrifuged to concentrate bacteria, and 100 tl of a suspension in fresh SOC was plated onto LB- 
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agar plates containing the appropriate selection antibiotic. The plates were incubated at 37°C and 
growth of colonies was examined 12 - 16 hours later. These `master plates' were used to inoculate 
liquid cultures, sealed with parafllm and stored at 4°C for up to 5 days. 
24.8. Bacterial Culture 
Liquid cultures of transformed E. coli strains were inoculated transferring one colony of a `master' 
agar plate (see para. 2.4.7) per 5 ml LB broth supplemented with the appropriate selection 
antibiotic. Cultures were incubated at 37°C in an orbital shaker at 180 rpm for 16 - 20 hours. These 
cultures were either used for long-term E. coli stock-preparation (para. 2.4.9), small-scale DNA 
preparation (`miniprepý, or were used to inoculate larger culture volumes either at a 1: 100 ratio 
(low copy plasmids), or 1: 500 for high copy plasmids. Liquid cultures from pre-cultures were also 
incubated at 37°C in an orbital shaker at 180 rpm for 16-20 hours. 
2.4.9. Freezing and Thawing ofE. coii Stocks 
Stationary-phase E. coli cultures were pelleted by centrifugation at 13,000 xg for 1 minute and 
resuspended in 30% sterile-filtered glycerol. The suspension was mixed, snap-frozen in liquid 
nitrogen and immediately transferred to -80°C for storage. To reconstitute frozen stocks, an 
aliquot of frozen culture was streaked onto an LB-agar plate containing the appropriate selection 
antibiotic that was subsequently incubated at 37-C overnight. 
2.4.10. DNA Purification 
DNA purification was routinely performed using the QlAprep spin Miniprep kit (small scale) or 
the Qiagen Plasmid Maxi Kit (large scale), according to the manufacturer's instructions. While 
small-scale purifications were usually performed using 5 ml of overnight cultures of E. cok, the 
large-scale preparations were performed from 100 - 500 ml cultured bacteria (see also para. 2.4.8 
for culture preparation). The principle of both purification protocols is similar: first, bacteria are 
harvested by centrifugation and subsequently resuspended in a Tris-EDTA buffer containing 
RNase A. Then an alkaline lysis is performed using a NaOH/SDS-containing buffer. The reaction 
is stopped by adding a potassium acetate-containing buffer to neutralize the solution. In the case of 
large-scale preparations, the mixture is incubated on ice for a further 20 min to enhance the 
precipitation of genomic DNA, proteins, cell debris and the added sodium dodecyl sulphate, while 
the plasmid DNA remains in solution. The precipitated debris is subsequently removed by 
centrifugation. The resulting supernatant is applied to a resin-loaded column that binds the plasmid 
DNA, and subsequently washed with a medium-salt buffer to further remove contaminants. The 
DNA is finally eluted with high-salt buffer containing low amounts of alcohol to eliminate non 
specific hydrophobic interactions. DNA from small-scale purifications was eluted using 2x 25 µl of 
sH2O, typically yielding 5 µg of DNA at a concentration of approximately 100 ng/µl (see 
para. 2.4.11). In case of large-scale preparations, the eluted plasmid DNA was further desalted and 
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concentrated by isopropanol precipitation and subsequent high-speed centrifugation. The DNA 
pellet was washed with 70% ethanol to remove residual salt and isopropanol, briefly air-dried and 
redissolved in a small volume of TE buffer, pH 8.0, typically yielding a concentration of 1-2 . tg/µl 
(see para. 2.4.11). 
2.4.11. Determining DNA Concentrations 
A dilution of DNA was prepared in a total volume of 1 ml, and transferred to a quartz cuvette for 
spectrophotometric analysis. The OD260 (absorption of DNA) and OD280 (absorption of Tyr and 
Trp residues of proteins) readings were taken, and an A26o/A280 ratio (hence DNA purity) between 
1.8 - 2.0 was deemed acceptable. The DNA concentration was calculated as follows: 
DNA [pg / ml] = OD260 x dilution factor xe (with e(DNA) = 50 pg / ml) 
24.12. Sequencing ofDNA 
DNA was sequenced by MWG Biotech, London, UK using the "value read" option. Per reaction, 
one tube containing 1-2 µg air-dried plasmid DNA and a second tube containing 10µM 
sequencing primer were prepared and dispatched. 
24.13. Determining Protein Concentrations 
Protein content was determined using the Bradford assay and spectrophotometric analysis. A 
standard curve was constructed using samples containing between 0- 50 gg of BSA. To these and 
the experimental sample Iml of Bradford reagent was added. Samples were mixed, and incubated 
for 10 minutes prior to measuring the OD595 was measured. Values for known concentrations 
could subsequently be used to calculate protein concentration of unknown samples. 
24.14. SDS-PAGE 
SDS-PAGE was routinely used to separate and visualize proteins. Poly-acrylamide gels were either 
purchased pre-cast from Invitrogen or cast by hand. Poly-acrylamide resolving gels were routinely 
made using a final 5- 12% acrylamide/bis-acrylamide stock solution in sH2O depending on the 
separation problem. To this (to a final concentration) was added: 0.4 M Tris-HCL pH 8.8,0.1% 
(w/v) SDS, 0.1% (w/v) APS and 0.04% (v/v) TEMED. The mix was poured into the cast and 
overlain with sH2O to ensure flat surface and to create a barrier between gel and air. Once set, 
poly-acrylamide stacking gel was poured on top, consisting of 5% acrylamide/bis-acrylamide stock 
solution, 125 mM Tris-HC1 pH 6.8,0.1% (w/v) APS and 0.1% TEMED in sH2O, and a comb was 
inserted to generate wells for protein loading. Once polymerized, the gels were immersed in SDS- 
PAGE running buffer. To required amount of samples, 10x SDS-PAGE loading buffer was added 
at 10% (v/v) and samples were denaturated at 100°C for 5 minutes before loading into the wells of 
the poly-acrylamide gels. Electrophoresis was performed at constant voltage of 90V for the initial 
30 minutes, then at 180V until the dye front had mi ated to the bottom of the gel. If required, to 
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visualize proteins, gels were immersed in Coomassie stain for 30 minutes. Staining was followed by 
repeated washes in destaining solution until protein bands were detected as clear blue bands over a 
transparent background. 
2.4.15. Western Blotting and Immunodetection 
Proteins separated by SDS-PAGE were transferred from the gel to PVDF membranes by Western 
blotting. Therefore, membranes were wet in methanol and placed over the gel. The gel and 
membrane were sandwiched together between six pieces of Whatman 3MM paper and two foam 
pads, all soaked in transfer buffer. The assembly was placed in a blotting cassette, and transferred 
to a mini-Trans Blot Cell (BioRad) electrophoresis tank containing transfer buffer. The transfer 
step was performed with the application of constant current (200 mA) across the cassette for 180 
minutes at 4°C. Blots were, if required, stained using Ponceau stain to verify successful transfer. 
Membranes were then rinsed with PBS and incubated in blocking solution for 1 hour under gentle 
rocking. Primary antibodies (refer to para. 2.1.8) were added in PBS-T containing 5% (w/v) dried 
skimmed milk or 3% (w/v) BSA, at sufficient volumes to immerse blots entirely for at least 1 hour 
at room temperature or overnight at 4°C with gentle rocking. Blots were washed thrice for 
30 minutes per wash in excess PBS-T. HRP-conjugated secondary antibodies (para. 2.1.8) diluted 
in PBS-T were added and blots were incubated for 30 minutes at room temperature with gentle 
rocking. Again, blots were washed thrice for 30 minutes per wash in excess PBS-T. For detection 
of immunolabelled protein, the enhanced chemo-luminescence (ECL)-plus system (GE 
Healthcare) was used according to the manufacturer's protocol. Membranes were subsequently 
wrapped in saran wrap and exposed to hyperfilm (GE Healthcare) for varying periods to detect the 
luminescence, before film was developed in a Curex 60 developing machine (AGFA). 
2.4.16. Mammalian Tissue Culture 
All work involving the eukaryotic cells listed in para. 2.1.2, were performed in sterile Class II 
vertical laminar flow cabinets until fixation or lysis of cells. Cell lines were cultured at 37°C in a 
humidified atmosphere maintained at 5% CO2. Upon reaching confluency (every 2 -3 days), cells 
were passaged. Growth media was removed by aspiration, cells were washed in sterile PBS and 
incubated with 1 ml trypsin-EDTA solution per 75 cm2 for 2 minutes at 37°C. Cells were 
suspended in 10 ml growth medium and dissociated by pipetting before being transferred into a 
sterile 15 ml reaction tube. After centrifugation for 3 min at 3,000 xg (at room temperature), the 
pellet was resuspended in 10 ml fresh growth medium, and required numbers of cells were 
transferred into new flasks (2 x 106 cells per 75cm2-flask containing 15 ml growth media). 
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24.17. Cryo-preservation and Reconstitution ofEukaryotic Cells 
Routinely, cells from a confluent 150 cm2-flask were detached and centrifuged as described under 
2.4.16. The cell pellet was resuspended in 10 ml of DMEM supplemented with 10% (v/v) DMSO 
and 25% (v/v) FBS. The cell suspension was transferred in 1-ml aliquots into cryovials (Nunc), 
stored at -20°C for 2 hours, then at -80°C for 16 hours before being transferred to liquid nitrogen 
for long-term storage. In the reverse thawing process, cells were removed from the liquid nitrogen 
storage, and thawed rapidly at 37°C. To remove DMSO, cells were washed by transferring them to 
10 ml pre-warmed growth media and centrifuging for 3 min at 3,000 x g. The pellet was 
resuspended in 6 ml growth media and transferred into a 25 cm2-flask. 
2.4.18. DNA Transfection ofEukaryotic Cells 
To introduce plasmid DNA into eukaryotic cells, lipid-based or polyamine-based transfection 
reagents were used according to the manufacturer's instructions. Routinely, per 150.000 -200.000 
cells (50% -70% confluency), 2 µg of plasmid-DNA were used. Cells were cultured as per normal, 
and used 22 hours later. Larger constructs were transfected using a method based on calcium 
phosphate precipitation of DNA. Therefore, growth media was changed 3 hours prior to 
transfection to guarantee optimal pH. For transfection, 4 pg of plasmid DNA were diluted with 
sH2O to a final volume of 135 µl. Subsequently, 15 d of 125 mM CaC12 were added, and 150 tl of 
a 2x HBS solution were added into a second tube. Under gentle vortexing, the diluted DNA was 
transferred to the tube containing the HBS, and the transfection mixture was added drop-wise to 
50% confluent cell. Cells were cultured as per normal, and used 12 - 24 hours later. 
24.19. Transfection ofEukaryottc Cells with s1RNA Duplexes 
Routinely, cells were seeded at 9.5 x 105 cells per well (0 35 mm) of a 6-well plate (approximately 
30% confluency following 16 hours growth). The next day, cells were then washed twice in PBS, 
covered in 800 µl OptiMEM and returned to the incubator. Depending on the experiment, 0.1 - 
0.2 nmol of siRNA duplex (2.5 -5 µl of a 40 µM stock) was combined with OptiMEM in a sterile 
microcentrifuge tube to yield a total volume of 185 p1. In a second tube, 2.5 µl Oligofectamine 
(Invitrogen) was added to 12.5 µl OptiMEM. Both tubes were briefly mixed and left for 15 
minutes at room temperature. The tube contents were combined, mixed briefly and incubated at 
room temperature for a further 30 minutes. The transfection mixture was added drop-wise onto 
the cells and incubated at 37°C. After 6 hours, 500 µl ml of growth media containing 30% FCS 
was added, and cells were incubated for a further 66 hours. 
2.4.20. Preparation of Whole-cell Lysates 
Eukaryotic cells were washed once with ice-cold PBS before being lysed on ice using 60 µl cell lysis 
buffer per 9.5cm2-dish by scraping cells from the bottom of the culture dish. Cells were transferred 
into a microcentrifuge tube, incubated on ice for 5 minutes and lysates were cleared by 
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centrifugation (13,000 x g, 10 minutes, 4°C). The protein concentration in the lysates was estimated 
using the Bradford assay (para. 2.4.13). Lysates were stored at -20°C until subjected to SDS-PAGE 
(para. 2.4.14). 
2.4.21. Immuno labelling for Light Microscopic Analysis 
Unless stated otherwise, cells plated onto glass coverslips (0 22 mm) were washed once in PBS 
and fixed at 37°C for 15 minutes using 4% PFA. Cells were washed extensively in PBS to remove 
all traces of PFA and, if immunolabelling was required, permeabilized using 0.1% Triton X-100 
(v/v). Following permeabilization, unspecific binding was blocked incubating cells in P-BSA, 
which was followed by incubation with primary antibodies (refer to para. 2.1.8) in 100 µ1 of P- 
BSA containing 1 hour. Cells were subsequently washed three times in P-BSA and incubated in the 
dark with secondary antibodies (para. 2.1.8) in PBS for 1 hour (if required, fluorescent drugs such 
as TRITC-phalliodin were added at this stage). Cells were washed thrice with PBS, and once with 
H2O before mounting coverslips onto microscope slides using 5- 10 µl Mowiol or Vectashield 
with DAPI (Vectorlabs). If 0.5% (v/v) saponin in PBS was used for permeabilization, all 
subsequent solutions contained 0.1% saponin, but TritonX-100 was omitted. 
2.4.2 2 Fixed Cell Imaging 
Fixed cell imaging was performed using either a PerkinElmer U1traVIEW LCI spinning disc 
confocal scanner equipped with an Olympus IX-70 inverted epifluorescence microscope or a Leica 
AOBS-SP2 confocal microscope, equipped with an inverted Leica DMIRBE epifluorescence 
microscope. Lenses used were 40x (HCX Apo) with 1.25 numerical aperture (NA), or 63x (PL Apo 
BL) with 1.4 NA oil emersion objectives. Laser lines used (PerkinElmer UltraVIEW) were: an 
Ar/Kr laser to excite all `green' fluorophore (488-nm line) and the 568-nm line for `red' 
fluorophores; emission was collected using 525 ± 50 nm bandpass filters and 600 nm longpass 
filter sets respectively. Laser lines used (Leica AOBS-SP2) were an Ar/Kr laser (488-nm line) to 
excite GFP, Cy2 and Alexa488 fluorophores. He/Ne laser (543-nm line) was used for mRFP, Cy3 
or Alexa568; the 594-nm line and 633-nm line were used to excite Alexa594 and Alexa633/648 
fluorophores, respectively. A 405 nm diode laser was used to visualize DAPI staining. Confocal 
images were typically acquired at 100 - 500 nm separation of z-sections, and 8- 12 sections were 
routinely acquired. Images of single slices or maximum z-projections were initially processed using 
the respective UltraI IEW or Leica software. Optional post-processing was carried out as 
described (para. 2.4.24,2.4.25). 
2.4.23. Live Cell Imaging 
Live cell imaging was performed using an Ultra VIEW LCI spinning disc confocal scanner (Perkin 
Elmer) or a wide-field imaging system (controlled with Openlab 4 software (Improthion), to 
operate electronic focus, shutters and excitation filter wheel). Specifications for the U1traVIEW 
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system are listed under (para. 2.4.22). The wide-field system (in an environmental control 
chamber) equipped with a Leica DMIRB inverted microscope connected to a Hamamatsu CCD 
camera (ORCA ER Firewire; 12-bit digital) was used for digital imaging. A triple dichroic filter was 
used for DAPI/FITC/TRITC (460/20,520/35,600/40), and a 484/15 excitation filter for 
FITC/GFP. A 40x, (1.25 NA) objective and a 63x (1.4 NA) objective were used. For experiments, 
transfected cells grown on coverslips (0 22 mm), were transferred to holders and immersed in 
1 ml pre-warmed imaging buffer. Low level expressors were selected for imaging. Imaging was 
routinely performed for 5- 30 minutes, with capture rates of either 1 frame per second, or with a 
20-second delay for long-term imaging. 
2.4.24. Data Manipulation ofMovies and images 
For post-processing, live cell data for the recorded channels was exported from PerkinElmer 
Ultra VIEW or Leica confocal software as uncompressed movies. Using Image) (NIH public 
domain software), background correction was performed, routinely using the 'rolling ball' (set to 
50) option. The contrast was enhanced by setting the maximum of allowed saturated pixels to 
0.5% and normalizing it for all frames, and entire images only, before an RGB merge was 
performed to yield an overlay of the channels. Typically, movies were exported as QuickTime 
movies or avi files at a rate of 10 frames per second. Movies captured using Openlab software 
(Improtision) were cropped and merged using the Openlab software, and compiled as QuickTime 
movies. To obtain avi files, individual images were exported as tif files, and, using Volod! y 
software V4.0.1 (Improt lion), these were converted into avi movies, typically using Sorensen 
(Sorensen Communications) compression at maximum quality and at 10 frames per second. 
For image processing, obtained images from fixed cell analyses were merged using Leica confocal 
software (Leica Microsystems). Where applicable, contrast and brightness adjustments were made 
using Adobe Photoshop® 6.0 (Adobe Systems Inc. ), but was strictly performed for entire images 
only. 
2.4.25. Deconvolution ofImaging Data and 3D-rendering 
Images, typically 20 - 30 confocally acquired z-slices at a z-separation 100 - 200 nm, or as indicated, 
were iteratively deconvolved using Volody software V4.0.1 (Improti. rian). A point spread function 
(PSF) was calculated for each channel to be deconvolved and was iteratively applied to the raw 
data for 20 cycles, or stopped at 98% confidence (yielding a high degree of deconvolution with a 
manageable degree of computation). The processed images were then rendered in 3D, and either 
exported as avi files, or manipulated using AdobePhotoshop 6.0 (Adobe Systems, Inc). 
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Chapter 3- Role of Retromer in Receptor Retrieval 
3.1. Introduction 
This chapter describes the functional characterisation of endogenous SNX1 as part of a 
multimeric sorting complex, the retromer, and its role in sorting of endogenous hydrolase 
receptors. Besides SNX1, this chapter also describes an initial examination of the role of 
the closely related SNX2 in these processes. 
When commencing my PhD studies, the previously described role for SNX1 in pro- 
degradative transport (Kurten et al., 1996; Cozier et al., 2002) was under debate, since 
despite extensive efforts, this data could not be confirmed for endogenous SNX1 (Kurten 
et al, 1996; JG Carlton, PhD thesis3; Carlton et al., 2004; Gullapalli et al., 2004). In 1996, 
SNX1 had been identified as an interaction partner for the lysosomal targeting region of 
the EGF receptor (Kurten et al., 1996). While this was an exiting find, as it had identified 
the first mammalian sorting nexin, it had heavily relied upon overexpressing the protein. 
Whilst protein overexpression has long been the method of choice to examine the roles of 
a given protein, with the later discovered capacity of the SNX1-BAR domain to stabilize 
membrane curvature, or even to tubulate membranes in a concentration-dependent 
fashion (Carlton et al., 2004), there was concern about the reliability of the overexpression 
data. Indeed, while the original study reported that deleting the SNX1 C-terminus 
prevented downmodulation of the EGFR (Kurten et al., 1996), this region was only later 
identified as part of the BAR domain (Peter et al., 2004). Hence, this suggested that the 
effect of promoting EFGR degradation could be an artefact of overexpression-induced 
membrane tubulation directly or indirectly mediated by the BAR domain. 
Besides a pro-degradative function, a role for SNX1 in retrograde sorting - therefore away 
from the degradative route (Haft et al., 2000; Pfeffer, 2001) - had been discussed at the 
time. This model was based on identification of proposed mammalian orthologues of the 
yeast retromer complex (Edgar and Polak, 2000; Haft et al., 2000). In yeast, numerous 
studies had established an important role for this complex in the retrieval of late-Golgi 
complex resident proteins from a pre-vacuolar/endosomal compartment [see (Pfeffer, 
2001; Seaman, 2005) for review]. Hence, the finding that the yeast retromer component 
3 JG Carlton, Examining the Role of Mammalian Sorting Nexinr, Ph. D. thesis, University of Bristol, Bristol, 2004 
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Vps5p shared extensive sequence homology with SNX1 (Nothwehr and Hindes, 1997), 
and that SNX1 furthermore interacted with VPS35 (Haft et al., 1998; Gullapalli et al., 
2004; Rojas et al., 2007), the proposed cargo-selective component of a mammalian 
retromer complex, gave rise to a model which implicated SNX1 in retrograde sorting. 
Nevertheless, when commencing these studies, there was no direct evidence for a 
conserved function of retromer in mammalian cells, as a cargo was still elusive. For these 
reasons, at the start of my PhD I embarked on a project scrutinizing the proposed role for 
SNX1 as part of a mammalian retromer complex, investigating the relationship of SNX1 
to other components of the retromer and questing for possible cargo. 
The commencement of this project was greatly aided by the preliminary work of members 
in the Cullen Lab, including Dr Alex McGregor, Dr Gyles Cozier, but particularly Dr Jez 
Carlton, who must be thanked for the elaborate characterization of SNX1, and his work 
rebutting a role for endogenous SNX1 in EGF receptor trafficking. All work performed 
by, or with, those other than myself is accordingly acknowledged. 
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3.2 Materials 
General materials and methods, as well as exact media and buffer compositions and other 
reagents have been described in Chapter 2. We are indebted to Dr Muriel Mari, Prof Judith 
Klumperman and Prof Hans Geuze, Cell Microscopy Center, University of Utrecht, The 
Netherlands, for providing outstanding electron micrographs and in-depth ultrastructural 
analysis of endogenous SNX1, SNX2 and the characterization of endosome-to-TGN 
carriers. The anti-VPS26 and anti-SNX1 polyclonal antibodies and HeLaM cells were kind 
gifts from Dr Matthew Seaman and the anti-CI-MPR antibody was from Prof Paul Luzio, 
both Cambridge Institute for Medical Research, Cambridge, UK. The polyclonal anti- 
sortilin antibodies were kind gifts from Prof Claus M Petersen, Aarhus University, Aarhus, 
Denmark. 
3.21. Co-Jo calization Analysis 
To quantify the co-distribution of SNX1 with other cellular proteins, cells were processed 
for immunofluorescence labelling (see para. 2.4.21) and imaged, capturing 8-10 optical z- 
slices per visual field (para. 2.4.22). Co-localization analysis of two vesicular proteins in 
maximum projections was performed using the co-localization plug-in in ImageJ (NIH 
Image), creating a composite image of co-localizing vesicles. Enumeration of vesicles was 
done using the Colony Counter tool of ImageQuant TL software (GE Healthcare) for 
individual channels and co-localization composite images obtained through Image)-aided 
analysis. Degree of co-localization is expressed as percentage of all vesicles positive for the 
marker over total number of vesicles. 
3.2.2. Generation ofpmRFP-SNXI 
To obtain the red fluorescent protein (RFP)-SNX1 fusion construct, a pmRFP-SNX1 
eukaryotic expression vector was generated that made use of the pmRFP-Cl plasmid 
consisting of the "backbone" of the commercially available pEGFP-C1 (Clontech) but 
with the coding region for GFP being replaced by the sequence for monomeric RFP1 
(para. 2.1.4, originally developed by Dr Jez Carlton). A plasmid containing the mRFP1 
coding sequence was a kind gift from Prof Roger Tsien, UCSD, La Jolla, USA, and 
mRFPl was generated by stepwise evolution of DsRed (Discosoma coral) to a dimer and 
then to a true monomer designated mRFP1 (monomeric red fluorescent protein) with the 
excitation and emission peaks of 584 nm and 607 nm, which are -25 nm red-shifted from 
DsRed (Campbell et al., 2002). The sequence encoding for SNX1 was subcloned into 
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pmRFP-C1 from a pEGFP-CI-SNX1 construct (originally developed by Dr Alex 
McGregor) using the EcoRI and SaII restriction sites (for a complete vector map refer to 
Appendix 11.1; the resulting construct was sequenced (see Appendix I for primers). 
3.2.3. Generation ofpEGFP-C1-VPS35 
To obtain a green fluorescent protein-VPS35 fusion protein (GFP-VPS35), first, the 
coding sequence of VPS35 was amplified by PCR using pCMU-3xFLAG-VPS35 as a 
template (a kind gift from Dr Rohan Teasdale, University of Queensland, Brisbane, 
Australia); the sequence of the primers, containing a Xhol (5'-primer) and BamHI (3'- 
primer) restriction site, can be found in Appendix I. Using the XhoI and BamHI 
restriction sites, the sequence for VPS35 was inserted into the commercially available 
pEGFP-C1 (Clontech) plasmid. For a complete vector map refer to Appendix 11.2; the 
resulting construct was sequenced (see Appendix I for primers). 
3.2.4. CDS-CI-MPR Traflrcldng Assays 
HeLaM cells stably expressing a CD8-CI-MPR chimera were seeded onto coverslips (0 
22 mm) in 9.5 cm2-wells and treated with either control, or SNX1- and SNX2-specific 
siRNA duplexes as described in par 2.4.19. After 72 hours, cells were washed in ice-cold 
PBS, the coverslips were transferred to 3 ml pre-chilled DHB medium, and incubated at 
4°C for 15 minutes to stop traffic. Cell-surface CD8-CI-MPR was labelled with 1 µg anti- 
CD8 in 100 tl DHB medium, incubating cells for 30 minutes at 4°C. Coverslips were 
washed thoroughly with ice-cold PBS, then either fixed directly (0-minute time point) or 
transferred to wells containing pre-warmed (37°C) complete growth medium, and 
incubated for indicated periods and then fixed. Cells were processed for immunolabelling 
(refer to para. 2.4.21). In any case, the anti-CD8 antibody was detected using an 
appropriate fluorescence-coupled secondary antibody to visualize the CD8-CI-MPR. Fixed 
cells were imaged taking routinely 8 confocal z-sections at the same z-separation (typically 
480 run) and applying identical microscope- and laser-settings to all samples. The amount 
of TGN-resident anti-CD8 was determined by additional immunofluorescence-labelling 
with anti-TGN46. Co-localization in confocal images was quantified using LCSLite 
(Leica). 
3.2.5. CD8- uptake Assays 
HeLaM cells stably expressing CD8-CI-MPR constructs were grown on coverslips and 
transfected with plasmid DNA at 50% confluency (see para. 2.4.18). After 22 hours, cells 
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were washed with ice-cold PBS, the coverslips transferred to 3 ml pre-chilled DHB 
medium, and incubated at 4°C for 15 minutes to stop traffic. Cell-surface CD8-CI-MPR 
was labelled with 50 µg/ml RPE-coupled anti-CD8 (RPE-CD8) in DHB medium, 
incubating cells for 30 minutes at 4°C. Coverslips were rinsed with ice-cold PBS, then 
transferred to coverslip holders and mounted onto a heated microscope stage where pre- 
warmed (37°C) imaging buffer was added. Cells were inspected by epifluorescence, and 
uptake was followed for 10 minutes before confocal live cell imaging was started using a 
PerkinElmer LCI Ultra VIEW system. 
3.2.6. Sortilin Stability Assays 
Cells were transfected with the relevant control and SNX1-specific siRNA duplexes as 
outlined in para. 2.4.19 for 72 hours, then the treatment was repeated, and 20 hours into 
the second treatment, control and SNX1-suppressed cells were either lysed directly or 
treated with a freshly prepared 40 tg/ml-cycloheximide (CHX) solution. Where 
appropriate, lysosomal protease inhibitors (PI) in the form of 1mg/ml leupeptin and 
10 µg/ml E-64 were added. CHX and PI were replaced every 4 hours and cells were lysed 
after 12 hours. Of each sample, 20 µg protein, as determined by Bradford assay 
(para. 2.4.13), was subjected to SDS-PAGE (para. 2.4.14), Western blotting and immuno- 
detection (para. 2.4.15) using anti-sortilin, anti-SNX1 antibodies and anti-ß-actin 
antibodies as loading control. Quantification was carried out by volume integration using 
ImageQuant software (GE Healthcare). Results were normalised by dividing the intensity 
values obtained for the sample by the intensity of the band for the respective loading 
control. 
3.2.7. Preparation for Electron Microscopy 
Untreated, control- or SNX1-siRNA treated HepG2 cells cultured in 6-well plates (see 
para. 2.4.19) were grown to 80% confluency and the media was changed the day before 
fixation. On the following day, half of the media was removed and replaced with 8% PFA 
solution (in PB: 0.1 M phosphate buffer, pH 7.4), by gently agitating the plate, yielding a 
final concentration of 4% PFA. Cells were fixed for 15 minutes at room temperature, and 
the solution was subsequently replaced by one volume of 4% PFA in PB. After 4 hours 
incubation at room temperature, the plates were sealed with parafilm and transferred to 
4°C for 16 hours. The next day, cells were warmed to room temperature, the fixative was 
removed and cells were washed three times with O. 1M PB. The wells were then completely 
filled with 2% PFA in PB before being carefully sealed using parafilm and kept at 4°C until 
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being shipped at ambient temperature to Dr Muriel Mari at the laboratory of Prof Judith 
Klumperman and Prof Hans Geuze. All immuno-gold labelling, immuno-electron 
tomography and 3D reconstructions were performed by Dr Muriel Mari and Dr Dagmar 
Zeuschner as described previously (Slot et al., 1991; Zeuschner et al., 2006). Besides the 
listed antibodies (para. 2.1.8), these studies additionally used anti-AP-1 antibodies (Prof 
MS Robinson, CIMR, Cambridge, UK), anti-ASPGR (Prof AL Schwartz, Washington 
University, St Louis, MO, USA) and anti-Hrs (Dr S Urbe, University of Liverpool, 
Liverpool, UK). Furthermore, anti-CD63 (hybridoma cell line HSC6, obtained from the 
University of Iowa, Department of Biological Sciences, Iowa City, USA), anti-Alexa488 
and anti-GFP (both Invitrogen), anti-GGA3 and anti-Rab4 (both BD Biosciences) 
antibodies were used. 
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3.3. Preliminary characterization ofSNXJ and SNX2 
3.3.1. Sequence alignment of the sorting nexins Vps5p, SNXI and SNX2 
My reasoning to analyse both sorting nexins, SNX1 and SNX2, stemmed from the finding 
that the two proteins share approximately 63% sequence identity, and both are highly 
similar to yeast Vps5p (Figure 3.1): a search of the whole yeast genome against a data 
base of all human expressed sequence tags returned SNX1 and SNX2 as best matches 
suggesting orthology of these proteins (Haft et al., 1998). As there appears to be no 
mammalian homologue for the second yeast sorting nexin (Vpsl7p) it was argued that 
SNX2 might fulfil this role in a mammalian retromer complex as indeed, previous studies 
had established that SNX1 and SNX2 can form hetero- and homo-oligomers (Haft et al., 
2000). 
As can be seen from Figure 3.1, when comparing sequences of all three proteins (Vps5p, 
SNX1 and SNX2), a high degree of similarity is found - expectedly - over the length of the 
PX domain, which is the `selection criteria' or hallmark for the sorting nexin family. 
Besides the central PX domain, the three proteins also show extensive sequence homology 
at the C-termini containing the predicted coiled-coil/BAR domains. In contrast, the 
sequence conservation at the N-termini is relatively poor. Overall, SNX1 and Vps5p share 
-22% identity over 498 amino acids, while SNX2 and Vps5p are 21% identical over a 
stretch of 503 amino acids. 
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Figure 3.1 Sequence alignment of SNX1 and SNX2 and the yeast orthologue 
Vps5p. 
Sequences of human SNX1 (h_SNX1; see para. 2.1.6), SNX2 (h_SNX2; para. 2.1.6) and yeast 
Vps5p (NCBI Accession number AAB41798) were aligned using the CLUSTALW program 
available at the EMMBNET server (http: //www. ch. embnet. org) and the alignment was edited by 
hand. There is extensive sequence identity, especially over the PX domain (highlighted in yellow, 
with n-sheets and (x-helices of the PX-domain fold indicated). Identity is also found in the C- 
terminal half, containing predicted coiled-coil domains (highlighted in blue). Stars (*) indicate an 
identical amino acid at this position in all three sequences; dots (. ) or colons (: ) indicate similar or 
identical amino acids in at least two of the sequences. Black bar: PxxP motif; two genetically 
engineered mutants of SNX1 are indicated (Carlton et al., 2004): arrow head: K214R mutant (PX- 
domain mutant, cytosolic); red bar: KKR->EEE mutant (BAR domain mutant, cytosolic). 
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3.3.2. Determining the subcellular distribution of endogenous SNX1 and 
SNX2 
Initial studies were aimed at determining the relative distribution of SNXI and SNX2 in 
HeLa cells. In these assays we made use of antisera that specifically recognize SNX1 
(raised in rabbit) or SNX2 (raised in mouse) that showed no cross-reaction (data not 
shown, but compare Figure 3.8). The specificity of the antisera was furthermore 
confirmed by immunodetection of the respective SNX in SNX1- and SNX2-suppressed 
cells on Western blots (Figure 3.7). 
When I performed immunofluorescence-based light microscopic co-localization studies of 
the endogenous proteins, SNX1 and SNX2 displayed a punctate distribution throughout 
the cytoplasm, with enrichment in the perinuclear area (Figure 3.2) Substantial co- 
localization was observed on vesicular structures on both, the more peripheral, but 
especially on perinuclear vesicles. Quantification of the degree of co-localization revealed 
that over 90% of all SNX1-positve structures Ire also positive for SNX2 (Table 3.1). 
Similar results were obtained using antibodies against SNX1 raised in goat (data not 
shown). The observed punctate pattern and distribution of endogenous SNX1 agreed well 
with previous results assessing the subcellular distribution of overexpressed human SNX1 
analysing its association with vesicular and tubulo-vesicular structures of an early 
endosome (Kurten et al., 1996; Chin et al., 2001; Kurten et al., 2001; Teasdale et al., 2001; 
Cozier et al., 2002; Pons et al., 2003). 
merge 
Figure 3.2 Co-localization analysis of endogenous SNX1 and SNX2 
HeLa cells were fixed and processed for immunofluorescence analysis using antibodies against 
SNX1 (A1exa568, red) and SNX2 (A1exa488, green). Nuclei were visualized using DAPI. Scale bar 
is 20 µm. 
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It is of note that previous immunofluorescence-based analyses of the subcellular 
distribution of endogenous SNXI in HeLa cells had yielded conflicting results regarding 
the degree of co-localization with the early endosomal resident protein EEA1 (Gullapalli et 
al., 2004; Wang et al., 2004). I thus sought to analyse co-localization of SNXI and EEA1; 
as part of this analysis, I also analysed co-localization with lysosomal-associated membrane 
protein-1 (Lamp-1), a protein localized to multivesicular bodies (MYBs) and lysosomes. As 
can be seen in Figure 3.3 and from Table 3.1, while there is substantial, but not complete 





EEA1 (Alexa568, red) 
Lamp-1 (Alexa568, red) 
Figure 3.3 Co-localization analysis of SNX1 with early endosomes and MVB / 
lysosomal markers. 
HeLa cells were processed for immunofluorescence labelling using anti-SNX1 (A1exa488, green) 
and either anti-EEA1 (A1exa568, red) or anti-Lamp-1 (Alexa568, red) antibodies. Images shown 
captured using a PerkinElmer CltraI"IEWI LCI system are maximum projections of 10 - 12 z- 
sections. Scale bar is 10 µm. 
rIII, 
Marker Co-localization 
SNX2 88.3 2.5 
EEA1 65.8 ± 3.0 
LAMTP1 3.3 ± 1.1 
Lo-locallzauon was analysed by eye as 
coincidental localization of SNX1 with the given 
marker on every vesicle on at least five cells for 
individual z-sections of confocal images and 
given as percentage of the total number of 
vesicles counted in a given cell. 
Table 3.1 Co-localization analysis of SNX1 with different endosomal proteins 
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3.4. O ver exp ression of SNXI 
Besides analysing the localization of endogenous SNX1 in fixed cells, I also sought to 
examined the intracellular dynamics of fluorescently-labelled SNX1 fusion proteins to 
better understand the spatio-temporal `behaviour' of SNX1. 
Another aspect this chapter is the succinct illustration of the effects of strong 
overexpression on endosomal morphology, and examination of the effect of exposure to 
low temperatures on the association of GFP-SNX1 with intracellular membranes, as these 
findings have implications on experimental design. 
Routinely, in these assays cells were transfected with fluorescent GFP-SNX1 (para. 2.1.5) 
or RFP-SNX1 (para. 3.2.2) for 22 hours, then analysed by live cell imaging (LCI, par 
2.4.23), or fixed and processed for immunofluorescence (I) analysis using the previously 
described antibodies as reference markers (SNX1, SNX2, EEA1, Lamp-1). 
Generally, after 22 hours of expression, GFP-SNX1 displayed a vesicular appearance in 
the majority of cells and co-localized well with EEA1 (Figure 3.4 B), or endogenous 
SNX2 (data not shown) indicating the correct targeting of the probe. In a qualitative 
analysis of the LCI, I found these vesicles to be very motile (Movie 3.1.1), with the 
relatively smaller SNX1-decorated structures showing the highest motility. Over the course 
of short distances, movement of these structures is best described as `burst-like' and 
directional, and often accompanied by sudden changes in direction. The directionality, 
velocity and non-random quality of movements might suggest transport along 
microtubules. Larger structures appear more inert and movement is rather oscillatory. 
Fusion of vesicles and emergence of more tubular SNX1-decorated structures from these 
punctae was frequently observed. Unfortunately, analysis of vesicle movement in a more 
quantitative way by utilizing conventional single-particle tracking programs available to us 
proved to be not feasible, as the tracking problem is not trivial: changes occur, often 
simultaneously, at the level of directionality, signal intensity (factor and variation), velocity, 
as well as in size and shape of the particle due to tubulation out of the vesicle. It is not 
clear to us at this point, whether the more inert structures are a result of the higher protein 
content of the structure due to overexpression, or whether they represent less motile 
endosomal structures (Lakadamyali et al., 2006). 
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Besides the vesicular phenotype in low expressing cells, some cells exhibited extensive 
GFP-SNX1-decorated tubules (Figure 3.4 C), the fraction of which increased when the 
period of GFP-SNX1 expression was prolonged. The predominant occurrence of the 
`tubular phenotype' with increased expression time correlates with the finding that in in 
titm assays, SNX1 tubulates (or stabilizes) liposomes in a concentration-dependent fashion 
(Carlton et al., 2004). Thus, one would imply that longer expression time leads to 
accumulation of more GFP-SNXI, hence occurrence of increased tabulation. 
According to the intensity of green fluorescence and virtual absence of tubulation, cells 
displaying a vesicular appearance were deemed `low expressors'. In these cells, GFP-SNX1 
co-localized with EEA1 (Figure 3.4 B) to a similar extent observed for endogenous 
proteins (Figure 3.3 A), indicating that at these levels, membrane homeostasis is not 
detectably perturbed. In contrast, when examining cells that displayed notable tubulation, 
the EEA1-labelled compartment appeared on one hand partly enlarged (Figure 3.4 C, 
arrows) compared to low expressors (Figure 3.4 B), or non-transfected control (Figure 
3.3 A). On the other hand, on contiguous GFP-SNX1-labelled tubules, the discrete 
EEAI-positive vesicles appeared almost as `beads on a string' (Figure 3.4 C, boxed area). 
Strikingly, even in cells displaying high levels of GFP-SNX1 overexpression I found 
virtually no co-localization with Lamp-1 (Figure 3.4) in accord with the results for 
endogenous SNX1 (Figure 3.3). From this data, it appears that SNX1 selectively 
tubulates early endosomal membranes, or at least membranes inaccessible to Lamp-1. In 
strongly overexpressing cells, most of these tubules are rather `stable', meaning that when 
analysed by live cell imaging (Movie 3.1.2, which shows an example of an extensively 
overexpressing cell), tubules did not disintegrate and appeared as continuous membranes. 
Preliminary EM studies have indicated that strong overexpression of SNX1 can result in 
membrane-'superfolds' showing GFP-SNX1 localized beneath layers of endosomal 
membrane (Prof Judith Klumperman, personal communication). Likewise, preliminary 
FRAP experiments have shown that `stable' tubules are rather inert to fluorescence 
recovery after photobleaching (data not shown). This might indicate that under these 
conditions, photo-bleached GFP-SNX1 is not freely accessible to the cytoplasm, either by 
entrapment between membrane layers or by stable complexation, indicated by its ability to 
form large-size aggregates in titro (Haft et al., 1998; Haft et al., 2000). I have however 
chosen not to investigate this in further detail, but to concentrate on more physiological 
conditions. 
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Figure 3.4 Effects of strong overexpression of GFP-SNXI and exposure to low 
temperatures. 
HeLa cells transfected with GFP-SNX1 for 48 hours were transferred into ice-cold DHB medium 
for 45 min, and either fixed directly or following incubation in normal growth medium at 37°C for 
indicated times. Cells were processed for immunolabelling using the indicated antibodies and 
DAPI to stain nuclei. Exposure to 4°C rendered GFP-SNX1 largely cytosolic, while after 15 min at 
37°C, SNX1 had reassociated and displayed a vesicular distribution. Different degrees of 
overexpression are shown. Note enlarged EEA1-positive structures in strongly overexpressing cells 
(C), and GFP-tubules with associated EEAI (boxed area, C). Lamp-1 is virtually absent from 
tubules (D). Scale bar is 10 µm. 
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Another important results of this study was the finding that prolonged incubation at 4°C 
rendered most of the GFP-SNX1 probe cytosolic, while association of EEA1 (Figure 3. 
4 A) or Lamp-1 (data not shown) with vesicular structures appeared unaltered. It is well 
known that EEA1 localizes - by means of its FYVE domain (Stenmark et al., 1996), but 
also through interaction with RabS (Simonsen et al., 1998) - to the vesicular body and has 
not been found on tubular profiles. So besides increased affinity, membrane-geometry 
might be factor, as tubules might not be effectively preserved at lower temperature (see 
also below). 
Transferring cells to 37°C resulted in vesicular and tubular reassociation of GFP-SNX1, 
and was as a function of time and temperature (Figure 3.4 B, C, D); after 15 minutes, the 
distribution pattern in these cells was indistinguishable from cells not exposed to low 
temperature. At 4°C however, the protein was observed to be cytosolic in virtually all cells, 
while with increased time and temperature, I did observe GFP-SNX1-`tubulated' cells: if 
one considers these findings together with the observed relative inertness of membrane- 
tubules harbouring high amounts of GFP-SNX1, this suggests that the tubular profiles do 
not withstand cold temperatures. This notion was further reinforced when attempting to 
preserve tubules decorated with endogenous SNX1 (Chapter 5), which was only achieved 
when fixing cells at physiological temperatures. This would correlate with the 
interpretation that the SNX1-BAR domain equips the protein with a curvature sensor that 
requires a certain geometry to effectively associate with curved membranes (Carlton et al., 
2004). 
As a control, I additionally generated a vector encoding for a red fluorescent SNX1 fusion 
protein, consisting of a monomeric red fluorescent protein (RFP) and C-terminally of this, 
full-length SNX1 (refer to para. 3.2.2 and Appendix II. 1). At low expression levels, this 
construct exhibited identical localization compared to GFP-SNX1, confirming that effects 
were not caused by the properties of the GFP moiety (compare also para. 3.4). 
In the light of the functional data showing that strong overexpression of full length SNX1 
does enhance endosomal degradation (Kurten et al., 1996; Cozier et al., 2002), these data 
put into perspective the problems arising when not carefully monitoring levels of 
overexpression. Nevertheless, these results also demonstrate that given low expression 
levels and physiologic temperatures, overexpressed SNX1 appears not to grossly perturb 
endosomal morphology as examined by light microscopy. 
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3.5. Subcellularlocalization ofretromer components 
With these considerations in mind, I embarked on a project where I wished to examine the 
relative subcellular localization of SNX1 and SNX2 to other retromer components using 
live cell imaging (LCI) analyses and immunofluorescence-based co-localization studies. 
Although membrane association of SNX1 and binding to VPS35 had been shown 
biochemically (Haft et al., 1998; Haft et al., 2000), at commencement of these studies the 
subcellular localization of individual mammalian retromer components at microscopic 
level had not yet been established. 
I reasoned that this analysis could provide me with information about the nature of a 
retromer-resident subcellular compartment and provide cues about the itinerary of 
structures labelled with these proteins and potentially give insights into the function of a 
mammalian retromer complex. 
In case of VPS26, an antibody was available (a kind gift from Dr Matthew Seaman, CIMR, 
Cambridge, UK) allowing examination at endogenous protein levels. With the lack of an 
antibody recognising VPS35, I decided to generate a fluorescently-labelled VPS35 fusion 
protein. To do so, I genetically engineered a eukaryotic expression vector encoding for a 
green fluorescent protein (GFP) N-terminally ligated to the sequence encoding for VPS35 
(see para. 3.2.3 and Appendix 11.2). This furthermore provided me with a tool to 
examine intracellular dynamics of VPS35 employing live cell imaging analyses. 
VPS35 
In fixed cells studies, I found GFP-VPS35 localised to punctate intracellular structures 
(data not shown, but see Figure 3.5). When analysing cell co-expressing GFP-VPS35 and 
RFP-SNX1 using LCI analysis, both proteins co-localized well on vesicular structures as 
well as tubular profiles (Movies 3.1.1 - 3.1.3, Figure 3.5 A), which were not preserved in 
the fixed cell studies. The inspection of more than five cells (examined for at least 
2 minutes) also showed that in all cases, both proteins moved conjointly on vesicular 
structures in the cytoplasm, with the most highly motile structures moving toward the 
perinuclear area (top left corner, labelled as `Nu' in Figure 3.5 A). 
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A. 
B. 
Figure 3.5 SNX1 co-localizes with retromer components VPS35 and VPS26 
(A) HeLa cells were transiently transfected with RFP-SNXl (red) and GFP-VPS35 (green) for 
22 hrs and imaged live (see also Movies 3.2.1 -3.2.3). One frame of the movie is presented showing 
only the perinuclear area of a cell with `Nu' (merge) denoting nucleus, the edge of which is 
demarcated by a dashed line. Both proteins co-localize on punctate structures but also tubular 
profiles (arrows). (B) HeLa cells were fixed and processed for immunolabelling using anti-SNX1 
(Alexa488, green) and anti-VPS26 (Alexa568, red). Scale bar is 10 µm. 
Generally, as also described in para. 3.3 and Chapter 5, tubular profiles are notoriously 
difficult to preserve, whether at endogenous or low overexpression levels. Thus, I suggest 
that the poor detectabilty of tubular profiles at fixed-cell level is mainly due to the transient 
nature of the tubular compartment, as illustrated by LCI, as well as the documented 
instability of membrane association of SNX1 under certain fixation conditions (see 
para. 3.3). 
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To analyse co-distribution of different retromer components at level of endogenous 
proteins, cells were fixed and immunolabelled with antibodies recognizing VPS26 and 
SNX1 (Figure 3.5 B) or SNX2 (Figure 3.6), respectively. In these assays I observed 
some degree of co-localization between SNX1 and VPS26 on vesicular structures on 
peripheral structures, but co-localization was most prominent on vesicles in the 
juxtanuclear area (Figure 3.5 B). Likewise, I observed extensive co-localization of 
endogenous SNX2 and VPS26 (Figure 3.6 A, B). This result was somewhat expected 
given the extensive overlap observed between SNX1 and SNX2. To examine the co- 
localization on vesicular structures in more detail, images consisting of 16 confocal z- 
sections, at a z-separation of 122 nm, were deconvolved and 3D reconstructed using 
Volody software (Impromsion) (Figure 3.6 B). This type of analysis also revealed that 
juxtanuclear vesicles labelled for VPS26 and SNX2 were in very close proximity to the 
TGN (Figure 3.6 B; shown in magenta, some ribbons specified by asterisks), as 
determined by labelling for TGN46 (Ponnambalam et al., 1996). It was noticeable that 
distribution of both, the green and red fluorescence signal, often appeared `polarized' on 
vesicles (Figure 3.6 B). At the level of immuno-light microscopy is it however not 
possible to decide whether this truly represents sub-domain targeting. In this context, later 
immuno-electron microscopy studies examining the localization of SNX1 and VPS26 at 
ultrastructural level have indeed demonstrated that distribution on sorting endosomes is 
not identical (compare para. 3.6.7 and Arighi et al., 2004). 
Hence, in HeLa cells, the sorting nexins SNXI and SNX2 co-localize with the VPS- 
components in fixed cells and at a dynamic levels. While these co-localization studies do 
not provide insights into a functional relationship, they demonstrate that individual 
retromer components are closely spatio-temporally linked. 
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A. 
B 
SNX2 (Alexa488, green) 
Figure 3.6 Co-localization analysis of SNX2 and VPS26 
(A) HeLa cells were fixed and processed for immuno-labelling using anti-SNX2 (A 1exa488, green) 
and anti-VPS26 (Alexa568, red). (B) The 16 confocal z-sections, each at 122 nm z-separation, of 
the maximum projections shown in (A), were deconvolved and 3D-rendered using Volocity 
software (Improvision). A tilted and rotated view and a magnification, largely corresponding to the 
ROI shown in (A), is shown. `Nu' denotes nucleus; asterisks are placed on selected TGN ribbons 
as labelled by anti-TGN46 (Alexa633, magenta). Scale bar is 10 µm. 
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3.6. RNAi approach to investigate SNXI and SNX2 function 
The finding that overexpression of SNX1 caused a dramatic tubulation of early endosomes 
led us to seek for ways to examine SNXI function under more physiological conditions. I 
thus employed an RNA interference-based approach. Briefly, this technique pioneered by 
Andrew Z. Fire and Craig C. Mello [see also article by (Montgomery, 2006)] is based on 
the natural cellular RNA interference response to introduction of short RNA duplexes, 
with an apparent optimal length of 21 - 22 nucleotides for mammalian culture cells 
(Elbashir et al., 2001). The introduction of these small interfering RNAs (siRNAs) leads to 
specific silencing of genes complementary to the introduced the siRNA-antistrand and as a 
result, to suppression of protein expression. 
General remarks on the siRNA used in this study 
The siRNAs used were designed and previously characterized by Dr Jez Carlton (PhD 
thesis4 and Carlton et al., 2004; Carlton et at, 2005), and it was shown that suppression of 
SNXI using these sequences does not result in global trafficking defects, as no effects on 
EGF/EGFR of Tf/TfR internalization, recycling or degradation were observed. 
Results 
When treating HeLa cell with these duplexes for 72 hours, expression of SNX1 or SNX2 
was found to be markedly reduced as assessed by immuno-detection from whole-cell 
lysates (Figure 3.7), or immunofluorescence analysis (Figure 3.8). In cells treated with a 
non-targeted control siRNA, both, SNX1 and SNX2 were detected as 68-kDa band, 
respectively. Treatment with SNX1-specific siRNA routinely lead to 90% reduction of 
SNXI protein levels, as determined by volume integration of Western blots (Figure 3. 
7 A; compare Chapter 4, Figure 4.13 for further quantification). Likewise, when 
examining SNX1-suppressed cells by light microscopy, the fluorescence signal for 
immunofluorescence-detected SNX1 was very low or even undetectable indicating the 
absence of this protein in the treated cells (Figure 3.7; Figure 3.8 e, m). Likewise, 
SNX2-specific siRNA effectively suppressed SNX2 expression to greater than 80% 
(Figure 3.7 A and Chapter 4, Figure 4.13). And when assessed by immunofluorescence 
analysis, I routinely found the signal for SNX2 to be markedly reduced (Figure 3.7 C, D; 
Figure 3.8 j, n). It is to be noted that in some but not all instances, cells treated with the 
SNX2-specific siRNA showed a pronounced `triangular' shape, meaning that these cells 
4 JG Carlton, Examining the Role of Mammalian Sorting Nexins, Ph. D. thesis, University of Bristol, Bristol, 2004. 
70 
Chapter 3- Role of Retrorer in Receptor Retrieval 
were thinner and longer (or, from a different perspective, had a reduced volume). 
Compared to cells treated with SNXI-specific or control siRNA, I furthermore noticed 
that SNX2-suppressed cells proliferated less well. These are qualitative observations, and I 
have not further investigated this. These effects could however be linked to the 
documented interaction of SNX2 with Abstrakt (Abdul-Ghani et al., 2005), a protein that, 
in Drosophila, has been involved in many developmental processes, including cell-shape 
changes, localization of RNA and apoptosis (Irion and Leptin, 1999; Schmucker et al., 
2000; Irion et al., 2004). Its human homologue was shown to be ubiquitously expressed 
(Sekito et al., 2005) but has yet to be characterised in detail. Importantly though, previous 
studies using this siRNA duplex have found that trafficking steps, like TfR recycling and 
EGFR degradation were not perturbed, suggesting that global endosomal processes are 
not grossly altered in cells treated with the SNX2-specific siRNA QG Carlton, PhD thesis; 
Carlton et al., 2005). 
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Figure 3.7 Effect of siRNA-mediated suppression of SNX1 and SNX2 
(A) HeLa cells were treated with control, SNX1- or SNX2-specific siRNA for 72 hours, before 
being lysed and subjected to SDS-PAGE. After Western blotting, membranes were probed with 
anti-SNXI, anti-SNX2 and anti-(3-actin which served as loading control. (B-D) Cells plated on 
coverslips and treated with the respective siRNAs for 72 hours were processed for 
immunofluorescence detection. (B) Cells were simultaneously labelled with anti-SNX1 (Alesa488, 
green) and anti-TGN46 (A1exa594, red), nuclei were visualized using DAPI. The SNX1-signal is 
virtually absent, indicating successful suppression (TGN46 and DAPI serve as visual reference). 
(C) Cells treated with SNX2-specific siRNA were labelled with anti-SNX2 (Alera488). The signal is 
markedly reduced compared to control cells (D. ), in which cells treated with control siRNA were 
labelled with anti-SNX2 (Alexa488) and imaged under exactly the same conditions. Scale bar is 
10 µm. 
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Effects ofSNX1 suppression on endosomal integrity 
Importantly, when treating cells with the SNX1-specific siRNA, the integrity of the Golgi 
complex and endosomes appeared not to be grossly affected, as examined at the level of 
light microscopy: in these assays I labelled the Golgi compartments using the TGN- 
enriched protein TGN46 (Figure 3.7 B) or the medial- and cis-Golgi resident protein 
giantin (data not shown for HeLa cells, but compare Figure 3.20 for HepG2 cells yielding 
analogous results). When labelling SNX1-suppressed cells with anti-TGN46, the 
fluorescence pattern (Figure 3.7 B) was comparable to the fluorescence pattern observed 
in control cells (Figure 3.9), but maybe slightly `sprawled'. EM studies using SNX1- 
suppressed HepG2 cells later confirmed that at ultrastructural level, the TGN morphology 
was indeed not grossly affected by the treatment (Dr Muriel Mari, personal 
communication). Likewise, I found no obvious alteration in the localization of EEA1 (data 
not shown, but compare Carlton et al., 2004), and localization of the respective other SNX 
was unaffected, as was the membrane association of VPS26 in these cells (Figure 3.8). 
Membrane recruitment ofretromer components 
The observed preservation of the targeting indicates that the individual proteins can be 
independently recruited onto endosomal membranes. This is somewhat expected for 
SNXs as they possess Ptdlns3P-binding PX domains, but neither VPS26 nor VPS29 or 
VPS35 possess obvious membrane-binding motifs. Further still, it has been found that 
recruitment of the VPS-components is wortmannin-sensitive, suggesting a Ptdlns3P- 
sensitive `linker' (Rojas et al., 2007). Nevertheless, when assessing the localization of VPS26 
in cells jointly treated with SNX1 and SNX2 siRNAs, I did not observe a markedly altered 
localization, suggesting that VPS26 is recruited to endosomal membranes independently of 
SNX1 and SNX2. These data are thus indicative for existence of SNXs and VPS26 in two 
separate complexes, as has been suggested for the yeast retromer complex and, from co- 
immunoprecipitation analysis, for a mammalian retromer complex (Haft et al., 2000). 
These results are however at odds with other findings showing that joint suppression 
ablates VPS26 membrane recruitment (Rojas et al., 2007). At this stage, I do not know the 
reason for this discrepancy. One possible explanation might be the different suppression 
levels achieved. Indeed, I observed appreciably lower suppression levels for SNX2 
compared to SNX1, especially for jointly suppressed cells (an issue further discussed in 
para. 3.7 and Chapter 4). Hence, interpreted in this light, my data could imply that a 
minimal but critical level of SNX2 is necessary for VPS26 recruitment. 
72 























SNX1 (green) SNX2 (magenta) VPS26 
Figure 3.8 Localization and targeting of retromer subunits following siRNA 
treatment 
HeLa cells were treated for 72 hours with SNXI- and/or SNX2-specific siRNA (as indicated on 
the left). Cells were fixed and processed for IF analysis using anti-SNXI (Alexa488, green), anti- 
SNX2 (Alexa647, magenta) and anti-VPS26 (Alexa568, red) antibodies. Scale bar is 20 µm. 
73 
Chapter 3 -Kole of Retromer in Receptor Retrieval 
3.7. Exploring Retromer Cargo 
3.7.1. Introduction 
In the preceding studies I established that SNXI and other proposed orthologues of the 
yeast retromer complex co-localized on the same vesicular structures, and that individual 
retromer components were spatio-temporally `coupled' on their intracellular itinerary. 
Having furthermore a tool to hand that allowed me to manipulate cellular SNX-levels 
without detectably perturbing endosomal sorting, it became pertinent to set out for a 
functional characterization of sorting nexins in retromer biology. 
At the beginning of these PhD studies, a functional role for the mammalian retromer was 
still elusive. The yeast model served thus as reference point when exploring potential cargo 
for a mammalian retromer. In yeast, Ste13p/DPAP A (Matoba et al., 1997) - and VpslOp 
had been identified as `retromer cargo' as they directly bind to Vps35p (Nothwehr et al., 
1993; Marcusson et al., 1994; Cooper and Stevens, 1996; Nothwehr et al., 1999; Nothwehr 
et al., 2000). Possible homologues of VpslOp, a soluble hydrolase receptor, have been 
identified: this includes the multi-ligand receptor sortilin, which contains at its N-terminal 
luminal domain a stretch of amino acids that shows similarity to the yeast VpslOp domain 
(Westergaard et al., 2004; Ni et al., 2006). Sortilin, also identified as the non-G-protein 
coupled 100-kDa neurotensin (Ni) receptor 3, has been associated with various cell 
functions ranging from cell migration, cell growth to cell death [for review see (Mazella, 
2001)]. Sortilin has only been recently proposed to play a role in endosomal trafficking of 
sphingolipid activator proteins (SAPs) and acid sphingomyelinase (ASM) to lysosomes 
(Lefrancois et al., 2003; Hassan et al., 2004; Ni and Morales, 2006). Hence, like its yeast 
counterpart, sortilin also appears as a lysosomal hydrolase receptor; however the molecular 
machinery required for its intracellular transport was poorly defined at the beginning of 
these studies. 
Much better documented is the role of the mannose 6-phosphate receptors (MPRs) as 
receptors for soluble lysosomal hydrolases in mammalian cells. Both, the cation 
dependent (CD-) and a cation-independent (CI-) MPR ligate their cargo via recognition of 
a mannose 6-phosphate (M6P) `tag' added in the Golgi apparatus by the N- 
acetylglucosaminyl-l-phosphotransferase (Lang et al., 1984; Baranski et al., 1990; Baranski 
et al., 1991). In contrast to the mammalian system, vacuolar hydrolases of S. ceretiriae do 
74 
Chapter 3- Role of Retromer in Receptor Retrieval 
not appear to comprise M6P moieties, although a mannose 6-phosphate receptor-like 
protein (Mrplp) has recently been identified (Whyte and Munro, 2001). Into these studies, 
the CI-MPR was indeed confirmed as retromer cargo by two independent studies (Arighi 
et al., 2004; Seaman, 2004). While both studies showed that suppressing VPS26 expression 
using an RNAi-based approach resulted in mis-localization of the receptor from the TGN 
to endosomes, one study additionally showed that VPS35 was capable of binding the CI- 
MPR (Arighi et al., 2004). A role for sorting nexins in this process had however been not 
addressed. 
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3.72. Studies into the role of SNXI in retrograde CI-MPR transport 
In line with previous studies, when examining the steady state distribution of the CI-MPR 
in HeLa cells at immunofluorescence level, the receptor is predominantly localized to the 
TGN (Waguri et al., 2003), as indicated by co-distribution with TGN46 (Figure 3.9). 
Figure 3.9 Co-localization of SNX1 with TGN46 and the CI-. NMPR. 
HeLa cells were processed for immunotluorescence labelling using anti-SNX1 (Alexa488, green), 
anti-CI-MVMPR (Alexa568, red) and anti-TGN46 (Alexa633, magenta) antibodies. Shown are 
maximum projections of 10 confocal z-sections at 500nm-separation each. The merged image 
shows an overlay of SNX1- and the CI-iv[PR-channel, while the 633-channel (TGN46) was 
omitted for clarity. The CI-MMPR co-distributed with TGN46 and labelling of more peripheral 
vesicles was negligible Scale bar is 10 µm. 
In contrast, in cells treated with SNXI-specific siRNA duplexes for 72 hours (fixed and 
immuno-labelled with anti-CI-MPR and anti-SNX1), the distribution of the CI-MPR is 
clearly altered (Figure 3.10). In these cells, the receptor displayed a dispersed and 
punctate distribution, rather than TGN-like juxtanuclear enrichment. Importantly, this 
dispersal was unlikely due to disruption of the TGN itself, as I have previously shown that 
suppression of SNX1 did not grossly influence the appearance of this organelle (Figure 3. 
7 B). Thus, given the precedent for VPS26, I reasoned that the CI-MPR-labelled structures 
could be of endosomal origin, indicating an endosome-to-TGN transport defect in the 
SNXI-suppressed cells. Indeed, when co-labelling SNX1-suppressed cells with EIA1, it 
was found that the CI-T%1PR on more peripheral structures co-localized partially with 
EEA1 (Figure 3.11), demonstrating the endosomal nature of these punctae. Thus, the 
observed distribution was akin to the phenotype observed under VPS26-suppressed 
conditions (Arighi et al., 2004; Seaman, 2004). 
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Figure 3.10 Suppression of SNXI leads to vesicular distribution of the CI-MPR. 
HeLa cells treated with control and SNX1-specific siRNA for 72 hours were processed for 
immunotluorescence labelling using anti-SNX1 (Cv2, green) and anti-Cl-it1PR (CO, red) 
antibodies. (A) In control cells, the CI-MMPR shows predominantly a juxtanuclear concentration. 
(B) Upon SNX1-suppression, the distribution is shifted and CI-MPR appears punctate and 
dispersed. Scale bar is 10. tm. 
Variations in the phenotype of CI-MPR redistribution 
In spite of the clear phenotype in some cells, I noted that the degree of dispersal of CI- 
MPR was variable. In approximately 20% of all documented instances, suppression of 
SNX1 resulted in a strictly vesicular distribution as monitored by immunofluorescence 
labelling. It was then observed in virtually all cells that were clearly depleted of SNXI (as 
judged by the absence of fluorescence signal). In other cases, simultaneously with a clear 
vesicular population, a partial TGN accumulation was observed. In rare cases, when 
inspecting populations of SNX1-suppressed cells, I observed `islands' of cells having 
maintained unusually clear labelling for SNXI, indicating only minor or no suppression 
(Figure 3.12). While these `insular' cells showed the expected TGN-enrichment akin to 
control cells, a major population in these preparations also exhibited a TGN-enrichment in 
spite of a virtually absent SNXI labelling. I thus propose that in these cells, SNXI levels 
might not be suppressed to the highest level, but potentially below detection level of the 
antibodies. Hence, I suggest that the degree of dispersal directly correlates with the degree 
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of the suppression level, lending credence to a model in which minimal levels are required 
















Figure 3.11 SNX1 suppression results in endosomal redistribution of the CI- 
MPR. 
HeLa cells treated with control and SNX1-spccific siRNA for 72 hours were processed for 
immunofluorescence labelling using anti-CI-MPR (A1exa488, green) and anti-EEAI (Alexa568, 
red) antibodies. In the merged image for control cells, the perimeter of a cluster of three 
contiguous cells is outlined. (A) In control cells, the CI-MPR shows predominantly a juxtanuclear 
concentration and more peripheral EEA1-positive vesicles are devoid of CI-11PR (arrowhead). (B) 
Upon SNX1-suppression, the distribution pattern of the CI-MPR is shifted toward dispersal 
throughout the cytoplasm, where the receptor localizes to EEAI-positive vesicles (arrows). Scale 
bar is 10 µm. 
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B. SNX1 CI-MPR merge Redistribution is less prominent in pre- 
suppression. HeLa cells treated with SNX1-specific 
siRNA for 72 hours were processed for 
immunofluorescence labelling using anti-SNX1 
(. Mexa488, green) and anti-CIA1PR (A1exa568, red). In 
the 
merged image, SNX1-suppressed cells with a clear 
'I-MIPR redistribution are denoted with an asterisk, 
W xxhile X marks cells with a strong juxtanuclear labelling 
resembling cells with clear residual SNX1, despite 
siRNA treatment (ROH). Scale bar is 10 µm. 
Figure 3.12 Redistribution is less prominent in preparations exhibiting partial 
SNX1-suppression 
parations exhibiting partial SNX1- 
suppression. HeLa cells treated with SNXI-specific 
siRNA for 72 hours were processed for 
immunofluorescence labelling using anti-SNX1 
. 
Alexa488, green) and anti-CI-MMPR (A1exa568, red). In 
the 
merged image, SNX1-suppressed cells with a cleat 
('I-MIPR redistribution are denoted with an asterisk, 
while X marks cells with a strong juxtanuclear labelling 
resembling cells with clear residual SNX1, despite 
siRNA treatment (ROH). Scale bar is 10 µm. 
; ure 3.12 Redistribution is less prominent in preparations exhibiting partial 
SNX1-suppression 
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3.7.3. Examining the role of SNX2 in retrograde CI-MPR transport 
The finding that SNXI and SNX2 have the capacity to hetero-oligomerize ((Haft et al., 
1998) gave rise to a working model in which SNX2 might fulfil the role of Vpsl7p (the 
yeast component with no obvious homologue in higher eukaryotic cells). Further to this, a 
genetic precedent suggested that SNX1 and SNX2 might be functionally redundant: as 
gene knock-out studies in mice found that joint (SNX1 /; SNX2 ') gene deletion was 
embryonically lethal, while mice with single SNX1 ý or SNX2 ' gene knock out were 
phenotypically normal (Schwarz et al., 2002). 
Nevertheless, when I analysed the distribution of the CI-MPR in SNX2-suppressed cells,, I 
failed to observe a marked redistribution of the receptor (Figure 3.13). Although the CI- 
MPR appeared to be slightly less well clustered, the majority of the receptor was found in 
the juxtanuclear area. Therefore, at this stage, I concluded that the role of SNX2 in 










Figure 3.13 SNX2 suppressiu ll does nut markcdlv AItct steady-state distribution 
of the CI-MPR. 
HeLa cells treated with control and SN'X2-specific siRNA for 72 hours were processed for 
immunofluorescence labelling using anti-SNX2 (Cv2, green) and anti-CI-MIPR (Cy3, red) 
antibodies. (A) In control cells, the CI-ZPR shows predominantly a justanuclear concentration. 
(B) Upon SNX2-suppression, the distribution of the CI-MPR is not markedly altered. Scale bar is 
20 µm. 
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3.74. Kinetic Analysis of CI-MPR transport in cells suppressed for SNXI and 
SNX2 
The observation that in SNXI-suppressed conditions, the CI-MPR was redistributed to 
endosomal structures suggested that endosome-to-TGN transport step was blocked. To 
thus analyse the role of SNX1 in cargo flux, I chose an approach combining live cell 
studies and pulse-chase analyses: in absence of an experimentally suited ligand for the CI- 
vIPR, I made use of a CD8-CI-MPR reporter construct stably expressed in a HeLaM cell 
line that has previously been shown to exhibit similar trafficking properties to the 
endogenous receptor [(Seaman, 2004); see also Figure 3.14] 5. 
The CD8-CI-MPR chimeric receptor consists of the cytoplasmic, trafficking signal- 
containing tail of the CI-MPR fused to the N-terminal domain of CD8, which makes it 
possible to use anti-CD8 antibodies to label cell-surface localized CD8-CI-MPR and track 
the receptor intracellularly. The availability of a fluorescently-labelled anti-CD8 (R- 
phycoerythrin-CD8; RPE-CD8) made it furthermore possible to visualize the transport of 
CD8-CI-i\ PR in living cells (although it is to be said that the fluorophore is not very 
photostable and only allowed imaging for 2-3 minutes at a time). 
m The CD8-CI-MPR reporter construct. extraeellular Hel. a. M1 cells were stably transfected with a CD8-CI-MMPR N-terminus: CD8 chimera consisting of the cytoplasmic tail of the CI-MPR 
fused to the N-terminal domain of CD8. As CD8 is not 1 Plasma 
expressed in HeLa cells, an anti-CD8 antibody can be used membrane 
to selectively label CD8-CI-MPR at the cell surface and 
follow its transport inside the cell. 
Figure 3.14 The CD8-CI-MPR reporter construct. 
In an initial analysis, antibody-uptake experiments were performed in which cells were 
fixed at different time points after internalization to analyse the kinetics of plasma 
membrane-to-TGN transport of the CD8-CI-MPR (see para. 3.2.5 for experimental 
details). These assays compared transport in control and SNX1-suppressed cells; in 
controls, most of the antibody had reached the perinuclear area after 15 minutes (Figure 
3.15 A). At this time point, it co-localized well with SNXI (Figure 3.15 B), showing that 
the construct was delivered to SNX1-positive endosomes. After 25 minutes, virtually all 
anti-CD8 was clustered juxtanuclearly. In contrast, in SNX1-suppressed cells, the antibodvwas 
markedly less enriched in the perinuclear area (Figure 3.15 A), providing a first 
5 developed and kindly provided by Dr Matthew Seaman 
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evidence that SNX1 was indeed involved in the endosome-to-TGN transport step of the 
cargo. 






















Figure 3.15 Kinetic analysis of CD8-CI-MPR transport in SNX1-suppressed cells. 
HeLa-M cells stably expressing a CD8-CI-, 'v1PR chimera were treated with control or SNX1-specific 
siRNA. After 72 hours, cells were surface-labelled with anti-CD8 at 4°C. Cells were either fixed 
directly to assess surface-labelling (0 minutes), or after 15 and 25 minutes respectively. While in 
control cells most of the CD8-CI-MPR had reached the perinuclear area within 15 minutes of 
internalization (A, control siRNA), in SNX1-suppressed cells, much of the receptor was still found 
on more peripheral vesicular structures (A, SNX1 siRNA). (B) The perinuclear receptor partially 
co-localizes with SNX1 after 15 minutes uptake. Scale bar is 20 µm. 
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Next, I sought to extend these studies examining whether the receptor traffics through, or 
is transported within SNX1-positive endosomes. I thus attempted to investigate the 
dynamics of this process employing a live cell imaging approach. Antibody uptake- 
experiments were performed using CD8-CI-MPR expressing HeLaM cells, additionally 
transiently transfected with GFP-SNX1. Cell-surface localized receptor was labelled using 
an R-phycoerythrin-coupled anti-CD8 antibody. Cells were then transferred to a heated 
stage and warmed for 10 minutes observing the process by epifluorescence microscopy 
before image capturing was started (Movies 3.3.1 - 3.3.6; Figure 3.16). This way, 
reassociation of GFP-SNX1 was controlled (see para. 3.4) but it also allowed to select the 
time point when co-localization with the SNX1-labelled structures was maximal. As 
expected from the fixed cell analysis, after 10 minutes, CD8-positive structures were found 
to either co-localize or to be in conjunction with GFP-SNX1-decorates structures. 
In these assays (n = 3), I frequently observed `entry' of RPE-CD8 into GFP-SNX1- 
labelled structures of either tubular (Figure 3.16) or more vesicular nature (Figure 3.17), 
and movement of the two markers was often conjoined. I commonly observed GFP- 
SNXI being located to, or moving to, the cell perimeter co-localizing with cargo. But 
overall, motion was multi-directional, with GFP-SNX1 /RPE-CD8 structures showing 
occasional short bursts toward the cell centre. GFP-SNXI vesicles were frequently 
observed to `fuse' with other GFP-SNX1 decorated structures or come at least into close 
proximity. I also observed RPE-CD8 to exit a larger GFF-SNXI-labelled vesicle, and to 
traffic juxtanuclearly (Figure 3.17). It was however not possible to unequivocally clarify at 
the level of light microscopy whether this vesicle was completely devoid of GFP-SNX1. 
Likewise, the fluorescent cargo often appeared as rather large punctae, maybe representing 
aggregates. Again, for the discussed difficulties (para. 3.3), these observations retain a 
qualitative character, but importantly show that GFP-SNX1 /RPE-CD 8 vesicles, like RFP- 
SNXI /GFP-VPS35 (para. 3.4) traffic conjointly with a bias toward the perinuclear area. 
Taken together, the live cell analysis thus confirms and extends the fixed cell analysis, 
showing that RPE-CD8 is delivered to SNXI-positive structures. This data also shows that 
motile GFP-SNX1 vesicles move to the cell periphery, where they presumably take up 
RPE-CD8/CD8-CI-MPR As the CI-MPR is believed to be internalised via clathrin- 
mediated endocytosis (Pearse and Robinson, 1990; Kornfeld, 1992), it is conceivable that 
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Figure 3.16 CD8-uptake in live cells (ROI1). 
HeLaM cells stably expressing the CD8-CI-MPR were transiently transfected with GFP-SNX1 
(green) and surface-labelled with an R-phycoervthrin-coupled anti-CD8 antibody (RPE-CD8, red). 
Cells were transferred to a heated stage for 10 minutes before uptake of the antibody in one 
confocal section was imaged live (Movies 3.2.1 - 3.2.6). Stills of these movies are shown, time is in 
seconds. CD8-labelled structures co-localized with GFP-SNX1-positive compartments. A series of 
frames (ROI1) is shown, where a CD8-labelled structure appears to move `at the tip' of a retracting 
SNX1-positive tubule, but not within the tubules. For R012 refer to Figure 3.17. Scale bar is 
10 µm. 
the SNX1-postive endosomes receive cargo directly from CCVs in close proximity to the 
plasma membrane. 
In contrast to the results for SNXI suppression, when I investigated the effect of SNX2- 
suppression on the plasma membrane-to-TGN transport of the RP1;. -coupled anti-CD8 
antibody, I found the RPE-CD8 to accumulate in the juxtanuclear area with only slightly 
slower kinetics compared to control cells (Figure 3.19). In these SNX2-suppressed cells, 
after 25 minutes, most of the antibody had reached the juxtanuclear area, where it 
displayed a somewhat `sprawled' distribution compared to the fairly tight accumulation in 
control cells, but was not found as clearly redistributed as the receptor in SNX1- 
suppressed cell - again showing that the effects of SNX2 suppression are less pronounced. 
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To quantify- this, the amount of anti-CD8 at the TGN for SNX1-, SNX2-, and jointly 
SNXI- and SNX2-suppressed cells - judged by its co-localization with TGN46 - was 
measured (Figure 3.19) and confirmed the qualitative analysis: markedly less anti-CD8 
had reached the TGN after 24 minutes in SNXI-suppressed cells, while in SNX2- 
suppressed cells, co-localization was only slightly reduced compared to control cells. These 
data also show that jointly SNXI- and SNX2-suppressed cells `behave' like SNX1- 
suppressed cells in that the joint suppression leads to reduced co-localization with TGN46 
(Figure 3.19) and a comparable vesicular dispersal of the CD8-CI-MPR (as well as of 
endogenous CI-MPR; data not shown). 
In conclusion, the LCI and kinetic analyses thus furthered the previous steady-state 
observation in the way that they illustrate the flux of cargo through the SNX1-positive 
endosomes and, overall, these data clearly consolidate the involvement of SNX1 in the 











Figure 3.17 CD8-uptake in live cells (ROI2). 
HeLatil-CD8-CI-MMPR cells transiently transfected with GFP-SNX1 (green) and surface-labelled 
with RPE-coupled anti-CD8 (RPE-CD8, red). Cells were transferred to a heated stage for 10 min 
before uptake of RPE-CD8 as imaged live (Movies 3.2.1 - 3.2.6). Stills of these movies are shown, 
time is in seconds for the first and last frame, and interval between images is 2.5 seconds. CD8- 
labelled structures are delivered to a GFP-SNX1-positive vesicle, which they subsequently appear 
to leave (arrows). (For scaling compare Figure 3.16) 
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Figure 3.18 Kinetic analysis of CD8-CI-MPR transport in SNX2-suppressed 
cells. 
HeLaýM1 cells stably expressing a CD8-CI-MPR chimera were treated with control or SNX2-specific 
siRNA. After 72 hours, cells were surface-labelled with anti-CD8 at 4°C. Cells were either fixed 
directly to assess surface-labelling (0 minutes), or after 15 and 25 minutes respectively. Scale bar is 
20 µm. 
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Figure 3.19 Kinetic analysis of plasma membrane-to-TGN transport of CD8-CI- 
MPR. 
HeLaM cells stably expressing CD8-CI-ý`1PR were treated with the indicated siRNA for 72 hours. 
Cells were surface-labelled with anti-CD8, and either fixed directly, or after 2,8,16 or 24 minutes 
internalization. The amount of TGN-resident anti-CD8 was determined by labelling cells with anti- 
TGN46, and quantifying confocal images using LCSLite (Leica). Results are expressed ± the s. c. m. 
from three independent experiments (except the 2 minute time point, which is from two 
independent experiments; data courtesy of J. Carlton) 
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3.7.5. Analysing the role ofretromer in retrograde sortilin transport 
As discussed, the CI-MPR is structurally unrelated to Vps10p. Given that a role for M6P 
modifications in yeast hydrolases is still elusive, this suggests that mammalian retromer has 
evolved to a point where it interacts with cargo that differs from its yeast counterpart but 
that has analogous function and an analogous transport itinerary. But the mammalian 
genome does indeed contain homologous proteins of VpslOp. It was thus intriguing to 
investigate whether SNX1 was involved in a more general `retrieval scheme' or whether 
the observed effect was CI-MPR-specific. As explained in para. 3.7.1, the function of 
mammalian sortilin as lysosomal hydrolase receptor had been recently discovered 
(Lefrancois et al., 2003; Hassan et al., 2004; Ni and Morales, 2006). Until now, the 
intracellular compartments harbouring sortilin and thus, its intracellular transport and 
sorting have not been described in detail. It is not yet clear on which itinerary the receptor 
exits the TGN to reach endosomal compartments, and it is not clear whether this receptor 
is a recycling receptor like the CI-MPR. Indication that it might be targeted to the same 
exit sites at the TGN comes from the finding that like the CI-MPR, sortilin contains 
binding motifs for clathrin-coat components (Nielsen et al., 2001; Takatsu et al., 2001). 
Interestingly, there is also indication that both receptors may share the same cargo (Ni and 
Morales, 2006), which might imply that they act on similar itineraries. I thus sought to 
investigate whether this receptor was retrieved from endosomal compartments, and 
whether this occurred analogous to the CI-MPR, mediated by a retromer/SNX1- 
dependent mechanism. 
Sortilin displays only a restricted tissue distribution but its expression in fibrolamellar 
hepatocarcinomas has been reported (Evers et al., 1993; Ehrenfried et at., 1994). In 
contrast, MPRs are ubiquitously expressed, and their transport routes have been 
extensively studied in various cell types including the human hepatoma cell line HepG2 
[(Klumperman et at., 1993; Diaz and Pfeffer, 1998; Klumperman et at., 1998; Waguri et at., 
2003; Seaman, 2004); for review (Ghosh et at., 2003)]. For these reasons, the 
hepatocarcinoma HepG2 cell line was chosen, and as analysed by immuno-detection of 
whole-cell lysates using an anti-sortilin antibodies, it was revealed that this cell line indeed 
expresses high levels of the protein (Figure 3.22 A). In immunofluorescence-based 
assays, I found sortilin to be localized to the juxtanudear area in HepG2 cells, with 
noticeable, but comparatively little localization to endosomal structures (Figure 3.20 A). 
Co-localization with SNX1 was almost exclusively restricted to vesicles in the perinulear 
area. 
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Analysis of sortilin distribution in control and 
SNX1-suppressed cells. 
(A) HepG2 cells were treated with either control or SNX1- 
specific siRNA for 72 hours, fixed and processed for 
immunofluorescence analysis using anti-SNXI (Alexa568, 
red) and anti-sortilin (Alexa488, green) antibodies. Nuclei 
(DNA) were visualized using DAPI (blue). Maximum 
projections of 10 - 12 z-sections are shown. In control cells, 
sortilin shows a relatively tight perinuclear distribution, while 
in SNX1-suppressed cells, the accumulation appears less 
concentrated, with a substantial amount still on vesicular, 
more peripheral vesicles. Note that in SNX1-suppressed cells, 
the contrast in the sortilin-displaying images was enhanced by 
20% compared to the respective control images, as the 
signal was dramatically reduced upon SNX1 suppression (see 
text). Scale bar is 20 µm. 
(B) HepG2 cells from the same treatment conditions as in (A) 
were fixed and labelled with anti-giantin antibodies (A1exa568, 
red) to label the medial- and cis-Golgi complex. Nuclei were 
% isualized using DAPI (blue). In SNXI-suppressed cells, the 
Golgi structures appear sometimes `dilated' but not 
fragmented. Scale bar is 60 µm. 
Figure 3.20 Analysis of sortilin distribution in control and SNX1-suppressed 
HepG2 cells. 
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In contrast, when I examined the distribution of sortilin in SNX1-suppressed cells, I 
observed a dramatic change in the distribution, as now a marked proportion was found 
localized to vesicular structures (Figure 3.20 B). It is to note that in the presented images 
for sortilin (in SNX1-suppressed cells), the contrast in was enhanced by -20`Yo compared 
to the level in controls, as the sortilin/Alexa488 fluorescence signal was markedly 
decreased in SNX1-suppressed cells (see also para. 3.7.6). 
Like in HeLa cells, SNX1 suppression did not appear to affect Golgi morphology as 
judged by labelling SNX1-suppressed and control siRNA-treated cells for giantin (Figure 
3.20 B), a membrane-inserted component of the eis- and medial-Golgi (Linstedt and Hauri, 
1993), or as detected using anti-TGN46 antibodies (Figure 3.21). When I simultaneously 
assessed the distribution of the CI-MPR and sortilin in SNX1-suppressed cells, I found 
that both receptors were co-redistributed, indicating that both receptors failed to be 
delivered from an endosomal compartment to the TGN, as labelled by TGN46 (Figure 3. 
21). Notably, redistribution was less prominent compared to HeLa cells, which correlated 
with the finding that in control cells at steady state, the sortilin distribution appeared less 










Figure 3.21 Analysis of CI-MPR, sortilin and TGN46 in SNX1-suppressed 
HepG2 cells 
HepG2 cells were treated with either control or SNXI-specific siRNA for 72 hours, fixed and 
processed for immunotluorescence analysis using anti-sortilin (Alexa568, red), anti-TGN46 
(Alexa633, magenta), and anti-CI-i'v1PR (A1exa488, green) antibodies. Nuclei were visualized using 
DAPI (blue). Maximum projections of 10 - 12 z-sections are shown. CI-`1PR and sortilin show 
increased vesicular distribution in SNX1-suppressed cells while TGN46-fluorescence 
pattern appears unaltered compared to control cells. Scale bar is 10 µm. 
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3.7.6. Studies into the stability ofsortilin in SNXI-suppressed cells 
Having noticed that the immunofluorescence signal for sortilin was dramatically reduced 
upon SNXI suppression, I wished to determine the `fate' of the receptor under conditions 
of SNXI depletion in more detail. 
Given the precedent that in yeast cells lacking Vps5p (vps5L mutants), VpslOp is mis- 
localized to the vacuole, and that upon suppression of mammalian VPS26, internalised CI- 
MPR was shown to be diverted to the lysosome (Arighi et al., 2004), I reasoned that 
sortilin `trapped' in endosomal vacuoles might become subject to lysosomal degradation. 
Indeed, the observed reduction of signal for sortilin upon immunofluorescence analysis of 
SNXI-suppressed cells was indicative for a possible degradation of the receptor; I thus 
sought to quantitatively analyse the stability of sortilin and investigate the involvement of 
lysosomal degradation using biochemical assays. 
First, I analysed the steady-state levels of sortilin in whole-cell lysates cells by immuno- 
detection, and found that the receptor levels were markedly reduced in SNX1-suppressed 
cells compared to controls. When I quantified this effect by volume integration of the 
detected signals, I found that sortilin levels in SNX1-suppressed cells where decreased to 
50.6% ± 10.07% (standard deviation, s. d., for n=4 assays) of the control 
(Figure 3.22 A). To further determine the proportion of de novo synthesized sortilin in the 
remaining fraction, a series of cycloheximide (CHX) treatment assays were performed, and 
levels of sortilin were re-assessed. Here, cells were treated twice with siRNAs, and 
20 hours into the second treatment, 40 pg/ml CHX were added. Under these treatment 
conditions, sortilin levels were slightly more reduced (remaining 44.5% ± 4.25%, n= 3) 
(Figure 3.22 B, C). To verify that the decrease in sortilin levels was caused by proteolytic 
degradation, I next examined the relative stability in cells treated with lysosomal hydrolase 
inhibitors [protocol adapted from (Arighi et al., 2004; Carlton et al., 2004)]. Again, cells 
were either treated with CHX, or without CHX, and additionally, with the protease 
inhibitors leupeptin (1 mg/ml) and E-64 (10µg/ml) for 12 hours (CHX+PI and PI, 
respectively), before levels of sortilin and SNX1 were immuno-detected as described. 
Compared to CHX-treated control cells (normalized to 100%), addition of protease 
inhibitors could stabilize the remaining levels of sortilin: treatment with CHX+PI resulted 
in a 24% increase in control cells (124.1% ± 3.22%, n=3) and sortilin levels reached 
97.4% ± 8.81% for SNX1-suppressed cells compared to CHX-treated control cells 
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(Figure 3.22 C). Likewise, as Figure 3.22 D illustrates (a representative data set is 
shown), approximately 20% of the observed sortilin levels are a result from de novo 
synthesis (88.6%, from `SNX1-CHX+PI', compared to 107.9% from `SNXl-PI'). Thus, 
approximately 20% - 30% (net) are degraded as a result of SNXl suppression, indicate that 
in these cells, sortilin is poorly retrieved back to the TGN, and its endosomal retention 
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control. 
Figure 3.22 Biochemical studies into the stability of sortilin in SNX1-suppressed 
cells 
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3.7.7. Co localization analysis ofSNXJ and sortilin at ultrastructurallevel 
All electron microscopic (EM) analyses presented in this paragraph were performed by Dr 
Muriel Mari in the Lab of Prof Judith Klumperman and Prof Hans Geuze, while I only 
provided the siRNA-treated cells, accordingly fixed for electron microscopic analysis. I feel 
that this data adds significantly to the understanding of a retrograde transport machinery 
involving SNXI, and hence I decided to include some of the data, provided by courtesy of 
Dr Muriel Mario. 
In control cells, at light microscopic level, CI-MPR and sortilin are localized to the same 
organelle in untreated cells, but upon SNX1 depletion - as shown - redistributed to the 
same compartments. This suggests that they potentially employ the same transport 
mechanisms. Transport from the TGN to endosomes has been extensively studied in the 
case of the CI-MPR, and has been shown to require clathrin-coat machinery, including 
AP-1, GGAs and clathrin itself (LeBorgne et al., 1996; LeBorgne and Hoflack, 1997; Zhu 
et al., 2001; Doray et al., 2002). Indication that exit from the TGN might involve the same 
coats and carriers comes from the finding that in in vitro assays, sortilin has been shown to 
interact with GGA proteins (Nielsen et al., 2001; Takatsu et al., 2001), and that the C- 
terminus of sortilin contains the same, AP-1-binding sorting motif as the CI-MPR 
(Petersen et al., 1997). In contrast, possible coats on the endosomal site involved in sortilin 
recycling to the TGN had not been characterised yet. To analyse the identity the relation 
of this cargo to sorting nexins, ultrastructural EM analyses were performed on untreated 
and SNX1-suppressed cells. These studies led to characterization of SNX1-decorated 
`endosome-to-TGN carriers', or ETCs, which appear to selectively contain TGN-bound 
cargo. 
Initial EM analysis of the steady state distribution of receptors and SNX1 in control cells 
using immuno-gold labelling techniques (Slot et al., 1991) indeed showed that in HepG2 
cells the majority of cellular sortilin was found at the TGN (data not shown). Nevertheless, 
a fraction of SNX1 and sortilin was also found co-localized on tubular extensions of 
endosomes and extensive co-localization was observed on small vesicles located in close 
proximity to the TGN (Figure 3.23 A, B, D, E). These vesicles, as well as endosome- 
6 Mari M., Bujny M. V., Zeuschner D., Geerts W J. C., Griffith J., Petersen C. M., Cullen P j., Klumperman J., 
Geuze H j. (2007) Sortilin and Mannose 6-phosphate Receptors define a novel exit from early endosomal 
vacuoles for SNXI-dependent recycling to the TGN. Current Biology (submitted) 
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associated tubules positive for SNX1 contained electron-dense material as seen in the 
darker content and did not only harbour sortilin and SNX1, but also SNX2 (Figure 3. 
23 C), and the CI-MPR (data not shown). For the described defect in transport on the 
endosome-to-TGN route upon SNX1 suppression, these structures were named 
`endosome-to-TGN carriers', or ETCs. 
'rting nexrr; 1'` E. 
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Figure 3.23 Ultrastructural localization studies of SNX1, SNX2 and sortilin. 
Cryosections of HepG2 cells were double-immunogold labeled for sortilin with 10nm gold and 
SNX1, or SNX2, with 15 nm gold. Arrows indicate co-localization, large arrow in (A) points to out 
discontinuity of membranes of individual vesicles. 'E' indicates endosomal vacuole. (A) Co- 
localization of both proteins on tubules emanating from endosomal structures, and on small 
vesicular, electron-dense carriers (endosome-to-TGIF carriers, ETCs), (B) Clear co-localization on 
tubules emerging from an endosome containing internal vesicles, adjacent to the bi-layered 
clathrin-coat (arrowhead). (C) Co-localization of sortilin and SNX2 on ETCs. Scale bars are 
200 nm. (D, E) Three dimensional models of sortilin- (10 nm gold, pseudo-coloured in green) and 
SNX1-positive endosome-associated tubules (15 nm gold, pseudo-coloured in red) were obtained 
by Ei'v1 tomography of 250-500 nm thick cryosections as described in Zeuschner et al., 2006, 
demonstrating that the two proteins are clearly enriched on tubular profiles. Most profiles were 
non-branched tubules of 170 - 230 nm in length, and 20 - 50 nm in diameter, and vesicles. (Data 
courtesy of Dr Muriel Mari) 
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To judge whether these ETCs were indeed derived from endosomes, immuno-electron 
tomography was performed on thicker (250 nm) sections (Zeuschner et al., 2006), which 
increased the chance of detecting tubules attached to the endosomal vacuole (Figure 3. 
23 D). As the 3D-reconstructions of the tomographs show (Figure 3.23 E), the electron- 
dense, SNXI- and sortilin positive structures indeed show numerous connections with the 
endosomal vacuole, radiating out from the vacuole. Unlike the previously described 
tubular networks seen in recycling endosomes [for review see (Bonifacino and Rojas, 
2006)], the ETCs labelled by SNX1 were not interconnected but formed individual 
elements. 
Marker Co-localization Marker Co-localization 
SNX1 ++ * Rab11 (o. e. ) -- 
SNX2 ++ * Rab4 -- 
VPS26 ++)** Hrs -- 
CI-MPR/CD-MPR + Clathrin -- 
sortilin + AP-1 -- 
ASGPR -(5 % GGA3 -- 
TfR/Tf -- CD63 -- 
EEA1 -- Lamp-1/2 -- 
Table 3.2 Proteins localized to ETCs. (Compiled from data courtesy of Dr 
Muriel Mari) 
Localization of indicated proteins to ETCs as assessed by immuno-gold labelling and EM analysis 
of ultrathin cryosections of endogenous proteins, apart from Rabl1, which was overexpressed 
(o. e. ) in the form of GFP-Rabll, and detected using an anti-GFP antibody. Tf distribution was 
analysed after internalising Alexa488-conjugated Tf for 30 min and detecting with an anti-Alexa488 
antibodies. Scoring ranges from "++", which denotes strong/exclusive localization, to "- -", which 
denotes absence from ETCs. Levels of sortilin and CI-MPR are deemed "+" as only 20% of the 
total of detected receptor was found on ETCs (with the remainder at the TGN, on endosomes or 
at the plasma membrane), while SNXI, SNX2, VPS26 are found almost exclusively localized to 
ETCs (*): on ETCs and tubular profiles of endosomal vacuoles, but not body of the vacuole itself, 
(**): on tubules and on vacuole (Dr Muriel Mari, documented, but unpublished). Levels for 
asialoglycoprotein receptor (ASGPR) is deemed "-" as the minor amount of 5% of all cellular 
protein were found on ETCs. 
Furthermore, a detailed analysis was performed revealing the nature of the endosomal 
vacuole from which ETCs were derived, id est whether they are of `early endosomal' or 
`late endosomal' origin. The distinction of these two structures is not trivial; endosomal 
organelles are highly dynamic structures with a constant in- and efflux of proteins, and 
hence lack truly resident proteins. One possible categorization of endosomes at 
ultrastructural level into early and late endosomes is by their accessibility to ligands like Tf 
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and BSA-gold. Endosomes accessible to internalized Tf and BSA-gold after a 10-minute 
uptake pulse can be considered as early endosomes (Stoorvogel et al., 1987; Stoorvogel et 
al., 1991). In contrast, endosomes that were inaccessible to endocytosed Tf and only 
reached by BSA-gold after a 15-minute pulse were deemed late endosomes. Applying these 
criteria, sortilin and CI-MPR were present on early and late endosomes with comparable 
amounts (6.3% and 5% normalised to the total sortilin present in the cell). 
In a similar approach, combining characterisation with the number of internal vesicles 
[which reflect the maturation process of the endosomes; reviewed in (Sachse et al., 2002a)], 
`early endosomal vacuoles' were deemed structures containing one to eight internal 
vesicles, while structures containing nine or more vesicles were considered late endosomes 
(Table 3.3). Applying these criteria, ETCs were increasingly observed as `late stage early 
endosome'-associated (Table 3.3), with a sharp decline for vacuoles with nine or more 
vesicles. In similar assays, SNXI was preferentially found on tubules of endosomes 
containing five to six internal vesicles. With the reference of EEAl showing a clear-cut 
preference for endosomes with less than five vesicles (and a clear maximum for n= 2), 
SNXI might be regarded as a `late-stage early endosomal protein', which correlates with 




(30 min pulse) 
Characterisation 
1-8 -75% "early endosome" 
9 -22% "late endosomes" 
10 or more < 5% "late endosomes" 
Max association 
SNX1 5-6 internal vesicles 
17% for each 
Cate o 
EEA1 2 internal vesicles 
35% 
Table 3.3 Characterization of early and late endosomes (summary) 
Numbers determined from cryosections of HepG2 cells incubated with Tf conjugated to Alexa488 
for 30 min to saturate endosomal compartments with Tf. Endosomal vacuoles were subdivided in 
categories based on numbers of internal vesicle profiles. Vacuoles with up to about 8 vesicles had 
been reached by internalized Tf and were deemed early endosomes. From stage 8 internal vesicles 
onward, gradually less vacuoles were Tf-positive. These were deemed late endosomes. Likewise, 
form immuno-gold preparations (three grids), distribution of SNX1 and EEA1 was determined 
with regards to number of internal vesicles; maximum association is also shown as percentage of 
total of detected marker. 
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These ETCs are inaccessible to BSA-gold, and besides SNX1, sortilin and MPRs (both, the 
CD-MPR and Cl-MPR), none of the `classical markers' of early endosomes, late 
endosomes, or even previously described tubular networks from early endosomes were 
found on these structures (Table 3.2). It thus appears that ETCs represent novel exit sites 
from late-stage early endosomes. I: TCs are particularly distinct from the previously 
described tubular sorting endosomes (TSEs) (Peden et al., 2004), also referred to as 
tubular endosomal network (TEN), for example involved in recycling of the TfR 
(Bonifacino and Rojas, 2006); while the TEN appears as branched, and partially clathrin- 
coated, ETCs are non-branched, are negative for clathrin and moreover, do not contain 
Lamp-1 or CD63, which are found on `classical' recycling tubules or TSEs (Peden et al., 
2004). Most strikingly, ultrastructural analysis showed that the `TSE-bound cargo' TfR 
(Bonifacino and Rojas, 2006) and the ETC-located cargos, sortilin and CI-MPR, are 
localized to different tubules emerging from the same endosomal vacuole (Figure 3.24). 
It is furthermore of note that TSEs generally had a wider distribution around later stages 






Figure 3.24 Different tubular profiles with distinct cargo emerge from the same 
endosomal vacuole 
(A) HepG2 cells incubated with Tf conjugated to Alexa488 for 30 min were sectioned and 
immuno-gold-labelled using anti-sortilin (10-nm gold), Tf was localized using anti-A1exa488 (15- 
nm gold). Sortilin (thin arrow) and Tf (thick arrows) co-localize to the same endosomal vacuole 
('E') but arc localized to different emerging tubules. (A) HepG2 cell-sections were co-labelled 
using anti-sortihn (10 nm gold) and antibodies against the cell-surface asialoglycoprotein receptor 
(ASPGR, 15-nm gold). Albeit present at the same endosomal vacuole ('E'), sortilin (thin arrow) 
and ASPGR (thick arrow) do not -localize to the same tubules. Scale bars are 200 nm. (Data 
courtesy of Dr Muriel Mari) 
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The importance of SNX1 in the ETC biogenesis was investigated analysing HepG2 cells in 
which SNX1 had been suppressed (Figure 3.25). Strikingly, in these cells the number of 
endosome-associated ETCs (in a distance of < 100 nm from the endosomal vacuole) was 
reduced by almost 50% while the percentage of ETCs connected to the endosomal 
vacuole had almost doubled after SNX1- suppression. Overall, the amount of sortilin-gold 
was markedly decreased by approximately 58% compared to control cells, with the amount 
of TGN-resident sortilin most markedly reduced, while the levels of sortilin in endosome- 
associated ETCs were slightly increased. In SNX1-suppressed cells, the overall endosomal 
and TGN morphology was not markedly altered by the siRNA treatment, confirming and 
refining result obtained by immunofluorescence analysis (data not shown and Figure 3.7) 
While previous studies have shown that SNX1 localizes to endosomal, tubulo-vesicular 
structures in HeLa cells (Seaman, 2004) and HepG2 cells (Carlton et al. 2004), these 
studies extends this finding by showing that SNX1 and SNX2 both localize to tubular 
endosomal membrane profiles and vesicular carriers that contain TGN-recycling cargo, 
but not `classical' recycling cargo or components of the dathrin-coat machinery. 
Interestingly, this distribution differs from the ultrastructural localization determined for 
VPS26 in HeLa cells (Arighi et al., 2004), as VPS26 does not only localize to tubular 
profiles but additionally localizes to the vacuole body. Further still, co-localization of 
VPS26 with TfR on tubular profiles was also detected. While this study has not directly 
explored co-localization of SNX1 with the TfR, coincidental evidence showing that Tf and 
sortilin label distinct profiles (while sortilin is localized to SNX1-tubules), suggests that 
localization of the two retromer components show subtle differences. Thus, the findings 
corroborate a model in which the cargo selection, comprising the VPS26-containing 
subunit takes could place in the endosomal body, and the complex then could targeted to 
more `specialized' SNX-demarcated tubular profiles. 
The finding that in SNX1-suppressed cells the number of tubular profiles is increased but 
the number of ETCs is decreased to almost reciprocal levels indicates an important 
function of SNX1 in the generation of the carrier. Whether this is a direct effect or 
achieved by engaging additional machinery remains to be established. 
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Figure 3.25 SNX1 depletion causes increase in ETCs connected to the 
endosomal vacuole. 
Ultrathin cryosections of SNX1-suppressed HepG2 cells were immuno-gold-labelled using (A) 
anti-SNX1 (15-nm gold) and anti-sortilin (10-nm gold) antibodies or (B) anti-CI-MPR (15-nm 
gold) and anti-sortilin (10-nm gold). After SNX1 suppression, sortilin is still present in ETCs (A, 
arrows) that are often connected with the endosomal vacuole (`F'). (B) Sortilin and the Cl-MPR 
co-localize to the same endosome-connected ETCs also enriched with electron-dense material 
(arrows). Scale bars are 200 nm. (Data courtesy of Dr Muriel Mari) 
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3.8. Discussion 
In this chapter, I have explored in detail the role of endogenous SNXI in sorting and 
transport of the CI-MPR and sortilin. From this data, it appears that, SNX1 is indeed an 
orthologue of Vps5p in that it plays a conserved role mediating endosome-to-TGN 
retrieval of lysosomal hydrolase receptors. 
Lysosoma] degradation upon failed retrieval 
The finding that addition of lysosomal protease inhibitors rescued the receptor from 
lysosomal degradation strongly indicates that upon failure to be retrieved to the TGN, the 
receptor becomes subject to degradation in lysosomes. I have however not succeeded in 
visualizing the receptor at this organelle. The hypothesis that upon SNX1 suppression, 
sortilin is targeted to lysosomal compartment arises from the parallels drawn with its yeast 
orthologue, Vps5p, as in tps5L cells, Vps10p is mis-localized to the degradative vacuolar 
compartment (Horazdovsky et al., 1997; Nothwehr and Hindes, 1997). In this 
context, suppression of VPS26 has previously been shown to result in endosomal 
redistribution of the CI-MPR, and in these cells, was indeed delivered to lysosomes, as 
determined by co-localization with Lamp-1 (Arighi et al., 2004). This correlates with the 
finding of VpslOp mis-localization to degradative vacuolar compartments in yeast 
tps260 (Seaman et al., 1998). Likewise, SNX1-suppression has been shown to lead to 
destabilization of the CI-MPR in HeLa cells as determined by biochemical assays (Carlton 
et al., 2004) and HepG2 cells resulting in reduced immuno-gold counts (Dr Muriel Mari, 
personal communication). Hence, there is correlative evidence for the lysosomal targeting 
of sortilin. Interestingly, another study found that upon siRNA-mediated VPS26- 
suppression, or in VPS26-'- ES cells, the CI-MPR was delivered to the plasma membrane 
(Seaman, 2004). In the EM studies presented here, it was indeed found that besides the 
marked overall-reduction of sortilin levels in SNX1-suppressed cells, plasma membrane 
levels of sortilin were slightly increased, showing another parallel between different 
components and cargo. 
Retromer recruitment 
Further parallels between the yeast and mammalian retromer can be drawn when 
comparing the ability of the SNXl-BAR domain to sense membrane curvature (Carlton et 
al., 2004) and to possibly induce membrane tubulation, which is similar to Vps5p (Seaman 
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et at, 1998). The SNX1-BAR domain is in a first instance a dimerization module and 
targets SNX1 to highly curved membranes. Whether it is a curvature sensor, or induces or 
stabilizes membrane tubulation was still a matter of debate: compared to other BAR 
domain-containing proteins, its tubulation capacity is relatively poorly developed. It is 
however one of the few curvature-sensing BAR domains, as in in titm assays using 
recombinant SNX1, the extent of tubulation is strongly correlated with liposome diameter. 
Thus, the BAR domain provides a good cue for targeting of SNX1 to ETCs. In this 
context, the diameter of ETCs has been determined to 20 - 50 nm, which is consistent 
with liposome assays, in which a strong increase in binding was observed for liposomes 
with a diameter <- 50 nm. That the BAR domain is indispensable for association of SNX1 
with membranes has been shown by localization studies using a GFP-SNX1 carrying a 
BAR-domain mutation SNX1 (KKR-*EEE mutant, compare Figure 3.1; Carlton et at, 
2004), although one might interject that the mutations are quite drastic being a charge 
inversion [given that electrostatic interactions with membranes probably provide an 
important factor in the membrane association of BAR domains (Zimmerberg and 
McLaughlin, 2004)]. The data presented here showing that in SNX1-suppressed cells 
formation of endosome-associated tubules is not ablated, demonstrates that SNX1 is not 
crucially required for formation of these tubular profiles. The finding however that the 
number of ETCs is markedly reduced to 50%, strongly suggest that SNX1 is important in 
ETC formation. This is in line with the role of Vps5p in vesicle formation (Seaman et al., 
1998), and opens the exciting possibility that SNX1 is directly or indirectly involved in the 
fission of vesicular carriers from endosome-associated tubules. Thus, there appear to be 
several lines of evidence not only suggesting the conserved function of retromer in 
mammalian cells, but also suggesting conservation of the mechanism. This might also hold 
true for the sub-complex association: in yeast, studies have shown that Vps26p-Vps29p- 
Vps35p and Vps5p-Vpsl7p exists as distinct sub-complexes (Seaman et al., 1998). And 
while it had previously been suggested that mammalian retromer is recruited as a stable 
pentameric complex from the cytosol (Haft et al., 2000), a more recent study showed by 
co-immunoprecipitation that mammalian retromer assembles from two distinct sub- 
complexes like its yeast counterpart (Rojas et al., 2007). Similarly, upon depletion of 
VPS26, levels of VPS29 and VPS35 are substantially decreased indicating sub-complex 
instability, while levels of SNX1 and SNX2 appeared largely unaffected (Arighi et at, 
2004). Here, I show by IF analysis that in SNX1- and SNX2-suppressed cells association 
of a given SNX does not affect the membrane association of the respective other SNX 
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suggesting that membrane recruitment can occur independently of the respective other 
SNX. This could also be interpreted as an effect of the ability of SNX1 and SNX2 to form 
oligomers of alternate composition and existence as either homo- or hetero-oligomers 
(Haft et al., 1998; Rojas et al., 2007). likewise, the finding that VPS26 stays associated with 
membranes upon suppression of SNXI and SNX2 (whether individually or jointly) is 
indicative for the independent recruitment of both sub-complexes to endosomal 
membranes. This would in part also fit in with the observed differential localization at 
ultrastructural level. VPS26 was not only found localized endosome-associated tubules and 
ETCs (like SNX1), but (unlike SNX1) a substantial fraction was also found on endosomal 
vacuoles (Arighi et al, 2006). This differential localization might also include the 
TSE/TEN, as interestingly VPS26 was additionally found on TfR-positive tubules (Arighi 
et al., 2004), while previous EM studies have only found negligible co-localization between 
SNX1 and the TfR (Zhong et al., 2002), Likewise, Tf was prominently absent from ETCs 
but localized to tubules distinct from sortilin-decorated ETCs. One might thus 
hypothesize that VPS26 has a more extended distribution on endosomes and ETCs, 
which, admittedly is at first difficult to reconcile with a role for SNX1 in targeting the 
VPS-sub-complex to the vacuolar portion. Targeting to the vacuolar part might at least in 
part be mediated by other components- this could also include the receptor themselves, 
given these are transmembrane proteins. 
Opposing to the findings presented here, a recent study reported that, in their hands, 
membrane recruitment of the VPS-subcomplex was dependent on the presence of either 
SNXI or SNX2 (Rojas et al., 2007), which would also suggest that mammalian retromer 
differs from yeast in that regard. Unfortunately I do not know the reasons for these 
different findings, and it is obvious that the two studies furthermore differ in the 
conclusions whether suppression of SNXI alone is sufficient for efficient CI-MPR 
retrieval. Here I present clear evidence that suppression of SNXI is sufficient to markedly 
inhibit CI-MPR redistribution. While the abovementioned study argued that the difference 
might be cell type-specific, both studies appear to use the same cell type (HeLa), and 
furthermore, in this study I show that in HepG2 cells, the SNXI-specific siRNA used 
produces a similar phenotype with regards to the redistribution of the CI-MPR, but also 
with regards to a second unrelated cargo that appears to use the same pathway. It is worth 
mentioning that in agreement with Rojas and colleagues, I did indeed find markedly less 
redistribution in cell populations where SNXI was only partially suppressed, even in cells 
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that had no detectable levels of SNX1. Based on the data presented, these appear to be the 
cells Rojas and colleagues have predominantly examined. These data could at least in part 
be reconciled with a model in which a minimal, but critical threshold level of SNX1 is 
required to maintain endosome-to-TGN transport (see also Chapter 4). 
What about SNVX2? 
In our hands, SNX2 neither markedly influenced the steady state distribution of the CI- 
MPR, nor appreciably altered the kinetics of plasma membrane-to-TGN transport of a 
CD8-CI-MPR chimera. 
1) On a technical note, it is possible that the SNX2-suppression levels achieved in this 
study are not effectual to induce redistribution comparable to the phenotype observed 
under SNX1-suppressed conditions. Indeed suppression levels achieved for SNX2 were 
consistently lower than for SNX1 (see also Chapter 4). 
2) SNX2 might well be part of the retromer but simply `less functional' than SNX1, id est 
less efficient in the retrieval to the TGN, which could be reconciled with the proposed 
redundancy as evidenced by genetic studies (Schwartz et at., 2002). These knockout studies 
in mice showed that both, SNX1"'- or SNX2-1- mice were phenotypically normal (Schwarz 
et al., 2002), while the simultaneous knockout was embryonically lethal and embryos died 
at midgestation. Likewise, VPS26-'- knock out mice die with a similar phenotype (Radice et 
al., 1991; Lee et al., 1992). 
3) SNX2 might function at a different developmental stage. Furthering to the 
abovementioned knock out studies, mating studies with heterozygous mice indicated 
strong genetic interactions between SNX2 and VPS26, and weaker interactions between 
SNX1 and VPS26 (Griffin et al., 2005), highlighting the importance of SNX2 over SNX1 
in embryonic development. It is of note though that this function does not necessarily 
relate to retromer function in its `classical function' of a `hydrolase retrieval complex': in all 
primary MEFs or permanent mutant-MEF cell lines derived from the various knock out 
mice, the CI-MPR was not mis-localised (Griffin et al., 2005), although in VPS26"'- MEFs 
the retromer assembly was clearly perturbed as evidence by depletion of VPS35. Likewise, 
tissues associated with high expression levels of the retromer components in embryonic 
development showed no alterations in the CI-MPR localization. These results are not only 
at odds with the findings in cultured epithelial cells, but also with findings from VPS26 -'- 
embryonic stem cells, where the CI-MPR was redistributed to the plasma membrane 
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(Seaman, 2004; Griffin et al., 2005)'. Nevertheless, despite the lack of mis-localization of 
the CI-MPR, it is clear that VPS26- and simultaneous SNXI +SNX2-deletions are 
embryonically lethal. This might imply that SNX2, as well as other retromer components, 
may be involved in other functions than retrograde receptor retrieval. Specifically, this has 
recently been shown for SNX1 in the degradation of PAR-1 (Gullapalli et al., 2006), and 
potentially, for the VPS35-VPS26-VPS29 sub-complex in transcytosis of pIgR-pIgA 
(Verges et al., 2004) and for SNX2 regarding interaction with Abstrakt (Abdul-Ghani et al., 
2005) 8 
4) Following from the previous argument, it is feasible that SNX2 has simply a different 
function in retromer biology compared to SNX1: despite the extensive sequence identity, 
both proteins show molecular differences, for example, recombinant SNX2 does not 
induce liposome tubulation (Carlton et al., 2005), and strong overexpression in mammalian 
cells does not lead to tubule formation but rather swelling of endosomal compartments 
(data not shown and JG Carlton, PhD thesis). Although highly speculative, SNX2 could 
thus act as `negative regulator' by `titrating' SNX1 tubulation though hetero- 
oligomerization or yet unidentified direct or indirect interactions. The kinetic analysis for 
the jointly suppressed cells did indeed show a slight enhancement of CD8-CI-MPR co- 
localization with TGN46, although a sound conclusion on this matter would certainly 
require further detailed investigations. Further coincidental evidence comes from a recent 
study showing that agonist-induced degradation of PAR-1 is SNX1-dependent, but 
independent of other retromer components, and, importantly, distinct from the 
Hrs/Tsg1 01 -involving pathway. Strikingly, overexpression of SNX2, but not its 
suppression, markedly inhibited PAR-1 degradation. Further still, overexpressed SNX2, 
but not a PX-mutant (rendering SNX2 cytosolic) was capable of replacing SNX1 from 
endosomal membranes and prevent PAR-1 degradation (Gullapalli et al., 2006). 
5) Given that mRNA levels of SNX1 and SNX2 are largely non-overlapping, although not 
directly comparatively tested (Haft et al., 1998), it is also possible that SNX1 and SNX2 act 
as tissue-specific orthologues. Specifically, leucocytes as an example have almost no 
mRNA for SNX1, but very high levels of SNX2, although a functional significance has not 
been established, and mRNA levels do not necessarily reflect protein levels. 
7 Although it has been argued that technical differences generating the respective gene knock out could be 
causative for this difference (Griffin et al., 2005). 
8 The two latter studies have however not conclusively excluded a role for the other proposed retromer 
components. 
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The finding that suppression of SNXs other than SNX1 and SNX2 can lead to 
redistribution of the CI-MPR also raises the distinct possibility that retromer biology might 
be much more complex than previously anticipated. A recent RNAi loss-of-function 
screen revealed that of all 29 sorting nexins, suppression of SNX5 and SNX6 led to 
marked redistribution of the CI-MPR (Wassmer et al., 2007). Further still, suppression of 
SNX5 resulted in decreased steady state levels of a CD8-sordin chimera (Dr Thomas 
Wassmer, personal communication). Interestingly, the SNX1-targeted SMARTPoo1 
(Dharmacon) siRNAs used in this study were less effective with regards to inducing CI- 
MPR distribution, indicating how critical optimal suppression levels are to induce 
redistribution. It was furthermore found that simultaneous suppression of SNX5 and 
SNX6 resulted in destabilization of SNXI, probably amplifying the redistribution 
assuming that all three proteins are necessary for the retrieval step. 
We have also presented evidence for a novel exit site from early endosomes, which 
appeared to exclusively contain cargo destined for retrieval to the TGN. These endosome- 
associated tubules were non-branched, 170 - 230 nm-long SNX1- and SNX2-decorated 
tubules, containing CI-MPR, sortilin as well as CD-MPR and VPS26 (data not shown; Dr 
Muriel Mari). The same cargo was also found on a new type of carrier, the ETCs. 
Previously, the tubular sorting endosomes/tubular-endosomal network (TSE/TEN) had 
been characterized as tubule-based sorting from early endosomes (Bonifacino and Rojas, 
2006): these structures form extensive, branched networks and that transport a variety of 
cargo (ASPGRs, TfRs, Lamp-1, and the CI-MPR) to distinct destinations (plasma 
membrane, late endosomes/lysosomes and the TGN). In contrast to ETCs, buds off the 
TSE/TEN tubules were found to be decorated with `classical' clathrin-coat and adaptor 
proteins, including AP1, AP-3 and clathrin (Tooze and Hollinshead, 1991; Stoorvogel et 
al., 1996; Futter et al., 1998). Apart from CI-MPR, none of the aforementioned proteins 
were found on ETCs, while they most likely derive from the same vacuole. This also puts 
into perspective other machinery involved in TGN-retrieval of the CI-MPR: as Rab9 and 
TIP47 are both proteins present on late endosomes (Aivazian et al., 2006), it is unlikely 
that ETCs are involved in this `late' retrieval step. The two stretches in the cytoplasmic tail 
of the CI-MPR that contain the binding-site for TIP47 (Orsel et al., 2000) overlap with the 
two stretches containing the proposed binding sites for VPS35 (Arighi et al., 2004), maybe 
indicating `successive options' to ensure efficient retrieval. Besides the already mentioned 
components, AP-1 and PACS-1 (Crump et al., 2001) have also been implicated in CI-MPR 
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retrieval. And while AP-1 is present on TSE/TEN but not ETCs, and given that (minor) 
amounts of CI-MPR have indeed previously been found in the TSE/TEN of HepG2 cells 
(Peden et al., 2004), this might suggests that AP-1 /PACS-1 -mediated sorting of the CI- 
MPR occurs from the TSE/TEN. Interestingly, neither TIP47 nor PACS-1 have 
homologues in yeast, and it remains to be established whether - or to which extent - Rab9, 
TIP47, PACS-1, as well as VPS35 are involved in sortilin recycling to the TGN, or 
whether this represent a CI-MPR-specific retrieval-machinery. 
It is conceivable, although hypothetical, that as TSE/TEN also contains recycling cargo, 
transport to the TGN occurs first via the plasma membrane, while ETCs are a direct 
route: circumstantial evidence comes from the finding that sortilin and CI-MPR plasma 
membrane-levels are slightly enhanced in SNX1-suppressed HepG2 cells, and VPS"'-26 ES 
(Seaman, 2004). It will remain to be established to which extend the TSE/TEN is 
frequented under retromer-depleted conditions. 
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Chapter 4- Role of Retromer in Retrograde Toxin Transport 
4.1. Preface 
Much of the work described was carried out in the Bristol laboratory during the second 
and third year of my PhD, while the biochemical characterisation of retrograde toxin 
transport was made possible through collaboration with Dr Ludger Johannes at the Institut 
Curie, Paris, France. During two stays in his laboratory, I was able to learn the relevant 
techniques and carry out the described biochemical trafficking analysis. I would like to 
thank Mr Vincent Popoff at the Institut Curie for demonstrating the STxB-sulfation 
technique, and providing the VPS26 siRNA. I also would like to acknowledge the receipt 
of an EMBO Short Term Fellowship to assist financially in this undertaking. Lastly, 
sincere thanks again to my boss, Prof Pete Cullen, to fully endorse this project, and for the 
moral and additional financial support in order to accomplish this `mission'. 
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4.2. Introduction 
This chapter describes the work investigating the role of retromer, in particular SNX1, but 
also SNX2 and VPS26, in retrograde transport of the two bacterial toxins, Shiga toxin and 
cholera toxin. Both proteins have been extensively used as `tools' in cell biology to study 
intracellular pathways; in fact, the existence of retrograde trafficking from the cell surface 
to the Golgi complex and ER was demonstrated for the first time using Shiga toxin 
(Sandvig et al., 1992). 
Currently, it is not clear whether, or how, these toxins are sorted into TGN-bound carriers 
on endosomes. Here, I asked the precise question whether the retromer components 
SNX1, SNX2 and VPS26 were involved in this retrograde transport step of the non-toxic, 
receptor-binding B subunits of Shiga and cholera toxin -STxB and CTxB, respectively. 
4.2.1. Shia and Cholera Toxin -An Overview 
Retrograde transport pathways and machinery do not only allow for endosome-to-TGN 
transport of endogenous proteins, but are also utilized by exogenous `cargos' like toxins 
and viruses that are `hitching a ride' to reach their intracellular destination [see (Bonifacino 
and Rojas, 2006; Gruenberg and van der Goot, 2006)]. The bacterial exotoxins of Shigella 
dyrenteriae, Shiga toxin (STx), and Vibrio cholerae, cholera toxin (CTx), both belong to the 
family of ABS type toxins, comprised of a single catalytically active A subunit that confers 
the cytotoxicity and a pentameric B subunit that governs the association of the toxin with 
the cell surface (reviewed in (Sandvig and van Deurs, 2005). The B subunits assemble non- 
covalently with the A subunit, which consists of two domains: the A2-chain serves as 
tethering factor for the A and B subunits, while the cleavable Al-chain confers the 
enzymatic activity [review in (Lencer and Saslowsky, 2005)]. In spite very little sequence 
homology of the B subunits of STx and CTx, they are structurally highly similar and both 
bind to glycosphingolipids (Smith et al., 2004). The B subunit of Shiga toxin associates 
with globotriaosylceramide (Gb3) Qacewicz et al., 1986), whereas the B subunit of cholera 
toxin binds to the ganglioside GM1 with high affinity (Fishman et al., 1976). Association 
of the B subunit with their receptors leads to subsequent internalisation, with the exact 
mechanisms behind the toxin-induced uptake largely unknown. The toxins are at least 
partially delivered to endosomes (see par 4.2.2), then on to the TGN, and from there to 
the ER. From the ER, the cleaved A1-chains are retro-translocated into the cytosol, where 
they exert their cytotoxic action: in case of cholera toxin, the Al acts as an ADP- 
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ribosyltransferase that transfers ADP-ribose from NAD to the Gsa subunit to activate 
adenylate cyclase [(Spangler, 1992) and references therein]. Hence, increased cAMP 
production directly affects intestinal chloride secretion, causing the substantial secretory 
diarrhoea seen in cholera. The Al chain of STx acts as an rRNA N-glucosidase that 
interferes with ribosomal activity, thus inhibiting protein biosynthesis leading to cell death. 
As cells adjacent to one of the target tissues (the proximal nephron) are rich in Gb3, STx 
infection can lead to acute renal failure seen in haemolytic uremic syndrome [(O'Brien et 
al., 1992) and references therein]. 
4.22 Endosome-to-TGN transport ofShiga and cholera toxin 
For both toxins, STx and CTx, several mechanisms of cell entry, including clathrin- 
dependent and -independent mechanisms have been proposed. [see (Sandvig and van 
Deurs, 2002; de Haan and Hirst, 2004; Sandvig and van Deurs, 2005) for review; see also 
Chapter 1]. In spite of the many proposed entry mechanisms, toxins internalized by 
clathrin-dependent and -independent mechanisms may end up in the same endosomal 
compartments after uptake (Tran et al., 1987; Hansen et al., 1993). This suggests that at 
least partially convergent mechanisms for the different forms of entry exist. 
Transport to the TGN has been suggested to occur from early endosomes, rather than late 
endocytic compartments (Mallard et al., 1998; Mallard et al., 2002) and, at least in the case 
of CTxB, appears to bypass the endocytic recycling compartment (Sugimoto et al., 2001). 
A multitude of structural components and coats appears to be involved (see Table 4.1). 
Intriguingly, while there is data to suggest that STxB and CI-MPR require similar 
machinery for transport from early endosomes to the TGN (clathrin, epsinR, dynamin), 
there is also data suggesting subtle differences. While STxB endocytosis is not critically 
dependent on clathrin, its endosome transport to the TGN was shown to require dathrin, 
like it is the case for the CI-MPR. Similarly, transport of both, CI-MPR and STxB appears 
to depend on the clathrin adaptor epsinR (Saint-Pol et al., 2004). It is however of note that 
another study using an siRNA approach rather than overexpression (Saint-Pol et al., 2004) 
found that CI-MPR localization was unaffected when epsinR expression was suppressed 
(I-first et al., 2003). 
Interfering with AP1-function has been shown to re-localise the CI-MPR from the TGN 
to EE/ERC (Meyer et al., 2000; Crump et al., 2001), while suppression of this dathrin 
adaptor does not appear to affect STxB transport to the TGN (Saint-Pol et al., 2004). 
Which role the AP-1 -binding protein PACS-1 plays in STxB transport is not clear; PACS- 
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1 interacts with the CI-MPR (Wan et al., 1998) as well as with AP-1, and this interaction is 
crucial for mediating CI-MPR sorting (Crump et al., 2001). Further still, while STxB is 
absent from late endocytic compartments (Mallard et al., 1998), a retrieval machinery for 
the CI-MPR exists from late endosomal compartment, including the GTPase Rab9 and 
the coat component TIP47 (Lombardi et al., 1993; Diaz and Pfeffer, 1998; Carroll et al., 
2001). 
Unlike for STx, the molecular machinery involved in endosome-to-TGN delivery of CTx 
is less well understood. While it has been shown that both toxins can enter the Golgi via 
the same 'raft'/GPI-transport intermediates (Nichols et al., 2001), it not known whether 
both toxins use the same endosome-to-TGN carriers. The finding that overexpression of 
Rab7 as well as Rab9 in Niemann-Pick type C (NP-C) fibroblasts is capable of restoring 
the correct Golgi targeting of CTxB (Choudhury et al., 2002) suggests that CTxB can 
utilise pathways that differ from STxB but are similar to CI-MPR to reach the TGN. In 
these sphingolipid storage disease cells, glycosphingolipids (GSL) accumulate in endocytic 
structures, and Rab7, which mediates early to late endosome transport/conversion as well 
as Rab9, involved in late endosome to Golgi transport, can alleviate accumulation of GLS 







Rab6a' Yest'2 ? Yes3 
Rab6a Noe ? Yes* 3 
Rab7 ? Yes5 Nob Yes13 
Rab9 No* 6 Yess No7 Yes4 
Rab11 Yes 12 Nos No7 
Dyna- 
min 
Yes8 No14 Yes9 Yes9,10 
Literature 
1(Mallard et al., 2002) 
2(Del Nery et at., 2006) 
3(Utskarpen et at, 2006) 
4(Lombardi et al., 1993) 
5(Choudhury et at., 
2002) 
6 (Sandvig et al., 2002) 
7 (Iversen et at., 2001) 
9(Llorente et al., 1998) 
10(Nicoziani et al., 
2000) 
11(Lu et al., 2004) 
12 (Wilcke et al., 
2000) 
13 (Press et al., 1998) 
14(Massol et al., 2004) 







clathrin Yesl, 2 No5 Yes2 
AP-1 Nol Yes3,4 
epsinR Yesl Yesl ** 
Nob *** 
literature 
1(Saint-Pol et at., 2004) 5 (Iversen et at., 2001) 
2(Lauvrak et al., 2004) 6(Hirst et at., 2004) 
3(Crump et al., 2001) 
4(Meyer et at., 2000) 
* possibly at both sites (endosome <-º TGN); ** affected under conditions of epsinR overexpression 
*** localization of CI-MPR unaffected by epsinR suppression 
Table 4.1 Rabs and adaptors involved at the endosome/TGN interface 
Listed are (selected) Rab GTPases and clathrin-coat machinery implicated in endosome-to-TGN 
transport of Shiga, cholera toxin, ricin (an AB-type plant toxin) and the CI-MPR. 
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4.3. Materials and Methods 
For general materials and methods, buffer and media compositions, and suppliers, one is 
referred to Chapter 2. Here, methods specific to the investigation of retrograde transport 
of STxB and CTxB are described. If not stated otherwise, reagents were obtained from 
SigmaAldrich or Invitrogen. 
The VPS26-specific siRNA (sequence #3 AAC TCC TGT AAC CCT TGA GdTdT) was 
designed by Mr Vincent Popoff, Institut Curie, Paris, France, and obtained from Sigma- 
Proligo (SigmaAldrich); for the transfection protocol see para. 2.3.19) 
4.3.1. Sulfation Assays 
Material 
Sulphate-free DMEM custom-made (INVITROGEN) 
Na2[35S]04 (GE HEALTHCARE) 
Radio-Immuno-Precipitation Assay lx PBS, 
buffer (RIPA) 0.5% sodium deoxycholate 
0.1% SDS 
pH 7.4, stored at 4°C 
protease inhibitor cocktail (PIC) stock 1000x 
1mg/ml aprotinin, leupeptine, pepstatin, 
antipain 
IM benzamidine, 40 mg/ml PMSF in DMSO 
stored at -20°C 
Tris Trrcine gels 
Solution A 30% (w/v) acrylamide, 1.935% (w/v) bis- 
acrylamide 
Solution B 30% (w/v) acrylamide, 0.938% (w/v) bis- 
acrylamide 
Gel buffer 3M Tris, pH 8.45,0.3% (w/v) SDS 
100% glycerol 
TEMED, 10% APS (stock) (as described in Chapter 2, par 2.1.11) 
Resolving gel (all v/v), in sH2O 
0.32% solution A, 0.32% gel buffer, 0.13% 
glycerol, 0.032 %o TEMED, 3.2%o APS (stock) 
Stacking gel (all v/v), in sHZO 
0.08% solution B, 0.25% gel buffer, 0.8 %o 
TEMED, 8%o APS (stock) 
Electrophoresis buffer (anode) 0.2 M Tris, pH 8.9 
Electrophoresis buffer (cathode) 0.1 M Tris, pH 8.25,0.1 M Tricine, 0.1% SDS 
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Sample buffer (iris Tricine) 187.5 mM TrisHCI, pH 6.8,6% (w/v) SDS, 
30% (v/v) glycerol, 0.03% (w/v) phenol red 
Streptavidin beads 
ImmunoPure Immobilized Protein G 
B-(Suff, ) protein 
Anti-Shiga toxin (13C4) 
CTxB-Sulf2-biotin 
Gel fixing solution 
GF/C glass fibre filters 
Scintillation liquid (UltimaGold) 
Scintillation Counter 
Sulfa tion Assay - Methodology 
(PIERCE) 
(PIERCE) 
Dr Ludger Johannes, Institut Curie, Paris, 
France (Mallard et al., 1998) 
(Johannes et al 1997) 
(Amessou et al., 2007) 




The sulfation assays made either use of a modified STxB subunit (B-Sulf) genetically 
engineered to contain a tandem tyrosine sulfation site (Mallard et al., 1998), or a modified 
CTxB subunit (CTxB-Sulf2 biotin), containing a sulfation site as well as a biotin-tag 
(Amessou et al., 2007). For these assays, HeLa cells were treated with siRNA as described 
in Chapter 2 (par 2.3.19) and after 60 hours, cells were reseeded to ensure same cell 
numbers, either at a density of 120.000 cells per well of a 24-well plate (STxB), or 1x106 
cells per well of a 6-well plate (CTxB). The next day (72 hours after treatment), cells were 
starved for 2 hours in sulphate-free medium before 1 tM of a modified B-(Sulf) toxin 
subunit (per 120.000 cells) or 1 gM of the CTxB-Sulf2-biotin construct (per 1x106 cells) 
was surface-bound to cells at 4°C. After extensive washes with sulphate-free medium, 
toxin uptake was performed using media containing 0.5 mCi/ml radioactively labelled 
Na2[35S]04 for 20 minutes in case of STxB, or 40 minutes in the case of CTxB-Sulf2-biotin. 
Cells were then lysed in either RIPA+PIC-buffer for STxB, or in the case of CTxB, in 1% 
Triton X-100 (in PBS) containing a protease inhibitor cocktail before the toxin subunits 
were immunoprecipitated using either a STxB-specific 13C4-antibody and protein G- 
sepharose in RIPA, or using immobilized streptavidin for the CTxB-Sulf2-biotin construct. 
The supernatants were kept for further analysis of endogenous protein sulfation (para. 
4.3.2). The precipitates were washed using Tris-HC1 pH 6.8, then dried and resuspended 
in sample buffer, and heated to 95°C for 5 minutes, then centrifuged. The samples were 
subjected to gel electrophoresis using Tris-Tricine gels (25 - 30 mA/gel for 1 hour). The 
gel was incubated in fixing solution for 20 minutes, then dried using a BIORAD 583 gel 
dryer (ramp mode, 75°C, 90 minutes) and put on an erased phosphorimager film (GE 
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Healthcare) for at least one night before being analysed using a STORM phosphorimager 
(GE Healthcare) and appropriate software (ImageQuant, GE Healthcare), determining B- 
subunit-specific sulfation as intensity per area. 
4.3.2. TCA Precipitation ofImmunoprecipitation Supernatants 
In parallel with B-subunit-specific sulfation, global sulfation of cellular components was 
assessed. Therefore, trichloroacetic acid was added to a final volume of 10% to 
immunoprecipitation supernatants. The samples were vigorously mixed, and incubated at 
4°C for at least 30 minutes. A vacuum pump-connected filtration unit (Millipore) was used 
to transfer precipitated proteins onto glass fibre filters (Whatman). Therefore, filters that 
had been wet in 5% TCA were placed onto the unit, acid-precipitated proteins were added 
to filters, and washed with 1 ml of 5% TCA. Filters were subsequently transferred into 
scintillation vials, 3 ml scintillation fluid was added, and tubes were vigorously mixed. 
After 30 minutes incubation, samples were analysed by gamma counting (as counts per 
minute, cpm) using a liquid scintillation counter (LKB Wallac). The obtained values (cpm) 
were used to normalize the data obtained by autoradiography (area) as follows: 
CTL = [Area (B-subunit-specific sulfation) x cpmcnj/cpmcrL 
EXP = [Area (B-subunit-specific sulfation) x cpm ]/cpmc-m 
4.3.3. Fluorescendy4abelled Toxin Uptake Assays 
Cells were plated onto coverslips and treated with siRNA as described. Coverslips were 
then transferred to ice-cold DHB medium for 15 minutes. After incubation with the 
respective toxin subunit for 30 min at 4°C (Alexa555-CTxB (Invitrogen): 0.5 µg/coverslip; 
FITC-STxB Johannes et al., 1997): 1 gg/coverslip in DHB), cells were washed extensively 
to remove any unbound toxin. Subsequently, cells were either incubated at 19.5°C for 
1 hour or at 37°C and 5% CO2 for indicated periods to chase the toxin into the cells. Cells 
were then fixed using 4% paraformaldehyde and processed for immunofluorescence 
analysis as described previously (Chapter 2, para. 2.4.21). 
4.3.4. Live Cell Imaging 
Cells plated onto coverslips transiently transfected with RFP-SNX1 for 22 hours (refer to 
Chapter 2, para. 2.3.18) were transferred to ice-cold DHB-medium for 15 minutes. After 
incubation with I µg/100 t1 FITC-STxB in DHB for 30 minutes (to allow surface- 
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binding) excess toxin was removed and cells were transferred to 19.5°C for at least 1 hour 
before being imaged live using a PerkinElmer Ultra VIEW" LCI system (refer to Chapter 2, 
para. 2.4.23). For post-processing, live cell data for the recorded channels was exported 
from PerkinElmer Ultra VIEW as uncompressed movies. Where necessary, using Image) 
(NIH public domain software), background correction was performed using the 'rolling 
ball' option (set to 50). The contrast was enhanced by setting the maximum of allowed 
saturated pixels to 0.5% and normalizing it for all frames. All post-processing was 
performed on entire images only. An RGB merge was performed to yield an overlay of the 
channels. Typically, movies were exported as QuickTime movies or avi files at a rate of 10 
frames per second. 
4.3.5. Co localization Analysis 
To quantify the toxin distribution in control and SNX-suppressed cells after either 
30 minutes of FITC-STxB uptake or 40 minutes Alexa555-CTxB uptake (as described in 
para. 4.4.3), cells were additionally immuno-labelled with TGN46 or giantin, and imaged 
under identical conditions using confocal microscopy, taking 8- 10 optical slices per visual 
field. For several visual fields, yielding at least 50 cells per sample (if not stated otherwise), 
co-localization was analysed using MetaMorph software (Molecular Devices). Co- 
localization was determined for every optical section individually for one visual field at a 
time. From these values, the mean was calculated; the standard deviation gives the 
deviation between individual visual fields. The co-localization of STxB and SNX1 was 
performed using the co-localization plug-in in Image) producing a co-localization 
composite image. Enumeration of vesicles was done using the Colony Counter tool of 
ImageQuant TL software (GE Healthcare) on individual channels and the co-localization 
composite image obtained through Image)-aided analysis. 
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4.4. Results 
4.4.1. Analysis ofShiga toxin B-subunit transport through SNXI positive 
compartments 
Given that there is evidence that CI-MPR and STxB partially employ the same transport 
machinery from early endosomes, and given the role for SNXI in endosome-to-TGN 
transport, I sought to scrutinize the relationship between STxB and SNX1 in more detail. 
To initially examine whether endocytosed Shiga toxin B-subunit was transported through 
SNX1-decorated early endosomes en route to the TGN, I performed a series of fluorescent 
toxin-uptake assays, combined with an immuno-labelling approach. In these assays, HeLa 
cells were incubated with FITC-conjugated Shiga toxin B subunit (FITC-STxB) at 4°C for 
30 minutes to allow surface-binding of the subunit. Unbound FITC-STxB was removed 
by extensive washes prior to warming the cells to 37°C for various time points to 
internalize FITC-STxB. After fixation at 37°C cells were labelled with an anti-SNXI 
antibody, followed by fluorescently-labelled secondary antibody to examine co-localization 
of the two proteins. 
Inspection of samples for the different time points by confocal microscopy revealed that 
the FITC-STxB initially labelled the cell surface (Figure 4.1 A) but was rapidly 
internalised as after 10 minutes incubation it was found on intracellular vesicular structures 
(Figure 4.1 B). These FITC-STxB-positive punctae co-localized well with endogenous 
SNX1 on vesicular and tubular profiles in the cell periphery, but co-localization was most 
prominent in the juxtanuclear area (Figure 4.1 B). Co-localization was not complete 
however. When performing a quantitative analysis scoring all SNX1-positive structures for 
the presence or absence of FITC-STxB [and vice versa for STxB (see para. 4.2.6. for 
details)], it was found that 481 out of 696 SNX1-positive vesicles (for the representative 
experiment shown) were positive for FITC-STxB (69.10/6), while only 481 out of 1445 of 
all FITC-STxB punctae were SNX1-positive (33.3%). 
A similar partial co-localization of STxB with endosomal markers has been observed 
before (Mallard et al., 1998). When co-internalizing EGF and STxB for 1 hour at 19.5°C, it 
was observed that they display a `juxtaposed' distribution, and not all EGR structures were 
positive for STxB, while Tf and STxB were observed to co-localize almost perfectly under 
the same conditions and all Tf structures were positive for STxB (Mallard et al., 1998). 
This scenario suggest that STxB is delivered `non-selectively' to the entire endosome 
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population, but that SNX1 and EGFR are probably only localized to a distinct subset 
(compare also (Lakadamyali et al., 2006) for CME-ligands). 
The distribution of the two proteins furthermore appeared juxtaposed or polarized, and 
the `comet-like tails' emerging from FITC-STxB punctae were in most, but not all cases 
SNX1-negative (arrowheads, Figure 4.1 B, C). Thus, while it appeared that the toxin was 
delivered to the same endosome, it showed a differential distribution already perceivable at 
LM level (which given the achievable resolution was rather surprising). This tubular 
partitioning appears temperature-sensitive and incubation at 19.5°C still allows for 
internalisation of the toxin, but it subsequently fails to accumulate at the TGN (Mallard et 
al., 1998). To relate our findings to these results, FITC-STxB-surface-labelled cells were 
incubated at 19.5°C for 1 hour, which resulted in an accumulation of STxB in SNX1- 
positive structures (851 out of 2100 FITC-STxB-decorated structures positive for SNX1, 
40.0%), and residual labelling at the plasma membrane, as inspection of single confocal z- 
sections revealed. So while not all STxB was internalised at this temperature, STxB was 
also not delivered from endosomes/SNX1-positive structures to the TGN. 
Given the generally low overlap between SNX1 and STxB, it was possible that transit 
through SNXI-positive endosomes was a rapid event. Thus, in a fixed-cell `snapshot' 
scenario', one would detect STxB prior, during or after passing through the `SNX1 
endosome'. I thus sought for ways to examine STxB flux through the endosomal system 
using live cell analyses. Therefore, using LCI (para. 4.3.4), I examined FITC-STxB 
transport in cells that were transiently transfected with RFP-SNX1. As discussed 
previously, incubation at low temperature can render GFP-SNX1 cytosolic (Chapter 3, 
para. 3.3), while the probe was associated with membranes at 19.5°C. With the 
observation that at this temperature STxB was delivered to SNX1-postive endosomes but 
also still found at the plasma membrane, it allowed me study the early stages of toxin 
uptake into SNX1-positive endosomes in live cells. 
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Figure 4.1 Shiga Toxin B subunit localizes to SNX1-positive endosomes. 
Fluorescently-labelled Shiga toxin B-subunit (FITC-STxB, green channel) was surface-bound to 
HeLa cells at 4°C. Excess toxin was removed before cells were transferred to 37°C or 19.5°C for 
indicated times to allow for FITC-STxB internalization. Cells were fixed, immuno-labelled with an 
anti-SNX1 antibody (Alexa594, red channel) and subsequently imaged using a confocal 
microscope. Maximum projections of 8- 10 optical z-slices (480 nm z-separation) are shown. (A) 
Cells were fixed without incubation at 37°C (0 minutes). (B) After 10 minutes, the toxin displayed 
extensive co-localization with the SNX1-positive endosomal structures, as indicated by the yellow 
colour in the merged images. Note the subset of FITC-STxB tubules that were negative for SNX1 
(arrowheads in B and C). (C) The toxin could be `trapped' in SNX1-positive endosomes when 
incubated at 19.5°C for 1 hour. Scale bar is 10µm. 
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delivered to tubulo- 
vesicular SNX1-positive 
compartments. 
HeLa cells transiently 
transfected with RFP-SNX1 
were surface-labelled with 
FITC-STxB at 4°C for 
30 minutes and, after 
removing any unbound 
toxin, transferred to 19.5°C 
for 1 hour. Cells were then 
transferred onto a heated 
stage and uptake of toxin 
was imaged live in one 
optical z-section. Selected 
images of the movie (see 
also Movies 4.1) are shown. 
Time is given in seconds. 
Scale bar is 10 µm. 
Figure 4.2 FITC-STxB is delivered to tubulo-vesicular SNX1-positive 
compartments. 
Live cell confocal analysis of a single median z-section revealed that FITC-STxB was not 
only localized to static and motile SNX1-positive vesicles (Movie 4.1.1), it furthermore 
showed that on these vesicles, FITC-STxB and RFP-SNXI moved together in rapid and 
burst-like motions of vectorial nature (a total of n> 13 coverslips were examined). In 
addition, it appeared that FITC-STxB was indeed delivered to SNXI-positive structures 
and then progressing intracellularly in, or with, SNXI-decorated vesicles (Figure 4.2, 
arrows, Movie 4.1.2). Nevertheless, I also observed that more static FITC-STxB 
structures did not co-distribute with SNX1. In addition, I noted that STxB was not only 
delivered to SNXI-positive structures and tubules, but that structures appeared to fuse 
and exchange the fluorescent probe (Figure 4.4, arrows). Sometimes, distribution of the 
two components appeared polarized. It is however likely that this behaviour represents an 
artefact of the spatio-temporal resolution. The observation that FITC-STxB was delivered 
to and transported `within' SNXI-positive endosomes made it pertinent to examine 
whether this co-localization was preserved at later time points, and to which extent SNX1 
was involved in the delivery step of endosomal STxB to the TGN. Here, I found that after 
30 minutes, FITC-STxB became progressively enriched in the juxtanuclear area, where it 
co-localized extensively with TGN46 (Figure 4.4 A; Figure 4.5). Additionally, at this 
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time point, the toxin was still found on SNX1-positive endosomes. After 1 hour, 
localization to vesicles had almost completely ceased with FITC-STxB now being almost 
exclusively localized to the TGN (Figure 4.4 B). It was furthermore apparent that at this 
time point, SNX1 displayed predominantly a juxtanuclear distribution in immediate 






FITC-STxB punctae and 
SNXI-positive structures 
fuse and segregate. 
Shown is the same region of 
interest as in Figure 4.2. 
HeLa cells transiently 
transfected with RFP-SNX1 
were surface-labelled with 
FITC-STxB at 4°C for 
30 minutes and, after washing 
off any unbound toxin, 
transferred to 19.5°C for 1 hour. 
Cells were then transferred onto 
a heated stage and uptake of 
toxin was imaged live in one 
optical z-section. Selected 
images of the movie (see also 
Movies 4.1.1-. 2) are shown. 
Time is given in seconds. Scale 
bar is 10 µm. 
Figure 4.3 FITC-STxB punctae and SNX1-positive structures fuse and 
segregate. 
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Figure 4.4 From SNX1-positive structures, FITC-STxB is delivered to the 
perinuclear area. 
Fluorescently labelled Shiga toxin B-subunit (FITC-STxB, green channel) was surface-bound to 
HeLa cells at 4°C. Excess toxin was removed before cells were transferred to 37°C to internalize 
FITC-STxB. At indicated times cells were fixed and processed for immunofluorescence labelling 
using anti-SNX1 antibodies (Alexa594, red channel). Maximum projections of 8- 10 optical z- 






Figure 4.5 FITC-STx13 is delivered to the TGN46-labelled trans-Golgi network. 
HeLa cells labelled with FITC were transferred to 37° for 30 minutes before being fixed and 
immuno-labelled with anti-TGN46 (Alexa594, red channel). Maximum projections of 8- 10 
optical z-slices (480 nm z-separation) are shown. Scale bar is 10µm. 
119 
merge FITC-STxB SNXI (Alexa594) 
Chapter 4- Role of Relromer in Toxin Tran, port 
merge FITC-STxB SNX1(AJexa594) 
N N. ', 
15 94 
". I ý" '' s t' "" "" .1 
E 'W ,, . 
'.. l. "iaý "'. .. 
CY) 
Figure 4.6 Examination of juxtanuclear SNX1-enrichment in FITC-STxB. 
FITC-STxB (pseudo-coloured in pink) was allowed to internalize for 30 minutes), before cells were 
fixed and immunolabelled with anti-SNXI (pseudo-coloured in blue) and imaged using a 100x 
objective (The resulting images were colour-inverted using Adobe Illustrator). On SNXI-positive 
vesicles, the toxin appeared as punctae (arrowheads). In, or at, the TGIF, the toxin appeared 
diffuse, while SNX1 retained its vesicular distribution that appeared juxtaposed to the FITC-STxB- 
labelled TGIF (arrows). The adjacent cell at the top was not visibly labelled with FITC-STxB. Scale 
bar is 5 µm. 
Thus, from these results it was feasible to speculate that STxB was directly delivered from 
SNX1-positive structures to the TGN. To further test this hypothesis, I again used a live 
cell imaging approach. In these assays, to overcome problems associated with long-time 
imaging, such as phototoxicity and bleaching of the RFP-SNX1 probe, I allowed the toxin 
to be pre-internalised for up to 30 minutes before starting the imaging process'. In these 
assays, images were routinely captured every 6 to 7 seconds for at least 10 minutes. While 
FITC-STxB was first seen as compact punctae with RFP-SNX1-positive vesicles (Movies 
4.2, Figure 4.7), it was then seen to be `handed over' to the more diffuse FITC-STxB- 
labelling at (presumably) the TGN. Thus, it appears that the SNX1-labelled compartment 
is both, a transit and a transporting compartment for FITX-STxB to on its itinerary to the 
TGN. 
9 After surface-labelling and transfer to 19.5°C for 1 hour, coverslips were mounted onto a heated stage 
before the imaging procedure was started 30 minutes later. 
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Figure 4.7 Vesicular FITC-STXB reaches the TGN area in SNX1-positive 
carriers. 
FITC-STxB (green) was surface-bound to RFP-SNX1-trans fccted HeLa cells. After extensive 
washes and incubation at 19.5°C for 1 hour, cells were transferred to a heated stage and toxin was 
pre-internalized for 10 minutes, before the imaging process was started (see also Movies 5.2.1 - 
5.2.6). Shown are separate and merged frames of the ROI, time of the set is given in seconds 
(white numbers, top left). Note the FITC-STxB delivered to (presumably) the TGN (arrow). Scale 
bar is 10 µm. 
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4.5. Functional Characterization 
4.5.1. Effect ofSNXJ suppression on immunoiuorescence-based toxin traffic 
assays 
To examine whether delivery of STxB to SNX1-positive endosomes was required for 
transport to the TGN, I employed an RNA interference-based strategy combined with 
fluorescent-toxin uptake assay. I hypothesized that in a scenario paralleled to retrieval of 
the CI-MPR and sortilin, this procedure could block, or at least reduce the transport of 
toxin to the TGN, if SNX1 was critically involved in this transport step. 
Routinely, in these assays HeLa cells were treated with either the previously described 
control or SNX1-specific siRNAs for 72 hours and were surface-labelled with FITC-STxB 
for 30 minutes at 4°C. Then cells were either fixed directly or the toxin subunit was 
internalised at 37°C prior to fixation and immuno-labelling. An important result of the 
early time point analysis was that STxB appeared to label the surface in SNX1-suppressed 
cells to the same extent as in control cells, as analysed by confocal microscopy (Figure 4. 
8 A). This indicated that the siRNA treatment did not affect trafficking of the toxin 
receptor. I then embarked upon a detailed kinetic analysis of FITC-STxB endosome-to- 
TGN transport in SNX1-suppressed cells. As described for untreated cells, in control 
siRNA-treated cells the TGN accumulation became discernible as early as 8- 10 minutes 
after temperature shift, and was robustly developed after 30 minutes, for which an 
example is shown in Figure 4.8 B. In striking contrast to the control, in SNX1- 
suppressed cells FITC-STxB remained predominantly associated with peripheral structures 
after internalisation for 30 minutes (Figure 4.8 B). I thus extended the study examining 
the toxin localization at later time points (Figure 4.8 C, D). In these assays, the difference 
became even more evident, as in controls the toxin displayed a compact juxtanuclear 
accumulation at the TGN. In comparison, in SNX1-suppressed cells even after 120 
minutes, only few cells showed slight perinuclear toxin enrichment, while the majority still 
exhibited a dispersed peripheral localization (Figure 4.8 C, D; asterisk). 
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Figure 4.8 In SNX1-suppressed cells, endosome-to-TGN transport of STxB is 
perturbed. 
HeLa cells treated with indicated siRNAs were subjected to FITC-STxB uptake assays, tired at 
indicated times and immuno-labelled for SNXI (Alexa594, red channel). In cells treated with 
SNXI-specific siRN A, the immunofluorescence signal was markedly reduced. (A) Surface labelling 
was comparable in control and SNXI-suppressed conditions. (B) After 30 minutes internalization, 
the toxin showed juxtanuclear enrichment in control siRNA-treated cells, but remained associated 
with peripheral structures in SNX1-suppressed cells. Scale bar is 20. tm. (Fig. cont. overleaf) 
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Figure 4.8 (Cont. ) In SNX1-suppressed cells, endosome-to-TGN transport of 
STxB is perturbed. 
HeLa cells treated with indicated siRNAs were subjected to FITC-STxB uptake assays, fixed at 
indicated times and immuno-labelled for SNX1 (Alcxa594, red channel). Compared to control 
cells, in SNX1-suppressed cells, only moderate amounts of FITC-STxB had accumulated at the 
TGIF after 60 min (C) and 120 min (D) and the majority still displayed a punctate distribution 
(asterisks). Scale bar is 20 µm. 
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It is to note that although the toxin did not display a vesicular phenotype in the entire 
SNX1-suppressed population, it was evident that cells displaying a perinuclear enrichment 
of the toxin also possessed a comparably high proportion of vesicular STxB. This 
suggested that also in those cells, transport kinetics were partially altered. 
To quantify this effect, I scored the frequency with which I observed the appearance of 
the two distinct morphologies at single-cell level using epifluorescence microscopy (for 
n> 600 cells per condition). The two distinct scoring phenotypes were defined as either a 
`dispersed' appearance (Figure 4.9, asterisk), or a tight juxtanuclear toxin enrichment 
(Figure 4.9, marked with an x). A rigid scoring criterion was applied; even SNX1- 
suppressed cells with remaining perinuclear enrichment but more prominent TGN 
accumulation were assigned to the latter category. This type of `analogue analysis' revealed 
that after 30 minutes, 55% of control cells showed a clear TGN-like enrichment of the 



























Figure 4.9 Quantification of the reduced endosome-to-TGN transport of FITC- 
STxB in SNX1-suppressed cells. 
Toxin uptake assays were performed in control and SNXI-suppressed HeLa cells as described. 
After fixation, samples were inspected by epifluorescence microscopy and scored 'blindly' for 
either a TGN-like enrichment (x) or a vesicular appearance (*). Cells marked with (o) were not 
scored because of low toxin levels. To clarify, not all scored cells are labelled. (A) and (B) illustrate 
the scoring phenotypes; with FITC-STxB in the green channel and TGN46 (Alexa594) in the red 
channel for control and SNX1-suppressed cells after 30 minutes uptake. (C) Representative data 
for a set of control and SNX1-suppressed cells (n > 600) after 30 minutes toxin uptake. 
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This type of analogue analysis allowed me to define the kinetics of endosome-to-TGN 
transport of STxB by scoring the FITC-STxB distribution in both, control and SNXI- 
suppressed cells for different time points (Figure 4.10). 
It was apparent from these assays that over the course of 2 hours the percentage of cells 
with a perinuclear enrichment did not change notably, indicating that in a subset of cells 

















STxB accumulation in 
the perinuclear area was 
scored in control and 
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each time point). 
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Figure 4.10 Kinetic Analysis of perinuclear FITC-STxB accumulation 
As this assay is based on the assumption that SNX1 suppression does not interfere with 
integrity of the target organelle, id est the Golgi complex, I confirmed that following toxin 
uptake, neither the cis- and medial-Golgi as labelled using anti-giantin (Figure 4.11 A) nor 
the trans-Golgi network as labelled using anti-TGN46 appeared altered as examined at the 
level of light microscopy (Figure 4.11 B). It was evident that while in some cases, STxB 
appeared co-localized with TGN46 to some extent in SNXI-suppressed cells (Figure 4. 
11B, inset), the majority not co-localized with the TGN46-labelled compartment. 
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Figure 4.11 SNX1-suppression does not grossly perturb Golgi/TGN appearance. 
Control and SNX1-suppressed cells were subjected to a toxin uptake assay with FITC-STxB (green 
channel) for 30 minutes and then fixed. (A) Cells were immuno-labelled for SNXI (Alexa594) and 
giantin (Alexa633, cyan channel), a marker of the cis- and media/-Golgi complex. (B) Cells were 
immuno-labelled for TGN46 (Alexa633, red channel). Scale bar is 20 [im. 
127 
merge SNX1(Alexa568) giantin(Alexa633) FITC-STxB 
merge TGN46(Alexa594) FITC-STxB 
Chapter 4- Role of Retromer in Toxin Transport 
Hence, one of the advantages of the described `analogue approach' is that it is somewhat 
independent of marker proteins, in contrast to a digital co-localization approach that uses 
the marker as a reference point. On the other hand one could interject that the definition 
of the two phenotypes is somewhat arbitrary, although 1 took great care to carefully define 
the phenotypes. Thus, 1 additionally thought to substantiate these findings by analysing the 
co-localization STxB with TGN46 using a digital imaging analysis approach (MetaMorph 
software, Molecular Devices). This method confirmed the results from the `analogue 
`analysis, showing that 12% ± 1% (s. d. ) of internalized FITC-STxB co-localized with 
TGN46 after 30 minutes of internalization in SNX1-suppressed cells, which was markedly 
less than in control cells (37% ± 0.4% s. d. ). 
® Z 
40 RNA Si Co-localization of STxB with TGN46 SNX1 Cells treated with control or SNXI-suppressed siRNA were 
M 
35, SI RNA 
subjected to FIT(: -STsh uptake assays, fixed after 
F' 30 30 minutes and immuno-labelled with anti-TGN46. To 
25 quantify co-localization, 8- 10 confocal sections of several 
20 visual 
fields were analysed using MetaMorph software, 
M determining co-localization per individual z-section. In 
15 control cells, 37% ± 0.4% (s. d. ) STxli co-localized with 
M 10 TGN46; SNX1-suppressed cells showed 12% ± 1% (s. d. ) 
5 co-localization 
(s. d. determined from mean for individual 
0 visual fields for a total of n> 50 cells). 
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Figu re 4.12 Co-localization of STxB with TGN46 is markedly reduced in SNX1- 
suppressed cells 
Overall, these data are therefore consistent with a model in which SNXI is required for 
the efficient transport of Shiga toxin between the early endosome and the TGN, in a 
manner that under conditions of SNXI-suppression the rate of endosome-to-TGN 
transport of the toxin is markedly reduced. These assays do however not provide a 
functional evidence for delivery to the TGN. These issues were tackled in para. 4.4.3 
using a biochemical approach. 
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4.5.2. Functional analysis of the role ofsorting nexins in STxB transport to the 
TGN 
To further examine whether delivery to the TGN was dependent on SNXI, I employed a 
methodology that couples the arrival of the toxin B subunit at the TGN to a biochemical 
reaction, which can subsequently be quantified, and hence give an indirect measure for the 
amount of toxin at the organelle. 
For these assays, a modified Shiga toxin B subunit was used (B-Sulf) which has been 
genetically engineered to contain a tandem tyrosine sulfation site (Mallard et al., 1998). 
Since protein sulfation specifically occurs at the level of the TGN (Baeuerle and Huttner, 
1987; Niehrs and Huttner, 1990), the degree of sulfation, measured as incorporation of 
[35S]sulphate provides a direct read-out for the amount of B subunit at the organelle. 
Importantly, insertion of a sulfation site into the B subunit does not appear to alter its 
transport properties (Mallard et al., 1998). 
In these assays, I decided not only to examine sulfation in SNX1-suppressed cells, but also 
SNX2, as well as jointly SNX1- and SNX2-suppressed cells. The day before the assay, 
siRNA treated cells were re-seeded to ensure identical cell numbers for all conditions, but 
also to obtain identical wells for paralleled duplicate analysis (see para. 4.3.1). To ensure 
sufficient incorporation of the radioactively labelled [35S]-sulphate, siRNA-treated cells 
had to be depleted of non-labelled sulphate by incubating them in sulphate-free medium 
(see also para. 4.3.1). Then, B-(Sulf, ) was allowed to bind to the cell surface. After 
extensive washes to remove unbound toxin subunit, cells were transferred into pre- 
warmed medium (37°C) containing [35S]-sulphate for 20 minutes, which allows for 
measuring initial arrival of the toxin at the TGN (as determined by IF analysis). Cells were 
subsequently lysed and radioactively labelled B-(Sulf7) was captured by performing an 
immunoprecipitation (IP) using STxB-specific antibodies. Ultimately, following SDS- 
PAGE, the incorporated radioactivity was determined from autoradiographs by volume 
integration (see also Figure 4.13 B; inset). Importantly, I also determined the levels of 
endogenous sulfation under these conditions: sulphated proteins were acid-precipitated 
from the IP supernatants, then retained on glass fibre filters and radioactivity was 
measured by scintillation counting. This serves as an internal control of the experiment as 
well as it allows normalization of the sulfation data (compare para. 4.3.2 for details). 
For all assays performed, I routinely determined achieved protein suppression levels of 
cells treated with the respective siRNAs by Western blotting, confirming successful 
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suppression of protein expression in the entire cell population (Figure 4.13 A). Cells 
from the same siRNA-treated batches were subsequently used for the sulfation assay. 
To aid clarity, I chose to present the results for the respective siRNAs in consecutive 
order, starting with SNX1- (para. 4.4.2.1), followed by SNX2- (para. 4.4.2.2) and lastly, 
jointly SNX1- and SNX2-suppressed cells (para. 4.4.2.3). Some of the figures contain the 
pooled data for all conditions, as I felt it aids direct comparison and limits recapitulation of 
data. 
4.5.2.1. Effect of a SNXJ-spec siRNA on STxB sulfation 
In these assays, I regularly observed a clear decrease in sulfation in SNXI-suppressed cells 
(Figure 4.13 B). Band intensities of autoradiographs obtained from six independent 
assays, all in duplicates, were quantified using densitometry. The obtained values were 
normalized to overall protein sulfation (para. 4.3.2) and normalized to control values 
being deemed 100% (Figure 4.13 B). Compared to these, the degree of sulfation was 
clearly reduced [57% ± 24.4% (s. d. )] in SNXI-suppressed cells, indicating that endosome- 
to-TGN transport was effectively, but not completely, blocked in these cells. Nonetheless, 
in some instances, I observed that even comparably high levels of SNXI suppression did 
not result in a marked inhibition of STxB sulfation. This prompted me to determine to 
which extend the level of SNXI suppression influences the retrograde transport. Hence, in 
an attempt to correlate suppression efficiency with B-(Sulf, ) sulfation state, I compared 
achieved levels of siRNA-mediated suppression of each experimental set (x-axis) with the 
corresponding levels of B-(Sulf) sulfation for the respective experiments (Figure 4.13 C). 
From these experiments, I concluded that only suppression levels greater than 92% lead to 
marked sulfation inhibition, whereas suppression levels lower than 89% did not lead to a 
clear sulfation. Hence, without these `ineffective' levels, sulfation in the four sets (in 
duplicate) with suppression levels greater than 92% is reduced to 46.3% ± 13.05% (s. d. ) 
(Figure 4.13 C, pink closed triangles). These results further supported the model of a 
critical but minimal threshold level of SNX1 to maintain efficient endosome-to-TGN 
transport. 
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4.5.22 Effect of a SNX2-specific siRNA on STxB sulfation 
When I embarked on the toxin traffic project described in this chapter, a role for SNX2 in 
intracellular sorting was still elusive. As described in Chapter 3, SNX2 appeared to play 
only a minor role in promoting endosome-to-TGN transport of the CI-MPR. Thus I 
hoped to get further insights into SNX2 function using this quantitative biochemical assay. 
When I carefully quantified the levels of SNX2 suppression using densitometry (Figure 4. 
13 A), I found a reduction of cellular SNX2 to 81.3% ± 6.64% (s. d., n= 6) of control 
cells. This marked reduction resulted in a sulfation inhibition of B-(Sulf2) of 78% ± 26.7% 
(s. d., n=6 in duplicate), which was considerably less compared to the effect of SNX1 
suppression on toxin sulfation (Figure 4.13 B). Looking at the experimental sets 
individually, in 10 out of 12 individual data sets, the levels of B-(Sulf2) sulfation exceeded 
the levels observed under SNX1-suppressed conditions, after normalisation for global 
sulfation. Notably, even when suppression was greater than 91%, sulfation was not further 
inhibited, as it was observed for SNX1. From these biochemical assays, it thus appeared 
that SNX2 slightly, and less robustly (compare s. d. ) affected endosome-to-TGN transport 
of STxB. 
One problem I noticed early on, and have already discussed in Chapter 3, was that cell 
batches treated with SNX2 siRNA had lower cell counts after 72 hours. As lower cell 
numbers would affect the biochemical readout, I tried to compensate the effect by re- 
seeding equal cell numbers for all conditions the night before the assay. Unfortunately, 
there is no direct `input' control to normalize the sulfation signal against. It is pertinent to 
note that the levels of sulfation of endogenous proteins were also slightly reduced. Thus, I 
was concerned that the reduction in sulfation was also attributable to reduced cell 
numbers. This prompted me to further investigate the effect of SNX2-suppression on 
STxB transport using microscopy techniques. 
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Figure 4.13 Analysis of STxB sulfation in SNX1- and SNX2-suppressed cells. 
(A) Representative Western blots showing levels of siRNA-mediated protein suppression. The 
table summarizes achieved levels of suppression quantified using ImageQuant from n >_ 4 assays (n 
=6 for SNX1 and SNX2 individually). (B) The autoradiograph (inset) shows a typical result of a 
sulfation experiment using the B-(Sulf2) construct. The graph below summarizes results from 
n=6 for SNX1 and SNX2, n=4 for SNX1+SNX2 (each in duplicate) as percentage of control. 
Autoradiographs were quantified by densitometry and normalized to overall levels of protein 
sulfation. In SNX1-suppressed cells, sulfation was reduced by 43% ± 24.4% (s. d. ) compared to 
control cells, whereas in SNX2-suppressed cells sulfation was reduced by 22% ± 26.7% (s. d. ). In 
contrast, sulfation of STxB in jointly suppressed cells was increased to 127% ± 39.2% (s. d. ). (C) 
Levels of siRNA-mediated suppression as determined by Western blotting and quantified by 
densitometry were plotted against the levels of STxB sulfation (each data point represents mean 
from duplicates, normalized to global sulfation) for six experimental sets (pink triangles: SNX1 
siRNA , 
blue triangles: SNX2 siRNA; solid for individual, open for joint suppression). Lower 
levels of SNX1-suppression (< 90%) do not result in reduced sulfation (marked with asterisks). 
The regions were determined using the highest suppression level for SNX1 (x-axis) that was found 
not to induce a reduction in STxB sulfation (100°/6, y-axis). (D) Graph shows mean levels (± s. d. ) 
of overall protein sulfation for the different siRNA conditions from at least five different 
experiments (in duplicates). 
132 
CTL SNX1 SNX2 1+2 
CTL SNX1 SNX2 1+2 
Chapter 4- Role of Retromer in Toxin Transport 
In theory, one would deduce that a reduction in sulfation correlates with a reduced toxin 
arrival at the TGN. Hence, in fluorescent toxin-uptake single cell assays, one would expect 
decreased levels of FITC-STxB in the perinuclear area. Yet, conversely to what the results 
from the biochemical assay suggested, I found that in SNX2-suppressed cells, FITC-STxB 
showed predominantly perinuclear enrichment (Figure 4.14) after 30 minutes of 
internalisation. And, in some cells, the previously noted change in morphology (para. 3.5) 
was noted to result in the TGN being localized relatively closer to the plasma membrane 
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In cells treated with SNX2-specific siRNA, FITC-STxB 
is localized to the TGN. 
Surface-bound FITC-STxB (green) was internalized into SNX2- 
suppressed cells for 30 min (see para. 4.3.3). Cells were fixed and 
immuno-labelled using (A) anti-SNX2 (A1exa633, red) and anti- 
SNX1 (Alexa594, pseudo-coloured in magenta), or (B) using anti- 
TGN46 (A1exa594, red). SNX2 was successfully suppressed as 
indicated by the absence of signal. In these cells, STxB showed 
enrichment at the TGN, as indicated by the co-localization with 
TGN46. Arrow in R012 highlights closeness of TGN to plasma 
membrane. (C) Co-localization with TGN46 in confocal images 
from n> 50 cells was quantified using MetaMlorph. For each cell, 
co-localization in 8- 10 z-sections was analysed, s. d. was 
determined from mean for individual visual fields. See also Figure 
4.12. 
Figure 4.14 In cells treated with SNX2-specific siRNA, FITC-STxB is localised 
to the TGN. 
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Indeed, when I analysed the co-localization between internalized FITC-STxB and TGN46, 
I found that in control cell, 37% ± 0.4% (s. d. ) of STxB co-localized with the TGN 
marker (see also Figure 4.12), while in SNX2-suppressed cells 40`Yo ± 8% (s. d. ) did. 
Consistently, in these cells, I failed to observe a marked vesicular distribution of the toxin; 
when I scored the frequency with which I observed the previously characterised 
morphologies (being either a TGN-like enrichment or vesicular) I could not distinguish 
between control and SNX2-suppressed samples (Figure 4.15 A). Further still, the kinetics 
of FITC-STxB transport to the TGN were indistinguishable for the two samples (Figure 
4.15 B). 
Taken together, the data obtained from single-cell immunofluorescence analysis suggests 
that SNX2 suppression does not markedly alter retrograde transport of STxB, at least not 
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Quantification of STxB localization 
in SNX2- and jointly SNX1- and 
SNX2-suppressed cells. 
(A) The TGN- or vesicular appearance of 
FITC-STxB was scored in siRNA-treated 
cells described in Figure 4.9 for n> 600 
cells after 30 min toxin uptake. 
(B) Representative data set for TGN-like 
accumulation of FITC-STxB over time 
(n > 600 for each sample; scored for 30,60 
and 120 minutes) for control cells and, 
individually and jointly, SNX1- (compare to 






Figure 4.15 Quantification of STxB localization in SNX2- and jointly SNX1- and 
SNX2- suppressed cells. 
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4.5.2.3. Ef ect of joint treatment with SNXI- and SAM-specific siRNA on STxB 
suifadon 
As discussed in Chapter 3, joint suppression of SNX1 and SNX2 lead to a marked 
redistribution of the CI-MPR and reduced endosome-to-TGN transport kinetics. 
Regarding retrograde transport of STxB, through results obtained by sulfation assays and 
immunofluorescence-based analysis, I concluded that STxB retrograde transport was 
notably dependent upon SNX1 expression but was less reliant on SNX2. Hence, it was 
tempting to investigate the effect of joint suppression on the retrograde transport of STxB 
transport: if the two proteins do not serve the same route, and differ in their function, one 
would at least expect the sulfation reduction observed for SNX1 suppression. Assuming 
that SNX1 and SNX2 interacted as complex on exactly the same pathway [as suggested 
from the `retromer model' (Seaman, 2005; Pfeffer, 2001)], one may expect to see no 
further reduction in retrograde transport, assuming that both proteins acted 
`unidirectionally' in a `genetic null scenario'. As siRNA suppression was however not 
capable of suppressing expression 100%, joint suppression could further reduce retrograde 
transport. Likewise, in a model where the two sorting nexins were to act on different but 
paralleled pathways that would both contribute towards retrograde STxB transport, one 
might expect reduction in sulfation. 
When sulfation assays were performed, I surprisingly observed a striking upregulation of 
B-(Sulf) sulfation in the jointly SNX1- and SNX2-suppressed cells (Figure 4.13 B, C). 
In the course of these experiments, several other observations were made: when I 
quantified the suppression efficiency in these cells, I noticed that SNX2 suppression was 
even less prominent in the SNX1/SNX2 siRNA-treated cells, despite the same 
transfection protocol (Figure 4.13 A). This gave rise to the question whether SNX2 
expression was upregulated in SNX1-suppressed cells. Indeed, with the protocol used in 
this study, I found that SNX2 expression was slightly upregulated in SNX1-suppressed 
cells, but this effect was rather variable (median 123.8%, n= 4). Disappointingly, this 
apparent difference to previous findings (Carlton et al., 2004; Carlton et al., 2005b) can not 
be explained satisfactorily at this point; I suggest that it might be attributable to the 
different siRNA concentrations used in these studies10. This would imply that the 
transfection conditions and reagents used in this particular case would not compensate the 
10 NB: These findings are also at odds with the recent study from Rojas and colleagues (Rojas et al., 2007), 
which, obviously, for different protocols, can not be directly compared with the data presented here. 
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additionally produced protein. Nevertheless, from the proposed role for SNX2, it is not 
immediately evident how the weaker suppression of SNX2 in jointly suppressed cells may 
lead to an increase in sulfation; even more so in the light that in the jointly SNX1- and 
SNX2-suppressed cells I found SNX1 suppression to be greater than 90% (Figure 4. 
13 A, C). Here, I did not observe an upregulation of SNX1 expression in SNX2- 
suppressed cells (96.6% of control (median); n= 6). Interestingly, in the majority of cases, 
levels of SNX1 suppression in the jointly suppressed cells even exceeded the levels 
achieved with SNX1 siRNA treatment alone (Figure 4.13 C). Despite these high levels 
though, I failed to observe an effect on STxB sulfation (Figure 4.13 B); accordingly, 
when I plotted achieved levels of suppression against the level of sulfation after correction 
for global sulfation, values were always greater than 100% despite the higher suppression 
levels for SNX1 (Figure 4.13 C; open pink triangles = SNX1, open blue 
triangles = SNX2). Importantly, when I scrutinised the levels of endogenous sulfation, I 
noticed that joint SNX1 and SNX2 suppression lead to a substantial increase in global 
protein sulfation of cellular molecules to 147.7% ± 35.36% (n =5 in duplicates) (Figure 
4.13 D). As mentioned, the data shown in Figure 4.13 (B) and (C) are already corrected 
for global sulfation. Hence, it is crucial to point out that even without this correction B- 
(Sulf) sulfation values exceeded 100% in 9 out of 10 cases (87%). 
Taken together, the augmented sulfation of B-(Sulf) and endogenous proteins could be 
indicative for an enhanced delivery to the TGN under the jointly SNX1- and SNX2- 
suppressed conditions. As this data was not easy to reconcile with the results from the 
individual suppressions, I sought to examine the toxin localization under jointly 
suppressed conditions by microscopy using fluorescent toxin-uptake assays. I reasoned 
that if delivery was enhanced, I would see an increase in FITC-STxB at the TGN in these 
assays. However, when I examined jointly SNX1- and SNX2-suppressed cells after 30 
minutes uptake of FITC-STxB, I failed to observe an increased TGN accumulation. In 
samples with joint SNX1 and SNX2 suppression, the toxin predominantly displayed a 
vesicular distribution (Figure 4.15 A), which was indistinguishable to the localization 
observed in SNX1-supressed cells (Figure 4.9 C). Likewise, when I analysed the kinetics 
of toxin transport scoring the frequency of the previously characterized two distinct 
morphologies (Figure 4.9A, B), I could not discriminate between the jointly SNX1 - and 
SNX2-suppressed cells and only SNXI-suppressed samples (Figure 4.15 B). 
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From the results of the immunofluorescence analysis, it furthermore appears that SNX1- 
suppression is causative for the vesicular localization of STxB. Concordantly, in cells in 
which SNXI is suppressed, SNX2 appears more dispersed compared to control cells after 
30 minutes of FITC-STxB uptake (Figure 4.16). In contrast, SNX1 displayed an equally 
compact juxtanuclear enrichment in control and SNX2-suppressed cells (Figure 4.14 A). 
One interpretation of the obtained results that would reconcile the predominantly 
vesicular distribution observed in single cell assays and the increase in sulfation (of both, 
B-(Sulf2) and endogenous proteins) is to propose that the sulfation machinery was mis- 
localised to endosomes in the jointly suppressed cells. Unfortunately, our attempts to 
confirm proper targeting of the tyrosylprotein sulfotransferases TPST1 and TPST2 by 
immunofluorescence analysis proved unsuccessful, as all commercially available antibodies 
were unsuited. Earlier attempts by the Johannes Lab to use a cDNA approach were 
hampered by the finding that ectopically expressed TPST1 was mis-localised to the ER 












Figure 4.16 Analysis of SNX2 localization after FITC-STxB uptake in cells 
treated with SNX1-siRNA 
Control and SNX1-suppressed cell were subjected to a FITC-STxB uptake assay. The toxin was 
surface-bound at 4°C, then internalized at 37°C for 30 minutes. Fixed cells were immuno-labelled 
with anti-SNX2 (Alexa633, red channel). Scale bar is 10 µm. 
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localization of the sulfotransferases is not possible. Interestingly, the finding that 
downmodulation of certain proteins can affect endogenous sulfation levels has been 
observed before (Ludger Johannes, personal communication). Further still, a very recent 
study showed that in HEK 293 cells, SNX1 suppression altered level of sulfation of 
endogenous proteins in a similar assay investigating retrograde transport the plant 
cytotoxin ricin (Skanland et al., 2007). Importantly, in HeLa cells, I only observed an 
upregulation of overall protein sulfation in the jointly suppressed cells. 
Overall, the data presented here is consistent with the conclusion that SNXI is required 
for transport of STxB as its suppression led to a marked reduction in the transport of 
STxB to the TGN, and the retention of the toxin in vesicular structures. SNX2 appears to 
be less important in promoting the endosome-to-TGN `retrograde' step of STxB, at least 
under the experimental conditions of this study. 
These data furthermore illustrates that one has to take care when analysing data obtained 
by only one type of analysis; while the biochemical assay provides an elegant way to assess 
TGN delivery at the functional level, it shows that carefully monitoring the endogenous 
sulfation levels as well as cross-confirmation by other experimental methods is almost 
mandatory. 
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4.6. Investigations into the Role of VPS26in Retrograde STxB 
Transport 
I have not analysed the role of VPS26 in this process in detail; these assays were intended 
as further confirmation that the observed defect in endosome-to-TGN transport was 
specific and to see whether the process was retromer-dependent, as opposed to dependent 
only on SNXI. 
In an analogous approach to the previous analyses (para. 4.2.1 - 4.2.3), cells were treated 
with VPS26-specific siRNA and subjected to both, fluorescent toxin-uptake assays using 
FITC-STxB and sulfation assays utilizing the B-(Sulf, ) toxin subunit. The siRNAs were 
originally designed and characterized by Mr Vincent Popoff, Institut Curie, Paris, France. 
As Figure 4.17 A shows, in cells treated with control siRNA, VPS26 displayed a punctate 
pattern, and partially co-localized with FITC-STxB on vesicular structures in the 
perinuclear area. After 30 minutes uptake of FITC-STxB, most of the toxin was found 
juxtanudearly displaying a TGN-like enrichment. In cells treated with the VPS26 siRNA, 
protein expression of VPS26 was successful as the absence of signal shows". In these 
cells, FITC-STxB displayed clearly a vesicular pattern, reminiscent of the phenotype 
observed under SNX1-suppressed conditions. Like for SNX1, these vesicles partially co- 
localized with EEAl (indicating the endosomal nature of these vesicles, data not shown). 
To quantify this effect, sulfation assays were performed. I found that B-Sulf2 sulfation was 
markedly reduced to 38% ± 11.1 % (s. d., n=4 in duplicates) compared to control cells 
(Figure 4.17 B). Examining the levels of endogenous sulfation, I noticed that sulfation of 
cellular components was reduced to 69% ± 31.4% (s. d., n=4 in duplicates) (Figure 4. 
17 C). This was a comparably high - but variable - degree. I suggest that this could in part 
be due to the previously observed fragmentation of the Golgi, including TGN under 
VPS26 suppressed conditions, as indicated by labelling using anti-TGN46 and GM130 
(Seaman, 2004). While in these cells, a CD8-CI-MPR construct was still targeted to the 
TGN fragments (Seaman, 2004), indicating correct `targeting', one could surmise that this 
might interfere with TPST function, which, for the outlined reasons (para. 4.4.2.3), I was 
unable to address. 
11 Suppression was regularly confirmed by SDS-PAGE/Western blot analysis from whole-cell lysates and 
confirmed the reduction in VPS26 protein levels. 
139 




























Figure 4.17 Suppression of VPS26 perturbs endosome-to-TGN transport of STxB 
(A) Cells treated with either control or %TS26-specific siRNA were subjected to a FITC-STxB 
uptake assay. After 30 min, cells were fixed and labelled with anti-VPS26 (A1exa594, red). VPS26 
expression was successful, as indicated by the absence of signal in VPS26-suppressed cells, where 
FITC-STxB displays a vesicular distribution. Scale bar is 10 µm. (B) Control and VPS6-suppressed 
cells were subjected to a sulfation assay using the modified B-(Sulf2) subunit. Graph shows average 
from n=4 assays (in duplicate) adjusted for overall sulfation of endogenous proteins and 
normalized to control (± s. d. ). (C) Global sulfation under control and VPS26-suppressed 
conditions from n=4 assays (in duplicate, ± s. d). 
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4.7. Analysing the Role ofSNX1 and SNX2in Endosome-to-TGN 
Transport of Cholera Toxin B-subunit 
As outlined in the introduction of this chapter (para. 4.1), Shiga and cholera toxin are 
both AB5-toxins, and have been proposed o enter the TGN via "indistinguishable 
mechanisms" (Nichols et al., 2001) regarding GPI-positive intermediates. However, 
compared to Shiga toxin, not much is known about the mechanisms involved in 
endosome-to-TGN transport of CTxB. This prompted me to examine the effect of SNX1 
on retrograde transport of CTxB in more detail. 
Thus, I adapted the previously described STxB assays to study retrograde CTxB transport 
and a fluorescent toxin-uptake assay using A1exa555-CTxB (Invitrogen) was developed. As 
previously, cell treated with the respective siRNA for 72 hours were incubated in cold 
DHB medium on ice to stop intracellular transport. The fluorescent toxin subunit was 
bound to the cell surface for 30 minutes by incubating in ice-cold DHB media containing 
1 µg/ml Alexa555-CTxB. After removing unbound toxin, cells were either fixed directly to 
examine surface labelling or transferred to 37°C for the indicated times to allow 
internalization of the toxin. Cells were subsequently fixed and processed for 
immunolabelling using the respective anti-SNX antibodies. When I examined the surface 
binding of A1exa555-CTxB by confocal microscopy, I noticed that Alexa555-CTxB- 
labelling was equally heterogeneous in both, control and SNXI-suppressed samples. Not 
all cells were labelled to same extent, and a similar proportion displayed no or less readily 
detectable Alexa555-CTxB labelling (Figure 4.18 A). This most likely reflects the cell-to- 
cell variability of plasma membrane content of the CTxB receptor GM1 (Pang et al., 
2004). Importantly though, examining the cells visibly labelled with Alexa555-CTxB, I 
could not distinguish between plasma membrane-labelling of Alexa555-CTxB in control 
and SNXI-suppressed samples (Figure 4.18 A). I concluded that SNX1 suppression did 
not affect GMI levels at the plasma membrane. 
After internalizing A1exa555-CTxB for 15 minutes, the subunit showed extensive co- 
localization with SNXI -positive structures in control cells, with a slight enrichment in the 
perinuclear area. This distribution of Alexa555-CTxB was not markedly different in 
SNX1-suppressed cells (Figure 4.18 B). 
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Figure 4.18 Retrograde transport of CTxB appears to be unaffected by SNX1 
suppression 
Control and SNX1-suppressed cell were subjected to an Alexa555-CTxB uptake assay. The toxin 
subunit was surface-bound at 4°C, then cells were either fixed directly (A), or after internalization 
of A1exa555-CTxB at 37°C for 15 min (B). Fixed cells were immuno-labelled with anti-SNX1 
(Alexa488, green channel) and imaged using confocal microscopy. Scale bar is 20 µm. 
142 
merge SNX1(Alexa488, green) Alexa555-CTxB 






























Figure 4.18 (cont'd) Retrograde transport of CTxB appears to be unaffected by 
SNX1 suppression 
Control and SNX1-suppressed cell were subjected to an . -klexa555-CTxB uptake assay (red 
channel). The toxin subunit was surface-bound at 4°C, then internalized of A1exa555-CTxB at 
37°C for either 30 min (C) or 60 min (D). Fixed cells were immuno-labelled with anti-SNX1 
(A1exa488, green channel). Scale bar is 20 µm. 
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When cells where fixed after longer periods of internalisation, the toxin subunit displayed 
similar degrees of enrichment in the perinuclear area in control compared to SNX1- 
suppressed cell (Figure 4.18 B, C). This finding suggested that unlike the case for STxB, 
SNXI-suppression did not markedly perturb endosome-to-TGN transport of A lexa555- 
CTxB. I confirmed that the perinuclear enrichment of toxin corresponded to the Golgi 
complex by immuno-labelling with anti-giantin (following 40 min toxin uptake in SNX1- 
suppressed cells; Figure 4.19 A). This type of experiments also allowed me to quantify 
the degree of co-localization of A1exa555-CTxB with the Golgi marker giantin using two 





















control SNX1 SNX2 TGN Ves TGN Ves 
siRNA siRNA: control SNX1 
Figure 4.19 Co-localization of CTxB with giantin is not markedly reduced in 
SNX1-suppressed cells 
(A) Surface-bound Alexa555-CTxB was internalized into SNX1-suppressed cells for 40 min. Cells 
were fixed and immuno-labelled with anti-SNX1 (Alexa48, green) and the Golgi-marker giantin 
(A1exa633, magenta). In these cells, A1exa555-CTxB showed a clear Golgi enrichment. (B) Co- 
localization between A1exa555-CTxB and giantin after 40 min uptake was quantified using 
MetaMorph software (Molecular Devices). Co-localization was not reduced in SNXI-suppressed 
cells (27% ± 13% s. d.; 94 of 200 cells with detectable A1exa555-CTxB label) compared to control 
(13% ± 6% s. d; 71 of 149 cells with label) or SNX2-suppressed cells (15% ± 8%, s. d.; 21 of 43 
cells); s. d. determined from mean of visual fields (see para. 4.3.5 for details). (C) Quantification of 
proportion of TGIF-like enrichment or vesicular appearance of Alexa555-CTxB after 60 min 
uptake in control and SNX1-suppressed cells ('analogous approach' n> 650 cells). Scale bar is 
20 lam. 
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When employing the digital co-localization analysis approach using MetaMorph software, I 
found that co-localization between Alexa555-CTxB and giantin was not reduced in SNX1- 
suppressed cells (Figure 4.19 B). Quite the contrary, from these results it appears that co- 
localization was increased under SNX1-suppressed conditions. However, when 
interpreting the results from the digital quantification of CTxB and giantin co-localization, 
one has to bear in mind that the cells displayed heterogeneity for levels of Alexa555-CTxB 
uptake, probably owing to the heterogeneous levels of GM1 in HeLa cells (Pang et al., 
2004). The analysis algorithm is based on spatial overlap of pixels, and identical threshold 
levels had to be applied to all images from the different treatment conditions; for a cell 
that takes up less toxin relatively more pixels will fall below threshold level, especially in 
region where the toxin is less clustered, id est the cytoplasm. Consequently, as the co- 
localization is computed as spatially overlapping pixels over the sum of all pixels for the 
respective channel, this will be manifested as increased co-localization with giantin. Thus, 
due to the heterogeneity of label, this approach does not provide an absolute measure of 
Alexa555-CTxB at the TGN. The relatively large error bar is also indicative for this 
phenomenon. Importantly however, the co-localization is not lower than in control cells. 
Likewise, SNX2 suppression did not alter the degree of co-localization of CTxB with 
giantin, indicating that this sorting nexin is not critically involved in this transport step. 
Generally, the absolute co-localization of CTxB with giantin is relatively low, and even 
after 60 minutes a high degree of CTxB was detected on intracellular structures and even 
the plasma membrane. 
For the technical difficulties described, I also chose to evaluate the samples by eye scoring 
the frequency with which I observed either a TGN enrichment of Alexa555-CTxB, or a 
vesicular distribution. This type of analysis scoring over 650 cells per treatment condition 
confirmed that Golgi localization was observed with similar frequencies in cells where 
SNX1 was suppressed (70.2%) compared to control cells (77.3%) (Figure 4.19 C). 
Importantly, the `analogue' approach evaluated cells of all intensities in which Alexa555- 
CTxB was readily detectable by eye. It furthermore appeared that transport kinetics of 
Alexa555-CTxB in controls are faster than FITC-STxB comparing the frequencies of 
TGN-localization (Figure 4.8). I was however unable to examine this in a directly 
comparative study (see para. 4.8). 
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4.8. Attempts ofa Comparative STxB and CTxB Analysis 
It would have been desirable to further confirm the findings for CTxB using a biochemical 
assay. When these studies commenced, the Johannes Lab had just developed a tool to 
study retrograde transport of CTxB biochemically by using a sulfation approach with a 
genetically engineered CTxB-biotin subunit mutant. Despite several attempts however, I 
was unable to detect a strong enough signal by autoradiography. This is most likely due to 
the low GM1 levels in the cell line used in this study; quantification showed that 47% - 
49% of all cells exhibited readily detectable levels of Alexa555-CTxB when examined by 
epifluorescence microscopy, in line with the previously reported "significant differences" 
in GM1 levels in HeLa cells (Pang et al., 2004). 
Similarly, it would have been desirable to directly compare CTxB and STxB in the same 
cell using fluorescent toxin-uptake assays. These assays gave however inconsistent results. 
Firstly, the CTxB-label was generally low (compare para. 4.6), and secondly, in 70% - 80% 
of all cases cells were found to be positive for either one or the other toxin (Figure 4.20). 
This is not surprising given that it has been shown that the labelling pattern of the two 
toxins is strongly cell cycle-dependent and almost complementary (Majoul et al., 2002). In 
the few instances where co-labelling was observed, STxB was generally of very low 
intensity. In the very few instances, where cells were labelled with both toxins at acceptable 
intensities, the toxins were often found clustered in unusually enlarged structures, with 
suspiciously `perfect overlapi12 (Figure 4.21). These were not observed when incubating 
the cells individually with the probes. Moreover, unlike observations for the individual 
probes, these structures did not notably co-localize with SNX1; I chose not to evaluate 
these data further, as I suggest that this might at least in part represent toxin `co-clusters' 
attributable to receptor aggregates [the pentameric B subunit of cholera toxin can bind up 
to five gangliosides at once (Sixma et al., 1992; Merritt et al., 1994; Merritt et al., 1998). For 
Shiga toxin, the B subunit may dispose of as many as 15 binding sites for Gb3 (Ling et al., 
1998)]. 
12 (Given that at lower levels, the two probes did not exhibit this behaviour. ) 
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Figure 4.20 Analysis of joint labelling with Alexa555-CTxB and FITC-STxB 
Cells were surface-labelled with a mixture of FITC-STxB (green) and Alexa555-CTxB in DHB 
medium, rinsed, transferred to 3? °C for 30 minutes before being fixed. The merge illustrates 
preferential labelling for either STxB or CTxB. Generally labelling was very low in cells positive for 
both toxins, while it was furthermore noted that in these cells the toxin did not exhibit the 









Figure 4.21 Examining the co-localization in jointly FITC-STxB- and Alexa555- 
CTxB-labelled structures. 
Cells were surface-labelled with a mixture of FITC-STxB (green) and rlexa555-CTxB in DHB 
medium, rinsed, transferred to 37°C for 10 minutes before being fixed and immunolabelled with 
anti-SNX1 (Alexa633, magenta). The merge shows both, STxB and CTxB but SNX1 was omitted 
for clarity. Joint labelling with FITC-STxB and CTxB can lead to formation of enlarged punctate 
structures that rarely co-localize with SNX1 (arrowheads, inset). Scale bar is 20 µm. 
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4.9. Discussion 
In this study, combining single-cell fluorescent toxin uptake assays and biochemical 
population-based analyses, I show that RNAi-mediated silencing of SNXI markedly 
perturbs retrograde endosome-to-TGN transport of Shiga toxin B subunit. I furthermore 
show that in contrast to SNX1, the closely related SNX2 does not markedly alter the 
delivery of STxB to the TGN. Alongside with the data presented that RNAi-mediated 
suppression of VPS26 also perturbs retrograde STxB transport, this establishes that 
retrograde early endosome-to-TGN transport of Shiga toxin B subunit occurs, at least in 
part, via a SNX1-and retromer-regulated mechanism. The observed endosomal arrest of 
STxB under SNXI-suppressed conditions was highly reminiscent of the redistribution of 
CI-MPR/sortilin under the same conditions; in the following paragraphs I will discuss 
aspects arising from comparing results of Chapters 3 and 4 (see also Figure 4.22 for a 
model). 
From analysis of the role of SNX1 (Chapter 3) as well as VPS26 (Arighi et al., 2004; 
Seaman, 2004) in retrograde transport - on one hand of CI-MPR and sortilin, on the other 
hand of STxB - it is evident that at least some components of the retromer transport 
machinery must be shared between these two components/steps. Likewise, a requirement 
for clathrin and dynamin (Saint-Pol et al., 2004; Lauvrak et al., 2004), as well as lipid rafts 
(Falguieres, et al., 2001; Carroll et al., 2001) are common features of both, endosome-to- 
TGN transport of CI-MPR and Shiga toxin transport 
Possible relation ofclathrin and the retromer? 
Although I have not investigated this aspect in detail, there is coincidental evidence to 
suggest that clathrin and the retromer may operate in a successive manner. The E11i data 
presented here (Chapter 3) and previously (Carlton et al., 2004) show that SNX1-/CI- 
MPR-positive tubular profiles originate from a portion of early endosomal limiting 
membrane that does not possess a recognizable electron-dense clathrin coat. Likewise, 
SNX1 is not found ETCs, but STxB can be found on small vesicles highly reminiscent of 
ETCs where it co-localized with CD-MPR (Mallard et al., 1998). 
Conversely, VPS26 not only localizes to endosome-associated tubules and ETCs (Muriel 
Mari, personal communication), but also localizes to some extent to the bilayered clathrin 
coat (Arighi et al., 2004). From a very recent study, it furthermore appears that dathrin and 
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the retromer component VPS26 do not only co-localize on STxB-positive endosomes at 
EM level but upon their suppression, STxB appeared to be trapped in these distinct 
endosomal subdomains (Ludger Johannes, personal communication) 13. These findings 
corroborate a model in which clathrin and the different retromer components could act at 
distinct stages on the same transport pathway. LCI and EM analysis furthermore showed 
that STxB exits the endosomal vacuole via distinct tubules, compared to Tf (Ludger 
Johannes, personal communication) 13. Similarly, sortilin and CI-MPR were found on 
distinct tubules, compared to Tf (Chapter 3). Strikingly, upon clathrin suppression, Tf and 
STxB appear on the same tubule (Ludger Johannes, personal communication)13, further 
illustrating the role of clathrin in the sorting/cargo-separation process. 
Again, a `no-role' for SNX2? 
The finding that SNX2 only plays a minor role in promoting STxB retrograde transport to 
the TGN ties in with the lack of an effect of SNX1 suppression on CI-MPR retrieval to 
the TGN. Unlike the situation for SNXI, I was not able to establish a critical threshold 
level for SNX2-suppression with regard to B-(Sulf1) sulfation, meaning that even given 
comparably high levels of suppression, sulfation appeared slightly but not markedly altered 
compared to SNX1. The biochemical data must also be interpreted in the light of the 
effect on cell proliferation and morphological changes under SNX2-suppressed 
conditions, which I have not further characterized in this study. In assays less susceptible 
to potential effects of SNX2 suppression on proliferation rate, which furthermore allowed 
monitoring of suppression levels of individual cells, the toxin dearly accumulated at the 
TGN, which argues against a major role of this SNX in endosomal retention of the toxin 
and is in line with previous findings for the CI-MPR (Chapter 3 and Rojas et al., 2007)'. 
The unexpected finding that joint suppression produced a vesicular phenotype comparable 
to SNX1 but led to increased sulfation further complicates the interpretation. One 
constant finding is that inclusion of SNX1-specific siRNA results in peripheral, endosomal 
localization of CI-MPR, sortilin as well as STxB. 
Interestingly, while preparing this thesis, Skanland et al. reported that SNX2, but not 
SNX1, is important in retrograde transport of the plant toxin ricin (Skanland et al., 2007), 
which, like Shiga and cholera toxin, is an ER-trafficking toxin [see (Sandvig and VanDeurs, 
13 V. Popoff, G. A. Mardones, D. Tenza, R. Rojas, C. Lamaze, J. S. Bonifacino, G. Raposo, and L Johanns 
(2007) The Retromer complex and clathrin define an early endosomal exit site. J Ce! /Sa (in press) 
14 NB: Rojas et al. do not see an effect when suppressing SNX2 alone. 
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1996) for review]. This is particularly exciting in the view that it provides furthers our 
argument that SNX2 and SNX1 might (also) have independent properties: with regards to 
toxin traffic (Skanland et al., 2007 and this study), but also with respect to receptor sorting 
(see discussion in Chapter 3; Gullapalli et al., 2004 and 2006). So it could be possible that 
SNX2 either mediates transport out of the sorting endosome via SNX1-independent 
tubules (given the data presented here on SNX2 function and the finding that SNX1 
suppression did not affect ricin sulfation). Additionally, clathrin appears not to be 
important for ricin delivery to the TGN (Iversen et al., 2001), which further suggest that 
sorting into `ricin retrograde carriers' is different from sorting into 'STxB retrograde 
carriers'. 
Interestingly, after uptake, only a small fraction of the toxin reaches the Golgi (van Deurs 
et at, 1986; van Deurs et al., 1988), while a large fraction of ricin is recycled back to the 
cell surface (Sandvig and Olsnes, 1979), and maybe even to lysosomes (Sandvig and 
Olsnes, 1979), although this has been questioned more recently (Moisenovich et al., 2004). 
The finding that most of the internalized ricin is recycled is particularly exciting given that 
besides SNX2, SNX4 was found to be important in the transport step of ricin to the 
TGN. Our lab has recently shown that SNX4 is involved in mediating early endosome-to- 
ERC transport, as shown, inter alia, by the finding that upon its suppression, the TfR is 
mis-sorted to lysosomes15. In this context, the finding of Skanland and colleagues that 
suppressing SNX2 and SNX4 together had a somewhat additive effect on ricin transport 
suggests that they might function at slightly different steps (see below; and compare 
Figure 4.22 overleaf). So while SNX4 regulates transport of ricin to the ERC, it is not 
clear how it would be transported from here to the TGN. It might be recycled to the 
plasma membrane, or, if delivered to the TGN, this occurs in a manner independently of 
Rab11 (Iversen et al., 2001). 
So what about the `residual' STxB that reaches the TGN under SNX1-suppressed 
conditions? Although the correlation between sulfation level and suppression level is 
clear, it seems likely that other pathways contribute to STxB retrograde sorting in a rough 
estimation, this would otherwise mean that the remaining 5- 10% of SNX1 would 
account for as much as 40 - 60% of retrograde toxin transport. In contrast, VPS26 
15 CJ Tract, A. C. Rutherford, KJ. Palmer, T. Wassmer, J. Oakley, N. Attar, J. G. Carlton, J. Kremerskothen, 
D. J. Stephens, and P j. Cullen (2007) Sorting nexin-4 co-ordinates endosomal sorting of transferrin receptor 
with dynein-mediated transport into the endocytic recycling compartment. Nat Cell Biol (under revision) 
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suppression appeared much more efficient, although there are provisos that this might at 
(least in part) result from TGN fragmentation. Besides these technical issues, there is 
indication that STxB might take another route: the toxin has been shown to use a pathway 
taken by TGN38/TGN46 (Mallard et al., 1998), which is probably Rabll-dependent as 
overexpression of Rab11 affects both, STxB as well as TGN38/46 transport to the TGN 
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Figure 4.22 Working model of endosomal transport to the TGN for the cargo and 
components discussed 
Likewise, differences between STxB to CI-MPR transport arise when one considers the 
role of Rab9, which provides a retrieval pathway for the CI-M1PR from late endosomes 
back to the Golgi complex (Diaz and Pfeffer, 1998; Carroll et al., 2001; Barbero et al., 
2002). In contrast, it has been proposed (documented but not confirmed) that Rab9 is not 
required for STxB retrieval (Sandvig et al., 2002). This is interesting in the light that I have 
also presented data (based on fluorescent toxin-uptake assays) that SNXI -suppression 
does not appear to markedly reduce endosome-to-TGN transport of cholera toxin B- 
subunit. Taken together with the finding that Rab9 overexpression is capable of restoring 
correct Golgi targeting CTxB in NPC cells (Choudhurv et al., 2002), this might suggest 
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that CTxB endosome-to-TGN transport occurs at least in part from late endosomes. 
(Hence, one would expect CTxB to be absent from ETCs. ) 
On a more general note, uptake of Shiga toxin is a prime example to study variance of 
endocytic pathways used in different cell types. Like for CTx regarding requirement for 
caveolin (see Chapter 1, par 1.3.4), the fraction of toxin internalized by clathrin- 
dependent, as opposed to clathrin-independent mechanisms, seems to depend on the cell 
line used and on the conditions under which the cells are grown (Schapiro et at., 1998; 
Lingwood, 1999; Nichols, 2002; Sandvig et al., 2004). Especially in the light that 
expression levels of the receptors appear cell-cycle dependent (Majoul et al., 2002), even 
comparative studies using the same cell line might yield different results. 
16 
16 (cell cycle progress dependent on `batch age', starvation protocols, etc) 
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Chapter 5- Role of Sorting Nexins in Salmonella Invasion 
5. Z Preface 
The work described in this chapter was initially started when developing and overseeing 
the final year undergraduate projects of Ms Emily de Looze and Ms Frances Mulvany. 
While Ms Emily de Looze was involved in all initial SNXI-related fixed-cell and live-cell 
imaging, Ms Frances Mulvany was involved in work relating to SNXs other than SNXI. 
I am immensely grateful to Dr Mark Jepson, for help and advice with this project, and 
acknowledge the help of Ms Charlotte Perett with initial fixed cell assays, and advice on 
evaluation of invasion/adherence assays, and am grateful to Alan Leard for help with live 
cell imaging. 
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5.2 Introduction 
Bacteria may be considered true `cell biology experts', as pathogens like Salmonella 
Typhimurium (S. Typhimurium), the leading cause of food-borne gastroenteritis, have 
developed sophisticated ways to gain access to host cells and to utilise intracellular 
machinery and resources to replicate within them. This includes very refined mechanisms 
to stimulate uptake into non-phagocytic cells by influencing actin dynamics and involves 
extensive interactions with the host cells' endocytic machinery, as well as downmodulation 
of stimulatory effects on the cytoskeleton in order to allow for cell recovery. The 
mechanisms of orchestrating these effects must be highly regulated, and in many cases, the 
details and the degree of bacterial interactions with host cell organelles are still poorly 
understood. As these bacteria hijack and mimic cell function, studying the life cycle of this 
pathogen from a cell's perspective and analyzing the cellular targets and machinery 
exploited has thus the potential to provide information about both, bacteria and the cell 
itself. Here, I explored the role of sorting nexins in bacterial entry. 
5.2.1. Salmonella Typhimurium - Type III secretion 
A group of bacterial pathogens including the enterobacterium S. Typhimurium is capable of 
invading non-phagocytic cells by actively inducing, or triggering, their own uptake (Alonso 
and Portillo, 2004). Invasion of epithelial not only allows the pathogen to escape immune 
response but also enables replication within the host, as it establishes its replicative niche 
within its cells [(Knodler and Steele-Mortimer, 2003; Patel and Galan, 2005) for review]. In 
order to colonize and replicate within the host, Salmonellae employ a multitude of virulence 
factors, including two Type III secretion systems (TTSS) (Groisman and Ochman, 1997; 
Buttner and Bonas, 2002). These secretion systems translocate bacterial effector proteins 
into the host cell, which specifically interact with a variety of cellular targets. While the 
Salmonella pathogenicity island (SPI)-2 encoded TTSS plays no role in invasion, but is only 
induced after successful entry and is required for intracellular survival [(Waterman and 
Holden, 2003) for review], the SPI-1 system is already activated extracellularly and essential 
for invasion of non-phagocytic cells (Lostroh and Lee, 2001). On one hand, this gene 
locus encodes components of a multi-protein needle complex that acts as a `molecular 
syringe' (Kimbrough and Miller, 2002). On the other hand, it also encodes for the proteins 
injected through this `needle' into the cytoplasm of the host [(Ehrbar and Hardt, 2005) for 
review]. Through `functional mimicry', these effectors influence the cellular cytoskeleton 
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and interfere with host signalling function to achieve uptake in a mechanism resembling 
macropinocytosis. At early time points of infection, the proteins transferred into the host 
include the Salmonella invasion protein SipA (also known as SspA)", the Salmonella guter 
proteins SopE and SopE2 and the product of the Salmonella invasion gene SigD (also 
known as SopB). In brief, SipA binds actin, and has the capacity to catalyse actin 
polymerization and to bundle actin filaments (Zhou et al., 1999a; Zhou et al., 1999b; 
Galkin et al., 2002). SopE and SopE2 act as guanine-nucleotide exchange factors (GEFs) 
on different host cell Rho GTPases (Rudolph et al., 1999; Stender et al., 2000; Friebel et 
al., 2001), thus influencing cytoskeletal rearrangements (Hardt et al., 1998), while another 
SPI-1 effector, the Salmonella protein tyrosine phosphatase SptP acts as GTPase-activating 
protein (GAP) for Cdc42 and Racl (Fu and Galan, 1999; Zhou and Galan, 2001), thus 
reverting the effects evoked by SopE and SopE2. 
Of particular interest for this study is the SPI-1-encoded SopB. This bacterial virulence 
protein is a phosphatase presenting broad substrate specificity, hydrolyzing various 
phosphatidylinositol polyphosphates and inositol polyphosphates (Norris et al., 1998; 
Terebiznik et al., 2002; Hernandez et al., 2004; Mason et al., 2007) . 
This includes turnover 
of PtdIns(4,5)PZ (Terebiznik et al., 2002) yielding PtdIns5P (Mason et al., 2007), and 
additionally, as shown in in vitro assays the hydrolysis of 5-phosphates from Ptdlns(3,5)P2 
and Ptdlns(3,4,5)P3 (Marcus et al., 2001). Further still, generation of Ins(1,4,5,6)P4 from 
Ins(1,3,4,5,6)P5 in in vitro and in vivo assays has been demonstrated (Zhou et al., 2001). Due 
to the conflicting results regarding its enzymatic specificity, the exact molecular function 
and its in vivo targets are still matter of debate. However, it is dear that PPIn and the active 
subversion of the phosphoinositide metabolism by the bacteria play an important role in 
the invasion process of this pathogens (Pizarro-Cerda and Cossart, 2004). 
17 Ssp: Salmonella secreted protein 
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5.22. Bacterial invasion and interactions with the host cell's endosomal 
system 
Through concerted action of the translocated SPI-1 effector proteins, S. Typbimurium first 
induces changes in the actin cytoskeleton leading to extensive ruffling. Upon closure of 
membrane tips, extracellular-liquid filled macropinosomes are produced, which can be 
empty or contain bacteria. These Salmonella-containing vacuoles, or SCVs, are thus initially 
derived from plasma membrane but quickly resemble early endosomes [see (Knodler and 
Steele-Mortimer, 2003) for review]. Kinetic studies have shown that within 5 minutes after 
infection, early SCVs become enriched in PtdIns3P (Pattni et al., 2001), and hence recruit 
Ptdlns3P-ligands and their respective interacting proteins, like EEA1 (Steele-Mortimer et 
al., 1999) and Rab5 (Scott et al., 2002). At these early time points SCVs also acquire 
components of the endocytic recycling system, like Rab4 (Smith et al., 2005), and 
transferrin receptors (Steele-Mortimer et al., 1999). Akin to endosomes, early SCVs are 
thought to gradually mature into `late SCVs' (Gorvel and Meresse, 2001): they acidify 
(Rachman et al., 1996; Drecktrah et al., 2007) and acquire late endosomal proteins, such as 
Rab7 (Meresse et al., 1999), and lysosomal glycoproteins including Lamp-1 (Steele- 
Mortimer et al., 1999). The virtual absence of the CI-MPR on SCVs (Garcia-del Portillo 
and Finlay, 1995) has long been interpreted as indicator for limited, or selective, interaction 
with late endosomes. It was shown that acquisition of cathepsin D and cathepsin L is 
markedly delayed, indicating that the maturation kinetics are slowed down in SCV 
biogenesis compared to endosomal maturation (Garcia-del Portillo and Finlay, 1995; 
Steele-Mortimer et al., 1999). 
Besides acquisition of endosomal proteins, SCVs also employ intracellular transport 
machinery and interact with molecular motors, as they become progressively enriched in 
the perinuclear area with time, and are eventually positioned in close proximity to the 
TGN (see (Henry et al., 2006) for review). It is thought that maintaining the correct 
positioning enables the bacteria to escape lysosomal degradation and to establish a 
replication niche near the TGN (Beuzon et al., 2000; Salcedo and Holden, 2003; Abrahams 
et al., 2006; Deiwick et al., 2006). Here, interactions with the host are mediated by a set of 
`late' effector proteins, encoded by SPI-2. 
Given the capacity of SNX1 to bind to PtdIns3P and, moreover, its function as an 
important regulator of sorting processes between endosomes and the TGN, I sought to 
explore the role of SNX1 in SCV biogenesis. 
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5.3. Materials and Methods 
For general materials and methods, buffer and media compositions, suppliers and 
equipment, one is referred to Chapter 2. If not stated otherwise, reagents were obtained 
from SigmaAldrich or Invitrogen. 
5.3.3. Bacterial Strains 
In this study, the wild type strain SL1344 (Hoiseth and Stocker, 1981), an isogenic 
SL1344-OsigD deletion mutant (AsigD) and as control, a SL1344-AsigD strain 
complemented with a plasmid encoding for SigD and its chaperone SigE (SL1344-OsigD- 
pSigD-pSigE) were used (generously provided by Dr 0. Steele-Mortimer, NIAID/NIH, 
Hamilton, MT, USA). For all experiments, 100 . tl of an overnight culture were diluted in 
10 ml LB broth and grown to mid-log phase. For live cell imaging and colony forming unit 
assays, a multiplicity of infection (m. o. i. ) of approximately 50 in 1 ml of Krebs buffer or 
imaging buffer (see para. 5.3.3) was used; for fixed cell imaging, the m. o. i. was 50 or 150. 
The m. o. i. was calculated as follows: 
m. o. i. = N° bacteria/N° cells, while number of bacteria was determined 
spectrophotometrically using 1 ml of the bacterial culture and determining the ODD 
(while 1 OD600 corresponds to 1x109 colony forming units (cfu) per ml), and by having 
determined the number of cells when seeding the night before the assay using an 
improved-NEUBAUER hemocytometer (Marienfeld). 
5.3.4. Cloning ofpmRFP-2xFYVE 
The pEGFP-C1-2xFYVE vector was a kind gift from Prof George Banting, University of 
Bristol, Bristol, UK (Pattni et al., 2001). In this vector, using the Age! and BsrGI 
restriction sites the GFP-coding sequence was excised, and replaced with the sequence 
coding for mRFP, excised from pmRFP (see Chapter 2, para. 2.1.5. ) using the same 
restriction endonucleases (see also Appendix 11.3), and ligated into the vector (see par 
2.3.6). 
5.3.5. Infection Assays -Fixed Cell Analysis 
Cells (untreated, siRNA transfected or DNA transfected) were washed twice with pre- 
warmed (37°C) modified Krebs buffer (137 mM NaCl, 5.4 mM KC1,1 mbs MgSO4, 
0.3 mM KHZPO4,0.3 mM NaH2PO4,2.4 mM CaC12,10 mM glucose and 10 mN1 Tris 
base, adjusted to pH 7.4 at 37°C with HC1). Infection was carried out at the respective 
m. o. i. for 15 min in modified Krebs buffer at 37°C. Bacteria were removed and cells were 
washed extensively with PBS, supplemented with 0.9 mM CaCl2 and 0.5 m111 MgC12 
157 
Chapter 5- Role of Sorting Nexins in Salmonella Invasion 
(PBS++). Where appropriate, cells were incubated in PBS++ for further 15 min before 
being transferred into PBS++ supplemented with 16 p. g/ml gentamicin (Sigma) to prevent 
furher infection and then fixed using 2% PFA for 45 min at 4°C, or 4% PFA for 15 min at 
37°C to improve tubule preservation. Cells were then processed for immuno-labelling as 
described elsewhere (Chapter 2, para. 2.4.21), mounted on microscope slides using either 
Mowiol or Vectashield containing DAPI (Vector Laboratories). Imaging was performed as 
described (para. 2.4.23), and obtained images were merged using Leica confocal software 
(Leica Microsystems). Voloczty software V4.0.1 (Improthion) was used for compiling and 
compressing movies, deconvolution of data sets and 3D image volume rendering. Where 
applicable, contrast and brightness adjustments were made using Adobe Photoshop® 6.0 
(Adobe Systems Inc. ). If not stated otherwise, time points are given from the start of 
experiment, thus before infection. 
5.3.6. Infection Assays - Live Cell Imaging 
Transfected cells were washed twice with modified Krebs buffer and coverslips were 
transferred into pre-warmed (37°C) coverslip holders together with approximately 1 ml 
imaging buffer (125 mM NaCl, 42 mM HEPES, pH 7.4,18 mM glucose, 5.4 MM KC1, 
3 mM NaHCO3,1.6 mM MgC12 and 1.3 mM EGTA). For image capturing, a wide-field 
system in an environmental control chamber was used ['inverted Leica DMIRB microscope 
equipped with a Hamamatsu C4742-95 cooled CCD camera, controlled with Openlab4 
software (Improvision)]. Three focal depths were captured at 20-second intervals; bacteria 
were added at the indicated m. o. i. (para. 5.3.3) and cells were imaged for 25 to 30 
minutes. 
5.3.7. Quantification ofBacterial Adherence and Invasion 
Cells were treated with control or SNX1-specific siRNA (par 2.4.19) and invasion assays 
were performed as described (para. 5.3.5). After fixation, bacteria were immuno-labelled 
with an anti-Salmonella primary antibody omitting any detergent, followed by a FITC- 
coupled secondary antibody. Cells were then permeabilized using 0.1% TritonX-100 in 
PBS. Subsequently, all bacteria (inside and adhered) were labelled with the same primary, 
but a TRITC-coupled secondary antibody and mounted onto slides using Vectashield 
mounting medium containing DAPI (Vector Labs). Slides were analysed under 
epifluorescence counting total numbers of bacteria (TRITC-labelled) and number of 
adhered bacteria (FITC-labelled), the difference between the two yielded number of 
invaded bacteria. 
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5.3.8. Colony Forming Unit Assay (Gentamicin protection assay) 
HeLa cells were treated with siRNA for 60 hours as described, and then trypsinized and 
several wells of 120.000 cells per condition were prepared. The next day (totalling 72 hours 
of siRNA treatment) cells were washed twice with pre-warmed (37°C) modified Krebs 
buffer and three wells per siRNA condition were simultaneously infected with bacteria at 
the indicated m. o. i. for 15 minutes at 37°C. Bacteria were removed and cells were washed 
three times with PBS++, incubated in modified Krebs buffer for a further 15 minutes at 
37°C and subsequently, transferred to DMEM (+ 10% FCS) containing 50 µg/ml 
gentamicin to prevent further infection. After further 30 minutes at 37°C, cells were 
washed into DMEM (+ 10% FCS) containing 16 µg/ml gentamicin and kept at 37°C until 
lysed. At indicated times (from start of experiments), cells were washed once with PBS++, 
lysed (1% TritonX-100,0.1% SDS in PBS) and a serial dilution of lysates in PBS++ was 
plated in replicates onto LB-agar plates. After incubation for 16 hours at 37°C, the number 
of colonies was determined. For evaluation, the mean of the replicate plating was taken, 
separately for each assay (3 wells per condition). The mean of all 3 wells was then 
calculated, and the result was deemed one experimental set. 
5.3.9. Distance Analysis 
Maximum z-stack projections of images from bacterial infection and immuno-labelling 
experiments (carried out as described in para. 5.3.5) in control and SNX1-suppressed cells 
were evaluated. The distance covered from the plasma membrane by each 
bacterium/bacterial cluster was determined. As the exact point of entry can not be 
determined at the chosen time point (180 min p. i. ), I assumed that bacterial entry occurred 
at a. =O' in all cases (i. e. not taking into account entry from top of cell but only in the 
plane; copmpare also Figure 5.19). For single bacteria, the shortest distance from the cell 
edge in a straight line toward the cell centre PAPI-labelled nucleus) was measured. For a 
bacterial cluster, a straight line (the base) was constructed running through the centre of 
the cluster and from here an isosceles triangle toward the plasma membrane was 
constructed (the vertex representing the projected entry point). From this point, the 
distance covered for the fraction of the slowest and fastest bacteria was measured (see also 
model in Figure 5.19). Intracellular progress of at least six clusters from greater than 
three cells was analysed per condition. The error gives standard deviation from mean; 
significance was assessed with Student's t-test. 
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5.3.10. Analysis of Vacuolar Shrinkzng in GFP-SNXJ transfected cells 
Movies of real time infection assays using GFP-SNX1 transfected MDCK cells and 
infected with wild type SL1344 bacteria were used for this analysis. Using single frames of 
one focal depth (phase contrast, 1322x1024 pixels), shrinkage of vesicles was analysed as 
difference in area over individual frames". Area in pixels was determined using Image) 
(NIH Image). It was chosen to analyse the largest, rounded vesicles (indicative for sealing), 
which also had visibly ceased interacting with other SCVs. The frame where the area of the 
vesicle in question was observed to be largest was deemed t(start); the end point was 
determined either by virtual disappearance of the vacuole or, when the end of the image 
sequence was reached, the area was measured again at this time point. Speed of shrinkage 
was determined as the difference in area AA(end-start), expressed in pixels over time 
(expressed in frames); these units were chosen to mirror the somewhat qualitative 
character. 
18 In an ideal case scenario, one would choose to analyse change in volume; with the set-up used in this study 
this was however not possible. 
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5.4. Analysis ofSNXl recruitment to Salmonella-containing 
vacuoles 
5.4.1. Fixed cell analysis 
Given the ability of the SNX1-PX domain to bind to PtdIns3P, as shown in liposome- 
based assays (Cozier et al., 2002), I wished to examine whether SNX1 was recruited to 
Salmonella-containing vacuoles (SCVs). Therefore, infection assays using the Salmonella 
strain SL1344 were performed [modified from (Steele-Mortimer et al., 1999)]. In these 
assays, HeLa cells were challenged with bacteria for 15 minutes, after which time the cells 
were washed extensively to remove excess bacteria. The cells were then either fixed 
directly, or further incubated for up to 6 hours before being fixed and processed for 
immunofluorescence labelling to analyse recruitment dynamics (Figure 5.1 A). Cells were 
additionally treated with DAPI (which strongly binds to bacterial and cellular DNA) and 
TRITC-phalloidin (which binds to F-actin). These treatments enabled me to visualize the 
bacteria and the rearrangements of the actin cytoskeleton, respectively. 
Compared to uninfected controls, a striking shift in the subcellular distribution of SNX1 
was observed; within 15 minutes post infection (p. i. ), most of the cellular SNX1 was 
redistributed and appeared as `globular accumulations' at the site of infection (Figure 
5.1 B). At this time point, the cells exhibited dramatic actin rearrangements at sites of 
infection, and SNX1 appeared accumulated directly adjacent to, or underneath, these 
membrane ruffles. Analysis of later time points showed that this association was 
prolonged, as even 60 min p. i., SNX1 was still found to be associated with the SCVs'9. At 
this time point, the ruffling had ceased and the bacteria had progressed towards the 
perinuclear area (Figure 5.1 C). At the later time points (Figure 5.1 D and data not 
shown), SNX1 was no longer associated with SCVs, and instead had resumed a 
distribution similar to the pattern observed prior to infection. 
To analyse the kinetics of SNX1 acquisition in HeLa cells, SCVs were scored for the 
absence or presence of SNX1 at different times p. i., which showed that the recruitment of 
SNX1 to the SCV was rapid and transient (Figure 5.1 D). This prolonged association was 
also observed for a second epithelial cell line WDCK cells), a cell line that later was used 
for live cell analysis. 






































Figure 5.1 Analysis of SNX1 recruitment to Salmonella-containing vacuoles 
HeLa cells were either fixed direct! (uninfected) for 45 minutes in 2" ý' PFA at 4,, C, or were 
infected with SL1344 for 15 minutes, then gentamicin-washed prior to fixation at indicated time 
points. Cells were immuno-labelled for endogenous SNX1 (A1exa488, green) and stained with 
TRITC-phalloidin to visualize actin (red) and DAPI to label bacterial and cellular DNA (blue). (A) 
In uninfected cells, SNXI displayed a vesicular distribution with perinuclear enrichment. 3p. t. o. 
162 
Chapter 5- Role o% Sortie; A-evins in. S'almonella In zcioii 
SNX1 (AJexa488) DAPI TRITC-phalloidin merge 
60 120 180 240 300 360 
time/min 
15 min 60 min 
Chapter 5- Role of Sorting Nexins in Salmonella Invasion 
5.4.2. Further analysis of the plasma membrane-recruitment ofSNX. 
The observed localization of GFP-SNXI to (or very dose to) the plasma membrane 
prompted me to investigate this recruitment in more detail. It is well established that 
Ptdlns(4,5)P2 plays a central role recruiting actin-associated proteins to the plasma 
membrane (Sechi and Wehland, 2000). However, Ptdlns(4,5)P2 and actin also confer to 
membrane rigidity (Sheetz, 2001), which one would assume to be detrimental to the 
invasion process. It has been shown that invaginating areas at the S. Typhimurium-induced 
membrane ruffles are largely devoid a phospholipase C-81 PH domain-probe (PLCS-PH) 
(Hernandez et al., 2004). PLC81 ligates Ptdlns(4,5)P2 with high affinity (Garcia et al., 1995; 
Lemmon et al., 1995); hence, these observations suggested that that Ptdlns(4,5)P2 was 
selectively depleted from the base of the ruffle. 
As in the infection process `plasma membrane' identity appears to be rapidly converted 
into `endosome/SCV' identity, it prompted me to closer investigate the recruitment of the 
PtdIns3P-ligating endosomal protein SNX1 to the plasma membrane in this context. To 
be able to analyse the ruffles in detail, optical z-sections of images taken were deconvolved 
and subsequently 3D-rendered and animated to allow a `360° view' of the ruffles. This type 
of analysis showed that the protein not only clearly accumulated around the bacteria in a 
non-uniform fashion (Figure 5.2 top inset, Movie 5.1), but that SNX1 is directly present 
at the base of the TRITC-phalloidin labelled ruffle. Thus, coincidentally this data appears 
as `complementary' to the finding of the displacement of the PLC8-PH-probe from the 
base of ruffles. 
Figure 5.1 (cont'd) Analysis of SNX1 recruitment to Salmonella-containing 
(B) Upon infection, SNX1 was recruited to the site of invasion readily identifiable by prominent 
membrane ruffles and (C) stayed associated with the bacteria on their intracellular itinerary. (D) 
After 180 minutes, SNX1 had resumed its original distribution. (E) For the kinetic analysis of 
SNX1 association with SCVs over 6 hours p. i., between 50 - 150 SCVs were scored per assay for 
the absence or presence of SNX1 (n >_ 6 for 15 min and 60 min ± standard deviation, s. d.; n=2 
for 180 min and 360 min, error ± min/max). (F) SNX1 recruitment to SCVs is comparable in 
MDCK (n = 4, ± s. d., 50 - 150 SCVs scored per assay) and HeLa cells (n > 3, ± s. d. 50 - 150 
SCVs scored per assay) after a 15-minute bacterial `pulse' or further 45 minutes incubation. Scale 
bar is 10 µm. 
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Figure 5.2 Analysis of SNX1-recruitment to ruffles at the plasma membrane. 
MMDCK cells were infected with the SL1344 strain for 15 minutes. Cells were fixed, immuno- 
labelled and optical z-slices were acquired using a Leica SP2 AOBS system, dcconvol,, ved and 3D 
image volume rendered using Volocity software (Improvision); see also Movie 5.1 (Ai. -iii. ) SNX1 
(green) clearly accumulates at membrane ruffles (arrows) and around bacteria (boxed area in Ai., 
and magnification in Ai. ). Scale bar is 10 . tm. (B) Magnification of the membrane ruffle shown in 
(Aiii. ), with the green (SNXI-) channel omitted in (Biii. ). (C) One single optical z-section of the 
membrane ruffle shown in (Aiii. ) and (B), respectively, is displayed with insets on the left and on 
top of the image providing the respective YZ- and XZ-view. Note that SNX1 is localized as a ring 
around the bacterium. 
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The observed globular or meshwork-like manifestation of protein at the site of infection 
was furthermore markedly different from the appearance of the FYVE-domain containing 
protein EEA1 (Figure 5.3), or the appearance of a GFP-2xFYVE probe at the site of 
infection (data not shown, but compare Figure 5.9). These proteins were rarely clustered 
underneath the ruffle and exhibited a discrete vesicular appearance (Figure 5.3 A). 
Compared to the recruitment of the `pure' PtdIns3P-ligand, SNX1 stayed associated with 
the bacteria for a prolonged time (Figure 5.3 B, C). When the recruitment patterns of the 
two proteins were analysed comparatively by scoring only bacteria that were positive for 
SNX1 and/or EEA1 (the sum of which was deemed 100%), it was noticed that although 
68.1% ± 6.86% were positive for both markers after 15 min, there was a large proportion 
that was exclusively positive for SNX1 (31.2% ± 0.65%). After 60 min, this SNX1-positive 
fraction increased to 63.7% ± 0.72% whereas only few SCVs were still labelled for EEA1 
(Figure 5.3 B, C) . 
Hence, one can conclude that SNX1 is not only associated with `nascent' SCVs but with 
the `maturing' SCVs as characterized by its intracellular progress to the perinuclear area. 
That these SCVs are indeed `maturing' was furthermore confirmed by co-labelling with 
Lamp-1 antisera (Figure 5.3 D), which starts to accumulate on SCVs 20 - 30 minutes p. i. 
(Steele-Mortimer et al., 1999; and data not shown). 
These initial studies showed two important things: first, SNXI is indeed recruited to the 
site of infection in a unique manifestation pattern20, and second this recruitment is 
transient and prolonged. Numerous previous studies have analysed the recruitment of 
EEA1 (Steele-Mortimer et at., 1999; Scott et al., 2002; Deiwick et at., 2006), Ptdlns3P- 
reporter constructs like the described 2xFYVE (Pattni et al., 2001; Scott et al., 2002), as 
well as using the PX domain of the 40-kD subunit of NADPH, p4OPX (Hernandez et at., 
2004), which binds Ptdlns3P (Kanai et al., 2001). In spite of the different Ptdlns3P- 
ligands used, these studies find marked association of the different probes with SCVs 
maximally up to 20 - 30 minutes. This difference is unlikely to be due to their respective 
affinities for PtdIn3P, as the KD for Ptdlns3P of the SNX1-PX domain (micromolar 
range) is considerably higher than the KD of EEAl (nanomolar range), although no 
immediate comparative study exists (Gaullier et at., 2000; Cozier et al., 2002; Zhong et at., 
2002). Given the ability of SNX1 to additionally ligate Ptdlns(3,5)P2 (Carlton et at., 2004), 
it appears feasible to suggest that this binding-specificity of the SNX1-PX domain might 
20 compared to FYVE-ligating proteins and probes 
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Figure 5.3 Analysis of EEA1-recruitment to the site of bacterial invasion. 
Hel-a cells infected with SL1344 for 15 min were either fixed directly (. -\) or after further 
45 minutes (B) before being labelled with anti-SNXI (A1exa594, red), EEAI (A1exa488, green), 
DAPI (blue) and TRITC-phalloidin (magenta, 15-minute time point only). (A) Two regions of 
interest show the globular or tubular manifestation of SNX1 at the site of infection, whereas 
EEAI displays a punctuate distribution (arrowheads). (B) After 60 min, most bacteria show 
exclusive enrichment for SNXI (arrows), while fein are EEAI-positive (asterisk). (C) 
Quantification of marker enrichment scoring between 40 - 100 bacteria for enrichment of the 
respective marker in individual z-sections expressed as percentage of the sum of all SNX1- and/or 
EEAI-positive bacteria (n =3 for 15 min, n=2 for 60 min, error ± min/max). (D) HeLa cells 
infected with SL1344 for 15 min were fixed after 60 min and labelled anti-Lamp-1 (A1exa488) and 
DAPI (blue). Scale bar is 10 µm. 
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be involved in mediating the prolonged association. In this light, potentially, the targeting 
via the SNX1-BAR domain to only highly curved regions may explain the non-uniform 
distribution of SNXI on vacuoles and globular appearance (compare overexpression 
phenotype)Z'. 
5.4.3. Live cell analysis: Recruitment ofGFP-S1VX1 triggers tubule formation 
As I wished to further investigate the dynamics of the rapid and prolonged yet transient 
recruitment of SNX1 to the site of invasion, a live cell imaging (LCI) approach using a 
wide-field set up was chosen. 
Experiments were performed using either HeLa or MDCK cells transiently transfected 
with a vector encoding for a GFP-SNX1 fusion protein for 22 hours and great care was 
taken to select cells displaying low to moderate GFP-SNX1 expression levels for infection 
experiments (see par 5.3.6 for details). Images were taken every 20 seconds over a period 
of up to 30 minutes22. The time point of addition of bacteria is readily recognisable as a 
`white flash' )23. Confirming the fixed cell analyses, it was observed that GFP-SNX1 was 
readily recruited to the site of invasion, in both, MDCK cells (Movies 5.2.1 - 5.2.4; 
Figure 5.4) and HeLa cells (Figure 5.7 for fixed-cell analysis). In less than 15 minutes 
p. i., most of the cellular GFP-SNX1 had accumulated at the site of infection resulting in a 
loss of SNX1 at the perinuclear pool. 
Strikingly, live cell analysis revealed that the recruitment coincided with the appearance of 
numerous long-range GFP-SNX1-decorated tubules, while prior to infection only few 
short rage tubules were observed from internal SNX1 pools. The tubules emanating 
from 
the site of infection were considerably longer (see below) and appeared to be shooting off 
from the SCVs. After 5- 10 minutes, the tubules appeared to collapse or `retract' back on 
to the site of infection, and the protein stayed accumulated around the SCVs. In some 
cases, tubules were observed to make contact with cytoplasmic24, vesicular pools of SNX1 
(boxed area, Figure 5.4 C). The GFP-SNX1 recruitment and tubulation was most evident 
and pronounced at large vacuolar structures, being a multiple of the size of a bacterium in 
diameter (Movies 5.1.1 - 5.1.4; Figure 5.4, asterisks). 
21 Indeed, neither the K214R PX domain mutant (incapable of binding to PPIn), nor the KKR-EEE BAR 
domain mutant are recruited to infection sites, but remain cytosolic (data not shown). 
22 Movies are replayed at 10 frames per second. 
23 Bacteria are added as aliquots in LB medium during the 20-second interval between image capturing; due 
to its composition, LB medium will naturally 
have different optical `properties' than imaging buffer. 
24 as opposed to infection site 
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dynamic long-range tubules. 
MMDCK cells were transiently transfected with GFP-SNX1, then infected with SL1344 and imaged 
live (see also Movies 5.2.1 - 5.2.4). Selected frames of movies are shown (time is in seconds). (A) 
Phase contrast. Note size reduction of vacuoles (asterisk) with bacteria (arrowhead). (B) 
Fluorescent channel. GFP-SNX1 is recruited to bacteria and spacious SCVs. The protein labelled 
long-rage tubules that were occasionally observed to make contact with vesicular SN X 1-positive 
structures (boxed area). (C) Merge of phase contrast and fluorescent channel at 50"  ()pacity. Scale 
bar 10µm. 
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Figure 5.4 Live cell imaging shows that recruitment of SNX1 induces highly 
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Figure 5.5 Analysis of SNX5 recruitment of the SCV. 
Cells transfected with GFP-SNXS were infected Frith wild ttpe SL1344 and infection sra. imaged in real rime 
(see also Movies 5.3.1-5.3.2); stills from these movies are shown ('Nu' denotes nucleus), time is in 
seconds. Tubulation observed upon SNX5 recruitment is markedly less prominent, note the release of SCV 
content into the extracellular space toward the end of the movie from one of the SCVs (arrovwO. Scaly bar 
10µm. 
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When analysing phase contrast images, it was noted that these spacious structures 
underwent rapid size-reduction concomitant with the appearance of SN XI -tubules in the 
fluorescent channel. This data is representative for over n=3 independent experiment for 
each cell type (HeLa or MDCK cells) with over 10 cells imaged. 'T'abulation was observed 
in all cases but to a variable extent and generally it was observed to be most prominently 
developed in MDCK cells. In no case comparable tubulation was observed using other 
SNX/BAR proteins, such as SNX5 (compare Figure 5.5; Movies 5.3.1 - 5.3.2), or 
SNX2, SNX4, or SNX8 (data not shown). 
The finding that GFP-SNX1 was less readily detected on smaller vacuoles could suggest 
that the observed recruitment and tubulation is a size- and/or concentration-dependent 
phenomenon. In a simple logic one would suggest that increased ruffling leads to larger 
vacuoles, hence more membrane, which in turn is converted to relatively higher Ptdlns3P- 
levels that subsequently recruit (by avidity) more SNX1, which -indirectly or directly -- 
leads to pronounced tubulation. 
A quantitative characterization of the correlation between vacuolar size and degree of 
tubulation is not trivial, considering the poor control over the parameters, the stochastic 
nature of the process and overlap with endogenous processes. Nonetheless, in an attempt 
to estimate of the speed of the process, I analysed the shrinking of large vacuoles in (; I N- 
SNX1-expressing cells versus non-transfected cells present in the same visual held (Figure 
5.6; see also para. 5.3.10). Here, the difference in the area of light-lucent large vacunýlrs 
was measured over time (in frames), and it appears that cells visibly recruiting Gl' P-SN Xl 
to the vacuoles, shrank approximately 2.5 times faster than non-transfected cells in the 
analysed sample. 
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Figure 5.6 Analysing vacuolar shrinking in GFP-SNX1-expressing cells. 
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To better document the observed tubular nature of SNXI at the site of infection, I 
decided to fix the GFP-SNXI transfected (and bacterially infected) cells. Acquired 
confocal images were subjected to iterative deconvolution and 3D image volume 
rendering, animated and exported as movies, which allowed to fully appreciate the extent 
of tubulation (Movie 5.4; Figure 5.7). The results show that bacteria, as labelled by 
DAPI, were partially 'covered' with GFP-SNXI or had an extensive tubular network 
associated with them. Bacteria often appeared as clustered but even at lower bacterial 
numbers (bottom Movie 5.4 or Movies 5.2.1 - 5.2.4) extensive SNXI accumulation was 
observed. 
Given the precedent of artefacts related to SNX1 overexpression, these findings also 
raised concerns to which extent the observed phenotype was related to the procedure 
(Chapter 3, para. 3.3). Hence, it became pertinent to closer examine the infection sites at 
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Figure 5.7 Deconvolution analysis of tubular SNX1-decorated structures in 
SL1344-infected cells. 
HeLa cells transiently transfected with GFP-SNX1 were infected with SL1344 for 15 minutes, then 
fixed and treated with TRITC-phalloidin (red) and DAPI (blue). Optical z-slices were acquired 
(z = 4.76 µm, 29 sections) and, using Volocit, V4.0.1, data sets were deconvolved (98% 
confidence, or 20 iterations), 3D-rendered and animated, and sequence was exported as movie (see 
Movie 5.4). Scale bar is 10 µm. 
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5.4.4. Optimized fixation conditions allow for tubule preservation. 
To verify that these tubules were not an artefact of overexpressing the GFP-SNXI fusion 
protein, I sought for ways to visualize possible tubulation of previously undetected 
endogenous SNX1 (compare Figures 5.1,5.2,5.3). As discussed, it was noted that 
prolonged exposure to low temperature can affect the intracellular membrane morphology 
and render GFP-SNX1 cytosolic (Chapter 3, para. 3.3), so attempts were made to 
optimize the fixation protocol aiming to keep conditions as `physiological' as possible: in 
these experiments it was found that fixing the cells in 4% PFA (diluted in DMLMM rather 
than PBS) at 37°C resulted in successful preservation of SNXI-decorated tubules, in both, 
HeLa and MDCK cells (Figure 5.8 A, B). With this procedure, it was possible to preserve 
tubules decorated with endogenous SNX1 as contiguous `filaments' that were exclusively 
observed in direct proximity of bacteria, preserved up to a length of 25 . tm in length in 
MDCK cells (Figure 5.13 A). 
I thus felt confident that appearance of tubules at the site of bacterial infection was not an 




Figure 5.8 Optimized fixation conditions allow for tubule preservation. 
MMDCK cells (A) and HeLa cells (B) were infected with the SL1344 strain for 15 minutes, then 
fixed using 4% paraformaldehyde at 37°C for 15 minutes. Subsequently, cells were immuno- 
labelled with anti-SNX1 antibodies (A1exa488, green) and incubated with 
TRITC-phalloidin (red) 
and DAPI (blue) to visualize bacteria. Tubules (arrowhead) are emanating from bacterial clusters 
sites of infection Scale bar is 10 µm. 
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5.4.5. Investigations into the differential recruitment ofa 2. iFlYom' probe and 
SNXI 
One big challenge was to further characterize the observed SNX 1-decorated tubules (as 
opposed to vacuoles), as these structures were highly dynamic, short-lived and displayed 
high variance in extent of tubulation and scale. 
Initial attempts were aimed at better correlating the SNX1-structures to other SCV 
recruited probes. As shown, ELAI did not appear to label these structures in fixed cell 
assays. Likewise, when infection was recorded in real time in cells transfected with a (; f-(' 
2xFYVE probe, the appearance of the probe at the site of infection was markedly different 
from a SNX1 probe, whether on apparently empty `rnacroýpinoso>mes' (Figure 5.9; 
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In the course of these analyses, I also attempted real-time infection analyses when co- 
expressing an RFP-2xFYVE probe and GFP-SNXI to better monitor and dissect the 
different recruitment patterns in HeLa cells. It is to be said that these experiments are 
very challenging in the regard that first, cells co-expressing both proteins at acceptable 
levels25 were rarely encountered and second, cells targeted by bacteria can only be poorly 
predicted . 
The results obtained were however very interesting as they revealed a marked difference in 
the initial recruitment steps of the two proteins: while the RFP-2xFYVE probe localized 
around the entering pathogen, SNX1 appeared to be recruited to, or very dose to, the 
plasma membrane at an `angle' to the entering pathogen (Movie 5.6; Figure 5.10)'x. In 
contrast to SNXI, the fluorescent 2xFYVE probe was evenly distributed on the vacuolar 
membrane. As previously observed in MDCK cells (Pattni et al., 2001), the association of 
the 2xFYVE probe around the SCV was often transient and appeared as `flashes' as the 
probe repeatedly re-associated with the same tight fitting SCVs. Strikingly, in the shown 
example, marked tubulation of the SNX1-probe was not observed. At first this finding 
appears at odds with the previous studies, but it correlates with the absence of markedly 
large vacuoles. The absence of large vacuoles correlates with the absence of marked 
ruffling; and ruffling in HeLa cells was generally found to be less pronounced than in 
MDCK cells. So in conclusion, regardless of the 'vacuole size', SNX1 is recruited to the 
site of infection, but pronounced tabulation was not always observable at LM level. 
25 Defined as relatively low levels of SNX1 for the discussed reasons, while generally, the 2xFYVE probe 
was found very highly expressed, hence resulting in markedly different exposure times, which is highly 
undesirable when attempting to visualize dynamic events in a directly comparative study. 
26 The accompanying movie starts with an overlay of all three channels (phase, RFP-2xFYVE in red, GFP- 
SNXI in green), then a merge of the fluorescent channels (RFP-2xFYVE and GFP-SNX1), followed by 
RFP-2xFYVE, then GFP-SNX1. 
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Figure 5.10 Infection of cells co-expressing fluorescently labelled 2xFYVE and 
SNX1 shows differential recruitment of both probes to SCVs. 
HeLa cells were transfected with RFP-2xFYV'E and GFP-SNX1 and after 22 hours, infccti()n Was 
imaged live for approximately 30 minutes (see also Movie 5.6). Whereas the 2xFYVF-probe 
uniformly labelled vesicular structures and the SCV (arrow), SNX1 was found on vesicles and at 
the plasma membrane (arrowheads). Scale bar is 5 µm. 
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S. S. Characterization ofinfections using a ds%D mutant 
5.5.1. Fixed and live cell analysis ofSNX1 recruitment to sites ofinfection 
using a SL1344-E sigD strain 
The size of the vacuoles is linked to the ruffling induced by the bacterium, which is 
therefore not sufficiently controllable. So I chose to make use of a SL1344 mutant 
(SL1344-OsigD) to carry out infection assays. One reasoning behind utilizing this mutant 
stemmed from the previous finding that infection of Henle-407 cells with a isigD strain 
resulted in formation of only small vacuoles that additionally rarely fused with one another 
(Hernandez et al., 2004). Likewise, ectopic overexpression of SigD in mammalian cells has 
been shown to induce formation of large vacuoles (Terebiznik et al., 2002; Mason et al., 
2007). Thus, it appears that SigD is somehow involved in size regulation. 
Additionally, given the binding preferences of the SNXI-PX domain, my interest in 
investigating this mutant in more detail was sparked by the fact that SigD is a PPIn 
phosphatase: as discussed, at current state the literature is somewhat divergent about the 
substrate specificity, and - inter alia - Ptdlns(4,5)P2 (Terebiznik et al., 2002; Mason et al., 
2007), but excitingly, also Ptdlns(3,5)P2 and Ptdlns(3,4,5)P3 (Marcus et at, 2001) have been 
proposed as substrates from in trtm studies. 
So if in the cellular context, dephosphorylation of Ptdlns(3,5)P2 would considerably 
contribute to SCV-Ptdlns3P levels, one might hypothesize that in absence of SigD, 
PtdIns3P is not sufficiently generated at the infection site. This would appear to be a 
legitimate conclusion from the observed absence of a Ptdlns3P-ligating p4OPX-contruct 
when infecting with a AsigD strain (Hernandez et at, 2004). Furthermore, analysis of the 
PPIn species in infected cells using electrospray ionization mass spectrometry (ESI-MS) 
has suggested that cellular PtdlnsP [sic]27 levels are increased upon wild type-strain but not 
AsigD-strain infection (Hernandez et at, 2004). Following this logic, it implies that 
Ptdlns(3,5)P2 levels are elevated on the SCV in the absence of SigD, as had been 
suggested, but not shown (Hernandez et al., 2004). 
To investigate this hypothesis, I chose to analyse recruitment of SNX1 to sites of infection 
when using the AsigD mutant by LCI analysis. In these assays, HeLa cells were first 
transiently transfected with GFP-SNXl and after 22 hours infected with a SL1344isigD 
27 This ESI-MS set-up is capable to discriminate between mono- and bis-phosphorylation (lenk et al., 2003) 
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Figure 5.11 Analysis of GFP-SNX1 recruitment in cells infected with SI. 1344- 
AsigD 
Hcl, a cells were transfcctcd with GFP-SNXI for 22 hours, then infected with i SLI144 strain 
lacking SigD (AsigD). Infection was imaged live (see also Movies 5.7.1 -5.7.2); stills and a region 
of interest (Rol) from the movies are shown, time is in sccC)nds fromm the start of experiment. 
Although SNX1-positive tubules emanating from endosomal structures were observed (arrows, 
black and white), there was no pronounced enrichment of GFP S\Xl at the site of infection 
(arrowheads, black and white). Data is representative for three independent experiments with 
over 10 cells imaged Scale bar is 10 µm. 
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strain (Movies 5.7.1 - 5.7.2; Figure 5.11). Several observations were made: in these 
assays, I indeed failed to observe generation of spacious vacuolar structures upon infection 
with AsigD, as evidenced by the lack of large light-lucent structures in the phase contrast 
images (Figure 5.11; Movie 5.7.2). More over, in these cells accumulation of GFP-SNX1 
at the site of infection was not observed (Figure 5.11, arrowheads). While short-range 
tubules from endosomal compartments were evident (Figure 5.11, arrows), tubulation 
from SCVs was not detected, as the probe failed to accumulate. In a control experiment, 
using a SL1344-AsigD mutant complemented with a plasmid encoding for SigD and its 
chaperone SigE, recruitment of GFP-SNX1 was restored (Figure 5.12; Movies 5.8.1 - 
5.8.2). To further confirm these findings, I also chose to analyse the recruitment in 
MDCK cells at overexpressed (data not shown) and endogenous SNX1-levels (Figure 5. 
13). In no case, long-range tubules were observed upon infection with the AsigD-strain, 
although in some exceptional cases (when large vacuoles were produced) SNX1 was 
indeed recruited. The generation of spacious vacuoles when infecting cells using the isigD 
mutant was however a rare event. A correlation of the lack of tubules and/or recruitment 
with bacterial numbers appeared also unlikely as in wild type-infected cells continuous 
tubules of up to 25 µm (Figure 5.13 A, arrows)' emanated from infection sites with 
seven bacteria or less, while clusters of 10 - 20 isigD bacteria were not seen with 
associated tubules (Figure 5.13 B)29. 
Given that SNX1 is not recruited to the SCV or site of infection in spite its documented 
ability to bind to Ptdlns(3,5)P2 (Cozier et al., 2002), 1 consider it unlikely that Ptdlns(3,5)P2 
levels are elevated on SCVs in absence of SigD. This is supported by the finding the basal 
Ptdlns(3,5)P2 levels and Ptdlns(3,5)P2 levels after infection with a AsigD are equally low 
(Mason et al., 2007). 
So it appears that the absence of SigD could simply lead to persistence of Ptdlns(4,5)P2 
(Terebiznik et al., 2002). Very recently, another study convincingly showed that ectopic 
expression of SigD dephosphorylates PtdIns(4,5)P2 as its main substrate and in doing so, 
alters epithelial structure and function (Mason et al., 2007). Although not shown in an 
infection model, one would extrapolate from the findings by Mason and colleagues that in 
28 As measured from one confocal z-section 
29 Number of bacteria was analysed from co-labelling DNA with DAPI (channel omitted in Figure 5.13). 
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GFP-SNX1 (start) phase 
HeLa cells transfected with GFP-Stilt were infected with a SL1344-AsIgi) mutant that 
additionally carried plasmids encoding for SigD and SigE (SI, 1344-Asigl) pSig; 1)-pSigE), and 
infection was imaged live. Stills from these movies (Movies 5.8.1 and 5.8.2) and a region of 
interest (R(AI) are shown. Time is in seconds from start of experiment. Scale bar is 10 Etm. 
cells infected using a AsigD strain, Ptdlns(4,5)P, might not be appropriately converted and 
hence, given the binding specificity of the S`X1-Pt domain, there is no appropriate `cue' 
for SNX1 to be targeted to. This hypothesis was further supported by results from the 
analysis of the relation between actin-loss and SNX I enrichment in cells infected with the 
OsigD strain (see following paragraph). 
179 
Figure 5.12 Recruitment of GFP-SNX1 is restored using SL1344-AsigD bacteria 
complemented with SigD encoded for on a plasmid 
























Figure 5.13 Comparison of endogenous SNX1-decorated structures in SL1344 
wild type SL1344- or SL1344AsigD-infected MDCK cells. 
MDCK cells were infected a with wild type SL1344 or with a SL1344-AsigD strain for 15 minutes, 
then fixed and labelled for endogenous SNX1 (Alexa368, red). Maximum projections of two z- 
sections (at 488 nm z-separation) are shown. Tubules up to 25 µm could be preserved in control 
cells (arrows). In SL1344-AsigD-infected cells, SNX1 is mainly vesicular with no pronounced 
recruitment to bacteria or even unusual large vacuoles (arrowhead). Scale bar is 10 µm. 
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5.5.2. Further investigations into SL1344- Osi D induced SCVs 
PtdIns(4,5)P2 has an established role in cytoskeleton-plasma membrane linkage [(Yin and 
Janmey, 2003) for review], so to investigate the effect of AsigD strain-infections on SNX1 
recruitment and the actin cytoskeleton simultaneously, I performed a series of fixed cell 
analyses monitoring endogenous SNX1 levels and F-actin levels using TRIC-phalloidin. 
As expected, compared to the wild type strain, in cells infected with the LsigD strain for 
15 minutes, markedly less SNX1 accumulated at the site of infection (Figure 5.14). 
Careful inspection showed that while in cells infected with wild type SL1344, the majority 
of SCVs were observed to be SNX1-positive (Figure 5.14 A, E), in cells infected with the 
AsigD strain, bacteria appeared mostly `trapped' in actin-rich structures as visualized by the 
TRITC-phalloidin stain: here, no marked `shift' in the association of SCVs with TRITC- 
phalloidin and SNX1 was observed (Figure 5.14 C, D, E). Even after 60 minutes, when in 
the control, bacteria rarely co-localized with phalloidin-positive structures, most AsigD 
bacteria were still enclosed by tight-fitting phalloidin-positive SCVs (Figure 5.14 D). In 
cells infected with wild type strain I only occasionally observed `entrapment' after 
60 minutes (Figure 5.14 B). 
Quantification of the kinetics of actin-loss versus SNX1-enrichment was performed, 
analysing the co-distribution of actin and SNX1 at or in immediate vicinity of bacteria in 
single confocal sections. Here, I found that bacteria infected with the wild type strain 
clearly changed from actin to exclusive SNX1 enrichment over the course of one hour 
(Figure 5.14 E). In contrast, in cells infected with the AsigD strain, the respective 
fractions of SCVs positive for TRITC-phalloidin, TRITC-phalloidin+SNX1 or SNXl 
alone remained largely unaltered. Further still, the percentage of doubly labelled TRITC- 
phalloidin+SNX1 structures on AsigD-strain induced SCVs was markedly increased 
compared to wild type-induced SCVs. The apparent high level of co-distribution of actin 
and SNX1 was surprising but I feel that it is in the first instance a result of the method of 
analysis: while exclusively SNX1-labelled SCVs are readily identifiable due to the globular, 
clustered appearance of the protein at these sites (arrowheads, Figure 5.14 B, D), the 
SNX1 distribution at, or close to, SCVs that are also positive for actin is markedly 
different (arrows, Figure 5.14 B, D). Although single confocal z-sections were evaluated, 
it is not always immediately evident, whether the marker is `on' the SCV or just very dose 
by as endosomal SNX1 will also be detected. Especially in large-size dusters, this might 
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phalloidin+SNX1 
Figure 5.14 Kinetic analysis of actin- and SNX1-enrichment on wild type or 
LsigD SL1344 SCVs. 
Cells infected with wild type or the AsigD mutant strain for 15 minutes were either fixed directly or 
after further 45 minutes, and were then immuno-labelled with anti-SNX1 (A1exa488, green) and 
treated with TRITC-phalloidin (red) to visualize F-actin, and DAPI (blue) to visualize DNA. (A-D) 
Three merged tontotal z-slices, z(total) =1 µm, are shown. Arrows point out unusual SNXI 
manifestation on or near actin-positive structures; arrowheads highlight SNX1 accumulation as 
usually observed on SCVs. (F) Co-localization of bacteria with the respective marker was analysed 
for individual z-slices in the entire stack (10 - 12 z-slices at 480nm z-separation) and more than 
100 SCE's per set (n = 2, error gives minimum and maximum). Scale bar is 10 µm. 
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result in `entrapment' of endosomes. Nevertheless, these assays show a clear trend and 
while it might overestimate the degree of the jointly actin- and SNXI-labelled SCVs, 
`actin-only' and `SNXI-only' SCVs were readily distinguished. 
So this data suggests that in cells infected with AsigD mutant, the SCV conversion from 
`plasma membrane, Ptdlns(4,5)P2 enriched identity' to `endosomal, PtdIns3P enriched 
identity' is stalled. 
So how does this stalling affect the bacterial life cycle in the host cell? As discussed, the 
SCVs undergo a maturation process and it appears that the processes associated with this 
maturation and intracellular progress are crucial for optimal replication: acidification for 
induction of SPI-2, as well as tethering to the TGN to (potentially) branch off nutrients 
and `anchoring' to the TGN to maintain correct positioning. Nonetheless, earlier studies 
investigating the replication of a strain lacking SigD in T84 colonic epithelial cells 
(Bertelsen et al., 2004) after 10 hours did not detect an defect in replication for a OsigD 
mutant. Likewise, studies using a RAW 264.7 macrophage cell line found no replication 
defect after 15 hours (Drecktrah et al., 2005). It is to be said, that generally, in epithelial 
cells replication is initiated after a lag period of 4-6 hours, while in macrophages this 
phase is thought to take between 8- 10 hours (Knodler and Steele-Mortimer, 2003). 
Although preliminary data (n = 1), I have also investigated the effect of the AsigD mutant 
on replication in HeLa cells. In agreement with the cited studies, I did not detect a defect 
in replication when infecting cells with the AsigD mutant after 12 hours, compared to cells 
infected with wild type SL1344 (Figure 5.15). Interestingly, when I examined earlier time 
points (6 hours p. i. ), id est at the proposed onset of replication, I found a marked 
difference though: while in control cells bacteria had already started replicating, numbers 
of AsigD bacteria were found to be unchanged. While it would be desirable to further 
confirm these findings, they are in line with a model in which SCVs are stalled but will 
eventually start to replicate. 
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6 
S5 
SL1344 SL1344-AsigD Colony forming unit assay 
To analyse kinetics of bacterial 
replication (see para. 5.3.8) cells were 
infected with either wild type S1.1344 
or S1.1344-AsigD for 15 minutes, then 
cells were either lvsed directly or after 
incubation for indicated times. I. ysates 
were plated onto I. B plates (in 
duplicate) and incubated for 16 hours, 
before number of bacterial colonies 
was determined. N13: Data was 
obtained from triplicate analysis in 
replicate plating for control (error is 
min/max for triplicate), while data for 
SI. 1344-AsigD is from one 
experimental set in replicate plating 












Figure 5.15 Analysis of bacterial replication: SL1344 wild type and SL1344-AsigD 
strains 
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5.6. Studies into the role ofSNX1 in Salmonella infection 
One other question related to the functional significance of SNX1 recruitment to the 
infection site under `normal' infection conditions using the SL1344 wild type, where 
spacious bacteria-containing vacuoles underwent size-reduction. In macrophages, the 
maintenance of spacious phagosomes has previously been suggested to contribute to 
bacterial virulence and survival (Alpuche-Aranda et al., 1994) and it has been hypothesized 
that at early stages of infection generation and maintenance of large vesicles may provide a 
favourable environment for Salmonella to allow for transition to the SPI-2 encoded TTSS 
machinery (Hernandez et al., 2004). 
5.6.1. Effect ofSNXJ-suppression ob bacterial infection 
To dissect the role of SNX1 in the infection process, an RNA interference approach 
targeting SNX1 expression was chosen using the previously characterised siRNA 
(Chapter 3, para. 3.5). When analysing SNXI-suppressed cells after SU 344-infection 
assays followed by immunofluorescence detection, several observations were made (see 
also following paragraphs): first, the CI-MPR was enriched at the site of infection, which 
in control cells was virtually absent from SCVs (Figure 5.16). Second, bacteria appeared 
in most cases less clustered in SNXI-suppressed cells (Figure 5.17). Third, I observed - 
to a variable degree - TRITC-phalloidin positive vacuoles in SNX1-suppressed but not in 
control cells (Figure 5.18). 
5.6.2. CI-MPR recruitment to sites ofinfection in SNXI-suppressed cells 
The observation that certain proteins appear to be absent or undetectable on SCVs, most 
prominently the CI-MPR (Garcia-del Portillo and Finlay, 1995), has led to the general 
`paradigm' that SCVs only selectively interact with endosomes, and actively segregate from 
the degradative route. This view has however been scrutinised recently (Drecktrah et al., 
2007) uncovering an unprecedented degree of interactions of SCVs with the endo- 
lysosomal system, when assessing transfer of pre-loaded and newly incoming endocytic 
bulk-phase material to the SCV. 
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Generally, we would argue that the CI-MMPR is only a moderately appropriate marker for 
late endosomes, as a negligible amount of the CI-11PR is localized endosomally or at the 
plasma membrane at steady state (Waguri et al., Lin et al..; see also Chapter 3). Likewise, 
the receptor rarely traffics through late endosomes or pre-lysosomal compartments (Hirst 
et al., 1998; Lin et al., 2004). Given that at steady state the vast majority of the receptor is 
localized to the TGN, I would predict that detection on SCVs at LM1 level would be 
challenging unless it would, by some means, become enriched on SCVs during the 
infection process. 
In accordance with this, when I assessed CI-MMPR levels on SCVs, I could not detect 
notable labelling at L`1 level (Figure 5.16). Yet, in SNX1-suppressed cells, the receptor 
was found localized to the site of infection. Given that treatment with SNX1-specific 
siR. NA leads to accumulation of the CI-`MPR in endosomes, it appears plausible that upon 
infection, these `pre-loaded' endosomes are recruited to plasma membrane. 
The finding that under infection conditions, SNX1 is localized to SCVs might also help to 
consolidate the discrepancy that hydrolases delivered by the CI-MPR, but not the receptor 
itself is found on SCE's (Garcia-del Portillo and Finlay, 1995). 1 would postulate that 
recruitment of SNXI to macropinosomes and vacuoles could allow for efficient 








Figurc 5.16 Arrak sºs ut l; 1-`MPR-enrichment at the site of infection in SNiX1- 
suppressed cells. 
Control and SNXI-suppressed cells were infected for 15 minutes with SL1344, washed and fixed 
as described and immuno-labelled with anti-SNX1 (Alexa368, red), anti-CI-MMPR (Alexa488) and 
treated with DAPI (blue). While the CI-MMPR was largely absent from sites of infection in control 
cells, it co-localized with DAPI stained bacteria in SNX1-suppressed cells. Scale bar is 10 µm. 
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5.6.3. Role ofSNX1 in clustering bacteria 
One observation made is that in 60- 70% of all cases in SNX1-suppressed cells infected 
with SL1344, the resulting bacterial clusters appeared less tight than in control cells and 
were often stalled dose to the plasma membrane (Figure 5.17). It was also observed that 
in some cases, cells treated with the SNX1-specific siRNA contained, to a variable extent, 
TRITC-phalloidin-positive vacuoles (Figure 5.18), while under control conditions at 1 
hour p. i., F-actin was virtually absent from SNX1-positive SCVs. One possible 
explanation is that in SNX1-suppresssed cells, vacuoles are not efficiently reduced in size, 
and might therefore accumulate F-actin (Yam and Theriot, 2004). 
To further characterize the dispersal of bacteria after SNX1-treatment, the difference in 
intracellular progress of individual bacteria and bacterial dusters under control and SNX1- 
suppressed conditions was quantified. Therefore, the distance covered from the plasma 
membrane in both samples after 180 minutes (Figure 5.19) was measured (see para. 5.3.9 
for details). This type of analysis revealed that while in control cells the bacteria had 
progressed 16.8 µm ± 2.69 pm (s. d. ) on average, in SNX1-suppressed cells bacteria had 
covered a significantly shorter distance (9.5 pm ± 6.26 µm). As the pie chart illustrates, 
the range of distances is widest for SNX1-suppressed cells, which illustrates the observed 
scattering. While one fraction of bacteria appeared stalled at or close to the plasma 
membrane (blue quarter), the largest fraction showed progress between 10 to 15 gm (light 
green); this variance also explains the relatively large standard deviation (Figure 5.19). 
From these results, it appears that overall, intracellular progress of bacteria is less efficient 
in SNX1-depleted cells. Furthermore, as part of the analysis of intracellular progress I also 
analysed behaviour of the SL134-4-OsigD mutant (AsigD) in SNX1-supressed cells. Here, I 
found a mean progress of 12.2 pm ± 3.27 gm, which is farther than wild type bacteria in 
SNX1-depleted cells, although not significantly. It is however significantly less than wild 
type bacteria in control cells (Figure 5.19). 
So from this data I concluded that both factors, cellular SNX1 and bacterial SigD, are 
required for optimal perinuclear transport of SCVs. It furthermore appeared that in 
SNX1-suppressed cells, the AsigD mutant `alleviated' the stalling strikingly, in cells 
infected with the AsigD-mutant, specifically the plasma membrane-stalled fraction (0 - 
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5 µm), as observed for wild type, was conspicuously absent. I thus wished to examine the 

























Figure 5.17 In SNX1-suppressed cells, S. Typhimurium displays reduced 
clustering. 
Control and SNX1-suppressed cells were infected for 15 minutes with SL1344. After removing 
bacteria, cells were either fixed directly (A) or after further 45 minutes (B), and subsequently 
immuno-labelled with anti-SNX1 (A1exa568, green) and treated with TRITC-phalloidin (red) and 
DAPI (blue). Scale bar is 10 µm. 
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Figure 5.18 Visualization of actin-rich vacuoles in SNX1-suppressed and SL1344- 
infected cells. 
SNX1-suppressed cells were infected with wild type SL1344 for 15 minutes. Bacteria were 
removed and after 45 minutes cells were fixed and immuno-labelled using anti-SNX1 (Alexa488, 
green) and treated with TRITC-phalloidin (red) to visualize F-actin and DAPI (blue). Maximum 
projection of three z-sections (480 nm z-separation) is shown. Scale bar is 10 . tm. 
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Figure 5.19 Analysis of intracellular progression of wild type and AsigD bacteria 
in control and SNX-suppressed cells. 
Cells treated with control or SNX1-specific siRNA were infected with either wild type (for control) 
or OsigD bacteria (for control and SNX1-suppressed cells) for 15 minutes. Bacteria were removed 
and cells were fixed after a total of 180 minutes. After appropriate labelling, cells were imaged and 
distance covered by bacteria/bacterial clusters was measured for at least six clusters (s. d. ) in n=3 
cells, calculating the distance covered from the plasma membrane (para. 5.3.9). 
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5.6.4. Investigating the effect ofSNXJ suppression on bacterial replication 
Positioning in close proximity to the perinuclear/TGN area appears to directly influence 
replication (Beuzon et al., 2000; Salcedo and Holden, 2003; Abrahams et al., 2006), and a 
more distal localization may result in attenuated replication (Brawn et al., 2007). Given the 
observed stalling, I hypothesized that SNX1 -suppression could markedly decrease 
replication or delay onset of replication. To assess the effect of SNX1 suppression on 
replication, a technique combining RNA interference and the previously mentioned 
population-based replication assays (c. f. u. assays, see para. 5.2.3) was developed. 
To analyse kinetics of 
L7 bacterial replication (see para. 
p 5.3.7) in control and SNX1- 
6 suppressed cells, bacterial 
5 colonies obtained after a 15- 
min infection pulse and 4 
subsequent incubation for 
t ime indicated were 
control siRNA determined; for each 
UI 
__SNX1 siRNA condition, two sets with n=3 
>1 each (with replicate plating) 
0 were analysed; error is t U0 200 400 600 800 min/max per set. 
time/min 
Figure 5.20 Comparative analysis of bacterial replication kinetics in control and 
SNX1-suppressed cells 
In the following, the data obtained is presented in different ways to better illustrate the 
main conclusions reached for the SNX1-suppressed conditions compared to controls: 
first, after 12 hours, no marked difference in absolute numbers was observed; second, 
onset of replication appeared delayed; third, invasion appeared increased. 
As can be seen in Figure 5.20, there appears to be no marked difference in absolute 
numbers of bacteria at the late time points for SNXI-suppressed cells, indicating that 
bacterial replication is not defective (n = 2, in triplicates)"'. Nevertheless, for SNX1- 
suppressed cells, higher bacterial counts for the 15-minute time point were observed. A 
clearer representation of the data obtained from n=3 assays (in triplicate with replicative 
plating) is shown in Figure 5.21 (A) demonstrating an increase of bacteria in SNXI- 
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suppressed cells to 123.3% of the control value. That these bacteria had indeed 
successfully invaded was verified by an independent assay. In this assay, adhered bacteria 
and total numbers (adhered + invaded) were differentially labelled using Salmonella-specific 
antibodies, and the total numbers of bacteria invaded bacteria could be calculated 
(para. 5.2.7). These assays confirmed that invaded bacteria were shifted to higher numbers 
in SNX1-suppressed cells (compare Figure 5.22). Thus, it appears that despite increased 
bacterial numbers, these higher numbers are not maintained over the time course. 
Hence, the `replication index' (ratio of bacteria obtained after 16 hours compared to 
numbers after 1 hour) is lower for bacteria in SNX1-supressed cells (Figure 5.21). This 
might however be slightly misleading as, analogous to infections using the OsigD-mutant 
strain, bacterial numbers stagnated or even dropped in the first 6 hours p. i., which is 


























Figure 5.21 Analysis of bacterial invasion in control and SNX1-suppressed cells 
(A) Bacterial colonies retrieved from c. f. u. assays in SNX1-suppressed cells (see para. 5.3.8) after 
an infection pulse for 15 min and 45-minute incubation (in gentamicin-supplemented medium) 
were normalized to control siRNA-treated cells (mean from n=3 experiments, in triplicates with 
replicative plating, error: minimal and maximal deviation from mean). (B) Box and Whiskers-plot 
to analyse replication in control versus SNX1-suppressed cells. Replication Index was determined 
by dividing number of colonies obtained after 1 hour by numbers obtained after 12 hours 
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To analyse internalization at single 
cell level, bacteria were differentially 
immuno-labelled. Adhered and total 
(adhered + invaded) was 
determined, and invaded bacteria 
were calculated as A(total-adhered); 
a representative data set for n= 55 
cells is shown (total of n=3 
yielding same trend). 
Figure 5.22 Analysing number of successfully invaded bacteria. 
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5.7. Discussion 
It is well established that S. Tjphimut um can influence the endocytic uptake and endosomal 
system of host cells in very sophisticated ways to generate a unique vacuolar compartment 
in which it resides and eventually replicates. The list of endosomal proteins targeted to 
these Salmonella-containing vacuoles is still growing and this shows how seamlessly the 
SCVs `blend in' with the endosomal system. In many cases, the functional significance of 
these interactions for SCV biogenesis is unclear. 
This study suggests that SNX1 is critically involved in remodelling early Salmonella- 
containing vacuoles and empty macropinosomes. While previously interactions of the SCV 
with the endosomal/lysosomal system have been thought of as selective or limited, this 
work also proffers the idea that recruitment of appropriate sorting machinery could allow 
for removal of cellular proteins from the SCV. More specifically, the CI-MPR and other 
receptors could be effectively removed in the process, and hence not be readily detected. 
These data fit in with the recent finding that Salmonellae extensively interact with 
compartments delivering late endosome- and lysosome-content (Drecktrah et al., 2007). 
Several lines of evidence suggest that SNX1 is involved in the remodelling, and hence 
possibly the maturation process - of SCVs: SNX1 affects the SCV morphology, influences 
intracellular SCV progress, and stalls replication. How is this mechanistically achieved? 
Besides the points discussed, one model can be deduced from a recent study investigating 
the role of sorting nexins in macropinocytosis (Kerr et al., 2006). This study investigated 
SNX5 recruitment to nascent macropinosomes upon EGF stimulation, observing similar 
tubulation effects. This tubulation was not only microtubule-dependent but moreover, 
critically depended on the presence of SNX1, as tubulation was abolished in cells lacking 
SNX1. This interconnectivity becomes more comprehensible when taking into account 
that SNX1 and SNX5 do physically interact (Kerr et al., 2006; Wassmer et al., 2007), and 
that protein stability of SNX1 is critically dependent on the presence of SNX5 (Wassmer 
et al., 2007). Intriguingly, besides PtdIns3P, the PX domain of SNX5 additionally binds to 
PtdIns(3,4)P2 (Merino-Trigo et al., 2004), a phosphoinositide that is found at the cytosolic 
face of the plasma membrane (Gray et al., 1999; Oatey et al., 1999), that can be derived 
from Ptdlns(3,4,5)P2, a potential substrate of SigD (Marcus et al., 2001). Indeed, an Akt- 
PH reporter construct has been shown to localize to membrane ruffles (Steele-Mortimer et 
al., 2000) but not membrane invaginations (Terebiznik et al., 2002). Corollary, SNX5 is 
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recruited to Salmonella-induced vacuoles and could therefore act as a bridging molecule 
recruiting SNX1 to the plasma membrane. Nevertheless, it is interesting to note that unlike 
SNX5, SNX1 is not recruited to the plasma membrane upon stimulation with EGF 
(Cozier et al., 2002; Merino-Trigo et al., 2004) but found on sealed macropinosomes (Kerr 
et al., 2006). Further still, although serum starved cells shows membrane ruffling upon 
EGF treatment, they fail to recruit a 2xFYVE (Pattni et al., 2001). Thus, these results 
highlight that the extent of local PtdIns3P enrichment at the plasma membrane is specific 
to the infection process and allow for a model in which recruitment of SNX1 occurs 
independently of SNX5. 
The PPIn-binding specificity might also be important in the sense that through the ability 
of SNX1 to ligate PtdIns(3,5)P2 (Carlton et al., 2004), it might be implicated in the 
maturation, as this PPIn has extensively been associated with endosomal maturation 
processes (Michell et al., 2006). In the `cell context', Ptdlns(3,5)P2 can be generated by 
direct phosphorylation of Ptdlns3P through the 5'-phoshoinositide kinase PlKfyve, which 
is indeed recruited to nascent macropinosomes/SCVs (data not shown). Interestingly, the 
lack of PlKfyve has been associated with dramatically enlarged vacuoles in numerous 
organisms (Shisheva, 2001; Efe et al., 2005; Nicot et al., 2006; Rusten et al., 2006; 
Rutherford et al., 2006), suggesting an important role of PlKfyve, and Ptdlns(3,5)P2 
(Michell et al., 2006), in vacuolar size regulation and membrane homeostasis. SNX1 in turn 
appears to (directly or indirectly) reduce the macropinosome's size. 
Why would size reduction be important for optimal infection? In macrophages, it has long 
been known that phagosomes gradually contract en route to the perinuclear area (Racoosin 
and Swanson, 1993). Regarding S. Typhimurium infection however, the maintenance of 
spacious vacuoles appears to play an important role for optimal virulence in macrophages 
(Alpuche-Aranda et al., 1994). Accordingly, bacterial mutants defective in generating or 
maintaining large SCVs are attenuated in replication and survival (Alpuche-Aranda et al., 
1994; Hernandez et al., 2004). The data presented here indicates that size reduction might 
nonetheless be a necessary process for optimal multiplication. Suppression of SNX1 
results in persistence of actin-positive vacuoles and in stagnating numbers of bacteria in 
the first 6 hours after infection. There appear to be several possible ways in which size 
regulation could affect the invasion and infection process. Firstly, one would assume that 
the larger size might physically hamper intracellular centrifugal transport (Luby-Phelps, 
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2000). Positioning of SCVs close to the TGN and tethering to this organelle is however 
critical for bacterial replication (Beuzon et al., 2000; Salcedo and Holden, 2003; Abrahams 
et al., 2006; Deiwick et al., 2006). Centripetal progress and juxtanuclear positioning might 
also be important to avoid back-fusion with the plasma membrane. Naturally, the rapid 
conversion of the nascent SCV from plasma membrane-derived components to 
endosomal identity would allow for swift integration into the intracellular machinery. 
Furthers still, intracellular progress and maturation is associated with acidification of the 
SCV. Although acidification of SCVs is thought to be actively delayed Salmonella, it is 
nevertheless believed to be a key stimulus to activate TTSS2 activity (Coombes et al., 
2004). 
Mechanistically, SNX1 appears to be a good candidate protein to aid size reduction of 
SCVs, as it possesses a BAR domain, a domain that has been implicated in membrane 
tubulation (Peter et al., 2004; Zimmerberg and McLaughlin, 2004). In vitro studies have 
shown that the SNX1-BAR domain is capable to induce, or stabilize, tabulation of 
liposomes in a concentration-dependent fashion (Carlton et al., 2004). Thus, the data 
presented here on overexpressed as well as endogenous protein is in line with a model in 
which SNX1 participates in SCV tabulation and hence, in membrane removal from the 
vacuole body. It is however to be noted that compared to other BAR domains, the 
tubulation capacity of the SNX1-BAR domain (as determined in in vitro studies) is only 
poorly developed. In these in vivo studies however, I observed highly dynamic tabulation 
events, which makes it likely that additional, unidentified components are crucially 
involved in this process. The role of microtubules and microtubule-dependent motors at 
early stages of SCV biogenesis has however only been poorly studied. 
A note on tubules on SCVs: microtubule-dependent tubules emerging from SCVs have 
been described before. These structures termed Salmonella-induced filaments (Sifs) are 
dependent on the balanced interplay both, kinesins and dynein/dynactin (Guignot et al., 
2004). Sifs are rather stable structures and depend on expression of the (late) bacterial SPI- 
2 effector SifA (Stein et al., 1996). Although the function of Sifs is not entirely dear, they 
appear to play a role replication and probably SCV `dilation' [reviewed in (Guignot et al., 
2004; Henry et al., 2006)]. Mechanistically, bacteria that lack SifA fail to recruit the SifA 
kinesin interacting protein (SKIP) to SCVs, a host cell kinesin inhibitor, which prevents 
acquisition of kinesin mediating centrifugal transport (Boucrot et al., 2005). At the same 
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time, Rab7-interacting lysosomal protein (RILP) recruits minus-end dynein-dynactin motor 
complexes to SCVs (Marsman et al., 2004). So SifA might also be required to uncouple 
RILP/dynein from Rab7 (Harrison et al., 2004). 
So in this context, SNXI-decorated tubules have rather opposed characteristics: they are 
`fragile' and very transient; rather than leading to dilation of the SCV, these tubules 
coincide with size reduction, rather than preventing centripetal transport, they appear to 
facilitate centripetal SCV transport. The role of an bacterial effector in promoting SNXl- 
tubules is probably more indirect, as these tubules also arise in the normal context, but 
SigD is certainly involved in the sense that it provides an appropriate `recruitment cue'. 
Assuming that SCV maturation occurred similarly to endosome maturation, fusion but 
also fission, with concurrent removal of membrane and cargo are characteristics of the 
process. These findings may be interpreted in the light of the model proposed be Zerial 
and colleagues (Rink et al., 2005), and may propose a more general model for endosomal 
maturation: individual early endosomes are proposed to form a `network in time', and 
through repeated fusion and fission events, these structures are continually regenerated 
and renewed in the cell periphery. Enrichment of degradative cargo is achieved through 
repetitive fusion events in progressively fewer and larger endosomes, which are rapidly 
removed from the early-endosomal network in the cell centre. This maturation is 
characterized by the loss of Rab5 and the concomitant acquisition of Rab7 - while 
interestingly, SNXI tubulation appears to occur concomitantly with this conversion step 
(Kerr et al., 2006). Hence, under SNX1-suppressed conditions, like the case with PlKfyve 
suppression, the reduction in retrograde fission 
from the early endosome would thereby 
result in a progressive swelling of endosomal structures. Given the data presented here 
that SNX1 recruitment coincides with size reduction of large vacuoles in a concentration- 
dependent manner, while enlargement of vacuoles correlates with PlKfyve suppression 
levels, it is tantalizing to speculate Ptdlns(3,5)P2 might the direct key for membrane 
removal `out' of the vacuole. 
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As the data contained within each chapter of this thesis has been discussed ibidem, the 
following paragraphs are aimed at putting the conclusions reached into the wider context 
of endosomal trafficking and will provide an outlook on potential further research. 
Since the identification of SNX1 in 1996 (Kurten et al., 1996), huge progress has been 
made in recent years uncovering the roles of mammalian sorting nexins in endosomal 
sorting processes; specifically, the evidence that SNXs have important roles in cargo 
retrieval rather than pro-degradative transport is increasing - for SNX1 (see this thesis; 
Carlton et al., 2004; Rojas et al., 2007), as well as for SNX4 (Traer et al. 2007) 3' and as 
recently shown for SNX5 and SNX6 (Wassmer et al., 2006). In its regard, SNX1 plays an 
evolutionary conserved role as part of the retromer retrieval complex, and like its yeast 
counterpart, it also appears that the mammalian retromer complex functions to sort 
multiple cargos. 
One of the interesting remaining questions is how this retrieval is mechanistically achieved. 
Our findings strongly suggest that SNX1 is crucially involved in the generation of retrieval 
transport carriers. While the endosomal tubules appear `pre-formed' independently of 
SNX1 (compare EM studies), the scission step appears to require SNX1 - so how is this 
achieved? Coincidental evidence for a role of dynamin in the fission step comes from 
studies showing that efficient STxB- (Lauvrak et al., 2004) as well as CI-MPR- (Nicoziani 
et al., 2000) retrograde transport require this large GTPase. Whether SNXI can directly 
bind to dynamin is not known. It is however intriguing that numerous studies have linked 
SNX-BAR proteins to other N- or F-BAR proteins, and thus indirectly to dynamin. F- 
BAR proteins are cytosolic proteins that tubulate and deform membranes, probably by 
inducing membrane curvature (Dawson et al., 2006). Interestingly, expression of F-BAR 
proteins leads to membrane tubulation but when co-expressed with dynamin, tubules are 
vesiculated, presumably courtesy to the pinchase activity of dynamin. So far, all F-BAR 
proteins have been linked to plasma membrane events and actin dynamics (Itoh et al., 
2005). Regarding the relation of SNXs and other BAR proteins, the BAR protein SNX2 is 
an interaction partner for the F-BAR protein forming-binding protein 17, FBP17 (Fuchs et 
31 31 C . J. 
Traer, A. C. Rutherford, K . J. Palmer, 
T. Wassmer, J. Oakley, N. Attar, J. G. Carlton, 
J. Kremerskothen, D. J. Stephens, and P . J. 
Cullen (2007) Sorting nexin-4 co-ordinates endosomal sorting of 
transferrin receptor with dynein-mediated transport into the endocytic recycling compartment. Nat Cell Biol 
(under revision) 
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al., 2001), which in turn can bind to dynamin 1-3 (Kamioka et al., 2004). The BAR 
protein SNX4, which localises to early and recycling endosomes, can heterodimerize with 
amphiphysin 2 (Leprince et al., 2003); amphiphysin in turn can directly bind to dynamin 
(David et al., 1996; Takei et al., 1999). SNX9 has been shown to directly bind to dynamin 1 
and dynamin 2 via its N-terminal SH3 domain (Soulet et al., 2005); it might further be 
classified `inverse F-BAR' protein, given its N-terminal SH3 and C-terminal BAR domain 
and its recently identified inducible binding to WASp (Badour et al., 2007). Recruitment of 
dynamin may ultimately be required for vesicles fission, and given the PtdIns3P-binding 
capacities and subcellular localization of SNX2 and SNX4, this might even occur from 
endosomes. 
Another aspect that has only poorly been studied is, in a sense, the PX domain of sorting 
nexins: while most studies have concentrated on the phosphoinositide-binding abilities of 
this domain, it is not to forget that it also contains a PxxP motif that, at least potentially, 
may serve as binding site for SH3 domains. This has been described for p47l h°=, which 
intramolecularly, interacts with its C-terminal SH3 domain, hence providing an regulatory 
mechanism for membrane association (Karathanassis et al., 2002). Likewise, a recent 
genome-wide two-hybrid screen and in vitro binding approach has generated a protein- 
protein interaction map of yeast PX domains (Vollert and Uetz, 2004), showing that this 
motif indeed serves as protein-binding module. A precedent for SNXs, is the recent 
finding that SNX9 uses its PX domain to interact with the P13-kinase regulatory subunit 
p85 as well as its product, Ptdlns(3,4,5)P3 (Badour et al., 2007). This raises the distinct 
possibility that membrane association of sorting nexins might be regulated by 
phosphorylation status or accessory proteins binding to its PX domain. 
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Figure 6.1 Overview over results presented in this thesis 
SNXI is a peripheral membrane protein that (through coincidence detection by means of its PX domain and 
BAR domain) is targeted to PtdIns3P-/PtdIns(3,5)Pz-enriched, highly curved membranes of sorting 
endosomes. From here, it regulates endosome-to-TGN retrieval of a variety of cargo, probably as part of a 
pentameric sorting complex, termed the retromer (consisting of the cargo-selective VPS complex, and a 
sorting nexin `coat' complex). Owing to its BAR domain it is thought to stabilize membrane curvature, and it 
appears that SNX1 is critically involved in formation of the endosome-to-TGN transport carriers (F. TCs). 
Its role in regulating membrane transport and fission processes is also illustrated by the ability of SNXI to 
remodel SCVs and macropinosomes (Salmonellae shown as light-yellow ovals). It appears that upon infection, 
SNXI is directly recruited to the plasma membrane, probably owed to the ability of Salmonella effector 
proteins to subvert plasma membrane PPIn to 3-phosphoinositides. Generally speaking, SNXI promotes 
centripetal membrane and protein transport processes. 
Abbreviations: SCE' = Salmonella-containing vacuole (SCE'); SE (EE) = sorting endosome (part of the early 
endosome); LE = late endosome; ETC = endosome-to-TGN transport carrier; MfTOC = microtubule- 
organizing centre. 
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Overall conclusion: 
Over the past decade, especially with the technical progress in the field of RNAi 
technology and live cell imaging, advance in the field of endosomal sorting has been made 
at rapid pace. The development of multi-coloured fluorescent `protein-tags' with unique 
properties [see (Lukyanov et al., 2005; Giepmans et al., 2006) for review] and the 
availability fluorescently-tagged cargo have proven extremely useful to visualize and 
analyse events as dynamic as intracellular sorting. At the same time, the possibility to 
downmodulate specific proteins in eukaryotic cells using siRNA has provided a cost- 
effective and relatively fast means (as opposed to genetic knock out models) to analyse 
proteins function at endogenous levels. Taken together with ultrastructural analyses at EM 
level, structural insights, biochemical and genetic studies, an arsenal of complementary 
techniques is at hand to dissect endosomal sorting, even at the level of single molecules. 
Analysis of SNX1 over the past ten years provides a prime example of how these 
techniques have been put to good use to dissect its function, but have also reminded us of 
the pitfalls inherently associated with invasive experimental procedures: such as data 
obtained under chronic overexpression (given the later discovery that SNX1 stabilizes 
membrane curvature in a concentration-dependent fashion), regarding results of lipid- 
protein overlay-assays to analyse PPIn-binding (given the notion that the PX domain 
potentially inserts residues into the bilayer). The use of siRNA has made it possible to 
analyse the role of endogenous SNXI in retrograde transport of receptors and toxins, but 
as much as overexpression may have obscured SNX1 function, sole reliance on siRNA 
may equally distort the picture: the time frame necessary for siRNA treatment to be 
effective may result in upregulatory mechanisms or may cause alterations in cargo and 
membrane flux. The (nominally) same technique already produced divergent results 
(Carlton et al., 2004; Carlton et al., 2005b; Rojas et al., 2007). Through synergistic use of 
techniques, with a growing understanding of the nature and function of the protein and its 
context, we will be able to refine the methodologies and further define protein function. 
Nonetheless, it must be borne in mind that given the inherent properties of networks, it 
will be somewhat impossible to define a unique functional role. - so it might therefore be 
more worthwhile to look at the `concepts' that have already emerged from analysing 
sorting nexins (take PX-BAR coincidence detection) to extrapolate and further predict 
functional relations. 
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